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ABSTRACT OF THE DISSERTATION

Biomarkers of Bone Turnover in Vegetarians and Omnivores

by
Susan Kim Louie Lue
Doctor of Public Health in Nutrition
Loma Linda University, Loma Linda, California, 2002
Patricia K. Johnston, Chair

A cross-sectional study on fasting serum and 24-hour urine samples were used to
determine whether biochemical markers of bone turnover, resorption and formation,
differed in a group of 50 healthy premenopausal Caucasian women eating vegan,
lactoovovegetarian(LOV) and omnivorous diets.
The women, ages 20-42, had participated in a study of bone mineral
density(BMD). The three groups were comparable in mean age, BMI, calorie intake,
calories spent in exercise, kcal/kg body weight, protein/day, protein/kg body weight and
urinary creatinine.
Biomarkers included those of bone resorption—pyridinoline, deoxypyridinoline,
and N-telopeptides, and of bone turnover—serum and urinary osteocalcin(OC), skeletal
alkaline phosphatase, and propeptide-type-I-carboxyterminal-procollagen(PICP). In all
subjects, biomarker levels were significantly lower in women ages 27-33yr compared to

m

women 20-26yr and 34-38yr. Selected resorption and turnover biomarkers were
significantly and negatively correlated with BMD, and with Ca:Protein and Ca:P ratios.
Findings suggest women with both higher resorption and higher turnover rates are more
likely to have lower BMD of the spine and lower calcium intake in relationship to protein
and phosphorus, but not to calcium alone. Higher resorption and turnover were seen
where these ratios were lower, as in vegans.
A consistent trend was observed with vegans having the highest levels of bone
resorption and bone turnover markers while consuming the lowest Ca:Protein and Ca:P
ratios. Serum osteocalcin, a marker of bone turnover in adults, was significantly higher in
vegans than in LOVs. BMD, Ca:Protein, and Ca:P were significantly lower in vegans
than in LOVs. Higher bone turnover and an inadequate diet is consistent with the
significantly lower BMD found in vegans.
Increased biomarkers of turnover and resorption may be early predictors of future
osteopenia, especially in premenopausal women with low Ca:Protein and low Ca:P ratios.
This study found vegans were at risk, possibly because they consumed a diet very low in
calcium, particularly in relationship to protein and phosphorus. Such a diet may have
resulted in the significantly higher turnover rates found in the vegans as well as the
significantly lower BMD. A vegetarian diet that contains recommended levels of calcium
may help to achieve peak skeletal mass at maturity and provide a more stable bone mass
during menopause.

iv

TABLE OF CONTENTS

List of Tables

xi

List of Figures.......

xm

Acknowledgements

xiv

CHAPTER 1 - INTRODUCTION

1

A.

Introduction

1

B.

Statement of the Problem

2

C.

Purpose of the Study...............

4

D.

Importance to Public Health....

6

E.

Research Questions.................

7

F.

Theoretical Basis for the Study

8

CHAPTER 2 - REVIEW OF THE LITERATURE

15

A.

Osteoporosis

15

B.

The Physiology of Bone

15

C.

Factors that Affect Bone Remodeling.......

18

D.

Risk Factors for Osteoporosis....................

21

1.

Age, Gender, and Ethnicity............

21

2.

Reproductive History and Estrogen

27

3.

Body Build and Body Mass Index

30

4.

Physical Exercise................................................................

33

5.

Cigarette Smoking, Medications, and Medical Conditions

35

a.

Smoking

35

b.

Certain Medications and Medical Conditions

36

v

6.

Dietary Factors.....................................................

37

a.

Dietary Calcium.......................................

37

b.

Calcium Supplementation and Bone Loss

41

c.

Calcium Intake and Peak Bone Mass

42

d.

Calcium and Bone Metabolism

43

e.

Calcium Intake in Vegetarians...........................

44

f.

Dietary Protein...................................................

47

g-

Animal Versus Vegetable Proteins....................

50

h.

Dietary Protein in Vegetarian Diets...................

51

i.

Dietary Protein and Bone Health in Vegetarians

52

J-

Calcium-to-Protein Ratio....................................

54

k.

Calcium-to-Phosphorus Ratio

55

1.

Vitamin D

56

m.

Fluoride

58

n.

Caffeine

58

o.

Alcohol

60

P-

Sodium

60

q-

Calcium-to-Sodium Ratio

61

E.

Vegetarian Diet and Bone Mineral Density.

63

F.

Assessment of Bone Metabolism

69

1.

Biochemistry.................................................................

70

Specificity and Sensitivity of Biomarkers to Changes in BMD

72

1.

73

G.

Criteria for Biomarkers of Bone Turnover...................

vi

H.

Biomarkers of Bone Formation

76

1.

Osteocalcin (sOC, uOC)

76

2.

Skeletal Alkaline Phosphatase (sALP)...................

78

3.

Procollagen Type I C- and N-terminal Propeptides
(PICP, NPCP)..........................................................

79

Parathyroid Hormone (PTH).............................

80

Biomarkers of Bone Resorption.....................................

81

1.

Hydroxyproline.................................

81

2.

Pyridinoline Crosslinks—Pyridinoline (Pyr) and
Deoxypyridinoline (Dpy)..................................

81

N-Telopeptide Crosslinks (NTx).......................

83

Urinary Markers of Calcium Loss................................

85

1.

Urinary Calcium.................................................

85

2.

Urinary Sodium...............................

86

3.

Urinary Creatinine...........................

89

4.

I.

3.

J.

CHAPTER 3 - METHODS

90

A.

Research Design..................................

90

B.

Research Hypotheses...........................

91

C.

Study Participants................................

92

1. Operating Definitions.....................

93

a. Vegans............................ .

93

b. Lactoovovegetarians (LOV)

93

c. Omnivores..........................

93

vn

D.

Study Protocol

93

E.

Consent and Data Collection

94

1.

Dietary Intake.........................

94

2.

Health History Questionnaires

95

3.

Blood

95

4.

Urine

95

5.

Creatinine

96

6.

Serum Osteocalcin (sOC).... ..................................................

97

7.

Urinary Osteocalcin (uOC)...................................................

98

8.

Skeletal Alkaline Phosphatase (sALP).................................

98

9.

Procollagen Type I Carboxyterminal Propeptide (PICP).....

99

10.

Urinary Crosslinked N-terminal Telopeptides of Type I
Collagen (NTx)......................................................................

100

11.

Pyridinoline (Pyr) and Deoxypyridinoline (Dpy) Crosslinks

101

12.

Urinary Calcium (uCa).........................................................

102

13.

Urinary Sodium (uNa)...........................................................

103

14.

Quantitative Computed Tomography (QCT) Bone Scan..... .

104

Data Analysis ...................................................................................

104

F.

CHAPTER 4 - RESULTS
A.

B.

106

Subject Characteristics

106

1.

Age

106

2.

Height, Weight, and Body Mass Index (BMI)

106

3.

Bone Mineral Density

108

Dietary Patterns.....................

108

vm

C.

D.

E.

Nutrient Intake.

110

1.

Calorie and Protein Intakes

110

2.

Calcium and Phosphorus Intakes

112

3.

Nutrient Ratios

112

Biomarkers of Bone Turnover

113

1.

Bone Resorption

113

2.

Bone Formation and Bone Turnover

116

3.

Mean of Biomarkers for Diet Groups as Percent of the Mean
of All Subjects........................................................................

118

4.

Biomarkers by Quartiles of BMD..........................................

121

5.

BMD Differences by Quartiles of Biomarkers......................

121

6.

Biomarkers by Quartiles of Age.............................................

126

Correlations of Bone Biomarkers......................................................

128

1.

Inter-Correlation of Biomarkers

128

2.

Correlation of Biomarkers with BMD

132

3.

Correlation of Biomarkers with Dietary Ratios

132

CHAPTERS - DISCUSSION

135

A.

Subject Similarities and Differences

137

B.

Biomarkers and Age........................

138

C.

Biomarkers by Diet Groups.............

139

D.

Biomarkers and BMD

143

E.

Biomarkers and Dietary Characteristics

145

1.

Caloric and Protein Intakes

145

2.

Calcium Intake

146
ix

F.

3.

Ca:Protein Ratio

147

4.

Ca:P Ratio

148

Limitations

149

1.

Post Hoc Power Analysis

149

2.

Healthy Subject Bias......

150

3.

Cross-Sectional Studies

151

4.

Diet, Weight, Exercise, and Menstrual History.

151

5.

Vitamin D, PTH, and Growth Hormone..........

152

6.

Lean Body Mass

152

CHAPTER 6 - SUMMARY AND CONCLUSIONS
A.

B.

154

Vegetarianism and Bone Health......................................................

154

1.

Prevalence and Types of Vegetarianism..............................

154

2.

Concerns of the Vegetarian Diet Related to Bone Status....

154

Biomarkers, BMD, and Diet Among Premenopausal Vegan, LOV,
and Omnivore Women.....................................................................

155

1.

In All 50 Subjects

156

2.

In Vegans, LOVs, and Omnivores

157

160

REFERENCES

x

LIST OF TABLES
Table 1:

Major Factors Known to Affect Bone Remodeling....................

19

Table 2:

Incidence Rates of Hip Fractures by Region, Ethnicity, Gender,
Protein and Calcium....................................................................

25

Table 3:

The Vegetarian Diet and Bone Mineral Density

67

Table 4:

Criteria for Ideal Markers of Bone Turnover

74

Table 5:

Age, Anthropometric Measurements, and Bone Mineral Density
(Mean, SEM).....................................................................................

107

Summary of the Number of Years Subjects Consumed Vegan and
Vegetarian Diets.................................................................................

109

Table 7:

Dietary Characteristics (Mean/Day, SD)...........................................

111

Table 8:

Urinary Creatinine (Mean, SD).........................................................

114

Table 9:

Urinary Biomarkers of Bone Resorption (Mean, SD).......................

115

Table 10:

Serum and Urinary Biomarkers of Bone Formation (Mean, SD).....

117

Table 11:

Biomarkers of Resorption in Subjects in the Top and Bottom
Quartiles of BMD (Mean, SD)..........................................................

122

Biomarkers of Formation in Subjects in the Top and Bottom
Quartiles of BMD (Mean, SD)..........................................................

123

BMD in Subjects in the Top and Bottom Quartiles of Resorption
Biomarkers (Mean, SD).....................................................................

124

BMD in Subjects in the Top and Bottom Quartiles of Formation
Biomarkers (Mean, SD).....................................................................

125

Table 15:

Biomarkers in Subjects by Quartiles of Age (Mean, SD).................

127

Table 16:

Correlations Between Biomarkers of Bone Formation in the Entire
Study Population................................................................................

129

Correlations Between Biomarkers of Bone Resorption in the Entire
Study Population...............................................................................

130

Correlations Between Biomarkers of Bone Resorption and Bone
Formation...........................................................................................

131

Table 6:

Table 12:
Table 13:
Table 14:

Table 17:
Table 18:

xi

Table 19:
Table 20:

Significant Correlations Between Selected Bone Biomarkers
and BMD............................................... .................................

133

Significant Correlations Between Bone Biomarkers and Dietary
Calcium.........................................................................................

134

xn

LIST OF FIGURES
Figure 1.

Interrelationship Between Diet, Susceptibility Factors, Biomarkers
and Bone Health...............................................................................

14

Figure 2.

Research Design

90

Figure 3.

Mean + SEM of Resorption Biomarkers by Diet Group Compared
to the Mean of All Subjects.............................................................

119

Mean + SEM of Turnover and Formation Biomarkers by Diet
Group Compared to the Mean of All Subjects........................

120

Figure 4.

xm

ACKNOWLEDGEMENTS

The research reported in this dissertation could not have been accomplished
without the support and assistance of many people. I would like to extend my
appreciation to my committee members, Drs. Patricia Johnston, Ella Haddad, and
Suzanne Montgomery, for their guidance in the refinement of my dissertation. I am
especially grateful to Dr. David Baylink, Director of the VA’s Mineral Metabolism Labs
for allowing me to train in his labs, and Dr. Apurva Srivastava, Director of the Assay
Development Lab, who patiently taught me so much about bone biomarker assays and the
interpretation of data.
I thank Janett Yano and her family, the parents, Kim Tan and Chin Louie and
Betty Lue, my extended family, and the Home Prayer Meeting group who have helped to
make graduate school possible. I owe my deepest gratitude to my family, especially to
my husband, Larry, who gave me the confidence and constant encouragement to pursue
this academic degree. Finally, my special thanks to Charissa, Gregory, Noreen and Kara
who have adapted to the years of erratic schedules and lost evenings and without whose
love and humor I would not have been able to overcome the obstacles of this dissertation.

xiv

CHAPTER 1
INTRODUCTION

A. Introduction
Predominantly plant-based or vegetarian diets are now widely promoted as
protective against the chronic degenerative diseases of hypertension, specific cancers and
coronary heart disease (Beilin, 1994; Fonnebo, 1994; Fraser, 1994). However, no diet is
singularly better if nutrients, known and yet unknown, are not provided in adequate and
balanced proportions. For example, there are concerns that vegans, consuming one of the
most restrictive variants of the vegetarian diet, noted for its absence of all animal foods
including dairy and eggs, may have an increased risk for negative calcium balance,
leading to osteopenia or bone loss. Few studies have been conducted on the effect of the
vegan diet on bone metabolism and on the rates of bone formation and resorption.
The impact of diet on body structure is rarely altered in a matter of days, but
rather in months, years, or decades. Function, on the other hand, can be impacted in a
matter of days or weeks with nutrient loading or nutrient withdrawal. Effects, however,
may not be sustained despite maintenance of a nutrient load, due to threshold effects and
homeostatic balance. A dietary deficiency will ultimately deplete stores, negatively affect
balance, alter function and potentially affect structure. To monitor this process the
discriminant use of selected biologic or biochemical markers can be “cost-effective early
signals or surrogate predictors of the true significance of dietary change” (Milner, 1999).
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Biomarkers can indicate the presence and magnitude of a physiologic response to an
intake or exposure, often prior to clinical symptoms. Ideally, biomarkers should be
validated, universally accepted for their predictability, and valuable for conferring a long
lead time relative to the onset of disease.
The advancement of technology in recent years led to the development of very
specific and sensitive markers. In the area of bone research, traditional but less specific
markers such as hydroxyproline and total alkaline phosphatase have been rapidly
replaced by highly discriminating biomarkers of bone turnover such as bone-specific
alkaline phosphatase and pyridinoline crosslinks of type I collagen. Armed with these
new biomarkers, it is possible to address the concerns regarding the bone health status of
vegans, compared to dairy-consuming vegetarians and free-living omnivores.

B. Statement of the Problem
Osteoporosis, the bone thinning disease most often seen in people 45 years and
older, is estimated to cause 1.5 million new fractures annually in the United States with
an estimated annual cost in 1995 of $13.8 billion dollars, of which $10.3 billion (75%)
was for the treatment of white women. One-fourth of women over 65 years of age will
have one or more vertebral fractures and as women survive into their eighties and onethird will experience hip fractures (Melton, 1997). The prevalence of osteoporosis may
double by the year 2020 in the United States, affecting as many as 25 million Americans
at that time. This disease will be the major cause of skeletal fractures in the elderly,
contributing to approximately 90% of the hip fractures occurring in women over 65 years
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old. By 2020, the impact on the American health care system could exceed an annual
cost of $60 billion (Craig, 1996). Along with the enormous cost of medical and
supportive care is considerable disability, loss of livelihood and premature death. The
magnitude of the problem has policymakers, health practitioners, and researchers seeking
new treatments and avenues of prevention. Osteoporosis looms as a major public health
problem and efforts have been made to identify not only persons with confirmed disease
fractures but also to identify persons at risk. Of concern is the disproportionate number of
postmenopausal Caucasian females who experience osteoporosis, associated fractures,
and complications.
Studies suggest that the most rapid bone growth occurs in the early-mid
adolescent years with peak bone mass reached in the twenty's, and that bone loss occurs
slowly in adult women during the premenopausal years (Cohn, Aloia, Vaswani, Znzi,
Varetsky, & Ellis, 1981; Nordin, Need, & Chatterton, 1990; Nilas, Gotfredsen, Hadberg,
& Christiansen, 1988; Riggs, Wahner, Melton, Richelson, Judd, & Offord, 1986; Aloia,
Cohn, Vaswani, Yeh, Yuen, & Ellis, 1985). Ninety to 95% of bone mass is attained by
the end of longitudinal growth (approximately 18 years of age) but an additional 5-10%
of bone mass can be accrued after maximum height has been achieved (Recker, Davies,
Hinders, Heaney, Stegman, & Kimmel, 1992). Higher peak bone mineral density (BMD)
is suggested to be protective against the postmenopausal loss of bone and the risk of
osteoporosis. Lifetime calcium intake was found to be a factor in enhancing peak adult
skeletal mass (Metz, Anderson, & Gallagher, 1993; Halioua & Anderson, 1989). Thus, it
is important that adequate nutrients, particularly calcium, the principal mineral in bone,
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be consumed early in life. In western societies dairy is the major source of calcium in the
diet. Therefore, a vegan diet, containing no dairy or animal products, poses concern over
a possible low calcium intake in women. Because increasing numbers of adolescents and
young adults are adopting vegan diets it is important to assess their nutrient adequacy and
their effect on bone status. As bone gain continues until about age 30 with loss occurring
thereafter, a vegan diet consumed for an extended length of time during the teen and early
adult years is a concern.

C. Purpose of the Study
The purpose of this study is to use biochemical measures to evaluate bone
turnover, the balance between bone formation and bone resorption, in healthy
premenopausal Caucasian women consuming vegan, lactoovovegetarian and omnivorous
diets. Knowledge of bone turnover may help our understanding of the potential impact of
varying dietary practices on long term bone status. Young healthy Caucasian women
have a high risk for osteoporosis in later years and a pattern of low calcium intake may
negatively affect calcium balance and result in lower peak bone mass with greater risk for
osteoporosis after menopause and its attendant bone loss. Vegan diets, without milk or
dairy products, may be likely to be low in dietary calcium. Several studies have
supported the positive association of dietary calcium, milk, and calcium supplementation
during adolescence and its relationship to bone mineral density of the hip, forearm, and
spine in young premenopausal women (Welten, Kemper, Post, & van Staveren, 1995;
Nieves, Golden, Siris, Kelsey, & Lindsay, 1995; Recker, et al., 1992; Fehily, Coles,
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Evans, & Elwood, 1992). Studies have strongly correlated biomarkers of bone turnover
with calcium retention, depletion and repletion, and have generally found that biomarkers
predicted calcium retention better than did anthropometric measurements (Weaver,
Peacock, Martin, Plawecki, & McCabe, 1996; Akesson, Lau, Johnston, Imperio, &
Baylink, 1998).
Bone turnover is a process of bone resorption and bone formation. When the rate
of resorption is greater than formation, bone loss occurs. It was the consensus at a recent
symposium that the priority of bone research is to find ways to lower the turnover or
remodeling rate (Dawson-Hughes, 2000; Heaney, 2000c). The early age at which
fracture rates increase even with small decreases in bone mineral density is alarming
(Dawson-Hughes, 2000; Heaney, 2000c). Newly identified biochemical markers of bone
metabolism have been found to be useful indices for monitoring physiological changes in
bone before substantial changes result in bone frailty and fracture (Taylor, Lueken,
Libanati, & Baylink, 1994). Osteocalcin levels are elevated in both serum and urine
(sOC and uOC) when bone activities are increased as occurs with increased turnover
(Taylor, Linkhart, Mohan, Christenson, Singer, & Baylink, 1990).

Skeletal or bone-

specific alkaline phosphatase (sALP) is an enzyme whose activity is related to bone
formation. Urinary calcium has been one of the most widely used markers for measuring
bone resorption or breakdown until recently. Within the last few years numerous studies
have found improved specificity and sensitivity in determining bone resorption using
pyridinoline (PYR) and deoxypyridinoline (DPY) crosslinks as well as the N-terminal
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telopeptides of type I collagen (NTx), the predominant matrix protein released in bone
resorption. These biomarkers will be evaluated under different dietary patterns.

D. Importance to Public Health
With the advent of epidemiological studies that have linked major chronic
diseases to the westernized diet, there have been strong advocates for adopting a plantbased or vegetarian diet. Most notable have been medical doctors, such as Dr. Denis
Burkett, who pioneered the first scientific studies comparing high fiber diets of Africans
with low incidence of western diseases to the low fiber diets and high incidence of certain
diseases of Americans and Europeans. Industry, such as the Kellogg company, religious
groups, such as the Seventh-day Adventists, and research institutes, such as the American
Cancer Society have all promoted a plant-based diet for better health. The last century
and prominently in the last two decades, vegetarian diets have received a great deal of
support from the media. Many people are adopting these diets as adolescents or young
adults and maintaining them lifelong. There are many variations of vegetarian diets,
including the lactoovovegetarian diet and the vegan diet. The lactoovovegetarian (LOV)
diet contains milk, dairy and egg products with very little or no meat, poultry or fish in
the diet. This diet usually has a calcium content that is equal to or higher than
omnivorous diets (Marsh, Sanchez, Michelsen, Chaffee & Fagal, 1988; Ball & Maughan,
1997). The vegan diet contains no animal products, including no dairy foods. Data
suggest this diet may not be adequate in calcium (Lau, Kwok, Woo, & Ho, 1998; Chiu,
Lan, Yang, Wang, Yao, et al., 1997). Although no one gender or ethnic group solely
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consumes vegan diets, there is a greater public health concern when women consume
such diets low in calcium and particularly if they are Caucasian. Caucasian women,
compared to Black, Asian, and Hispanic women in the United States have the highest risk
for osteoporosis as they mature. Osteoporosis is costly, disabling, and potentially fatal.
If diet or lifestyle changes can modify or prevent disease risk, these need to be
investigated, reported, and the public educated.

E. Research Questions
The emerging new technologies have made it possible to identify subclinical,
even cellular changes before disease is manifested. High Pressure Liquid
Chromotographic (HPLC) methods have allowed researchers to separate and identify
intact and free peptides associated with bone formation and bone resorption, released
when bone is degraded. Radiation “tags” for specific substrates have made identifying
bone metabolites faster. Intact bone proteins, peptide by-products and even enzymes
involved in bone metabolism are all potential biochemical markers of bone metabolism.
Using some of these methods this study on biomarkers of bone metabolism sought
to answer the following research questions about healthy premenopausal Caucasian
women consuming omnivore, lactoovovegetarian, and vegan diets:
1) are there significant differences in the level of bone formation activity among
the three diet groups, and if so, which biomarkers of bone formation (serum
and urinary osteocalcin, skeletal alkaline phosphatase, procollagen type I Cterminal propeptide) are affected,
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)

2) are there significant differences in the level of bone resorption activity among
the three diet groups, and if so, which direct or indirect biomarkers of bone
resorption (N-terminal telopeptides, pyridinoline crosslinks, deoxypyridinoline
crosslinks, urinary calcium) are affected,
3) in the three diet groups do the bone formation and bone resorption biomarkers
correlate with the bone mineral density measured by QCT bone scans in these
same subjects (reported elsewhere by P. Johnston, 1997, 1999), and
4) in the three diet groups do the bone formation and bone resorption biomarkers
correlate with age, body mass index, years on vegetarian diet, urinary
creatinine, and various dietary factors (calories, protein, kcal/kg body wt,
protein/kg body wt, calcium, calciurmprotein ratio, phosphorus, Ca:P ratio,
etc.)

F. Theoretical Basis for the Study
To date, women appear to be at greater risk for osteoporosis than men, having an
average of 15% less bone mass and age-adjusted fracture rates 40% greater than men
(Craig, 1996; Melton, Crowson, & O’Fallon, 1999). Caucasian women in particular,
average 10% less bone mass when compared to African-American women, (Craig, 1996).
An especially dramatic increase in bone loss occurs in women after menopause and is
attributed to the age-related decline in estrogen levels. The risk factors for osteoporosis
include not only female gender, ethnicity, estrogen status, age, and family history, but
also the lack of weight-bearing exercise, an imbalance of dietary factors such as low
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calcium, high protein, high sodium intakes, and moderate to high use of alcohol, caffeine,
and tobacco.
Omnivorous diets in the United States contain generous amounts of protein, of
which more than half comes from animal sources, and of sodium (1987-8 Nationwide
Food Consumption Survey, Fleming & Heimbach, 1994). The oft cited Eskimo study by
Mazess and Mather (1974, 1975) suggested that higher meat diets with low calcium
intake could result in lower bone mineral density. For every gram of animal protein
consumed, the urinary loss of calcium increases 1 mg as the body excretes sulfates
abundantly found in S-containing amino acids of animal foods; legume and other plant
proteins contain lower levels of S-amino acids (McBean, Forgac, & Finn, 1994). Women
generally do not meet the recommended daily intakes for calcium because they do not
consume sufficient calcium rich foods such as milk, other dairy products, legumes, and
dark green vegetables. Without calcium supplements, the combination of low dietary
calcium, high dietary protein, and a high sodium intake may increase the risk of bone
loss. In load tests, sodium chloride can increase calcium excretion by as much as 30%
(Hesse, Siener, Heynck, & Jahnen, 1993). It is estimated that for every gram of sodium
ingested, the urinary loss of calcium increases 20-35 mg.
Lacto-vegetarians eat an occasional serving or no animal foods at all, with the
exception of dairy foods and eggs (lactoovovegetarians). Therefore, a lactovegetarian
diet can be higher in calcium and lower in S-amino acids than an omnivorous diet. Hunt,
Murphy, and Henderson (1988) reported 24-hour intakes of elderly females
(postmenopausal) living in California comparing the vegetarian and omnivorous diet.
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The study found no significant differences between the two groups of postmenopausal
women in daily intakes from the various food groups except for the meat/protein group.
As expected, the omnivores consumed significantly larger amounts of animal meats and
the vegetarians more beans and nuts. There were no significant differences in energy or
calcium intake or in their daily milk, fruit and vegetable or bread and cereal group intakes
(Hunt, et al., 1988). Shultz and Leklem (1983) compared 31 Seventh Day Adventist
(SDA) lactoovovegetarian (LOV) women in Oregon (mean age 46y) to 144 SDA women
on LOV diets in California (mean age 67y). They found the LOV diet contained higher
calcium content and lower percent fat calories than was reported for Caucasian women in
NHANES II (National Health and Nutrition Survey; National Center for Health Statistics
[NCHS], 1983). The vegetarian diet was also significantly higher in dietary fiber and
water-soluble vitamins. Tylavski and Anderson (1988) reported similar findings in the
intakes of elderly vegetarian females living in North Carolina. The vegetarian women in
these three studies were all classified as lactoovovegetarian.
The American Dietetic Association’s position paper on vegetarian diets suggest
that they may be associated with better calcium retention and can result in less bone loss
over time (The American Dietetics Association [ADA], 1993). A study of 1600
Caucasian women in Michigan found that those women following a lactoovovegetarian
(LOV) diet for at least 20 years had greater bone mineral density, with 18% bone loss
compared to 35% in omnivores by age 80 (Marsh, et al., 1988). A lactovegetarian diet
was considered protective against osteopenia.
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A total vegetarian or vegan diet where no animal foods are eaten—no meats, eggs,
or dairy foods—has raised some concern about its effect on bone mass (Chiu, et al.,
1997). These increasingly popular diets are thought to be low in S-amino acids, but also
may be low in dietary calcium unless there is very careful meal planning or supplements
are included.
A search of published research found few studies have compared the dietary
effects of vegetarian diets, and in particular vegan diets on bone density and even fewer
have looked at bone metabolism and the processes of bone formation and resorption.
With few exceptions the studies were on older women and showed that
lactoovovegetarian postmenopausal women may have more or similarly dense bone when
calcium intakes were comparable to omnivore controls. Ellis, Holesh, and Ellis (1972)
and Marsh, et al. (1988) found postmenopausal lactoovovegetarians had greater bone
density than omnivores, however Ellis, et al. subsequently retracted their report (Ellis,
Holesh, & Sanders, 1974). Tylavsky and Anderson (1988), Hunt, Murphy, Henderson,
Clark, Jacobs, et al. (1989), Tesar, Notelovitz, Shim, Kauwell, and Brown (1992), Reed,
Anderson, Tylavsky, and Gallagher (1994), and Lau, et al. (1998) did not find differences
in bone density between postmenopausal lactoovovegetarians and omnivores.
Before 1997, only two cross-sectional studies were conducted on younger
premenopausal vegetarian women. Marsh, Sanchez, Mickelsen, Keiser, and Mayor
(1980) found no difference in bone mineral density (BMD) at the radius between
lactoovovegetarians (LOV) and omnivores in women <50 years of age. Lloyd, Schaeffer,
Walke, and Demes (1991) found a non-significant but slightly lower spinal BMD in

11

LOVs compared to omnivores. Lactoovovegetarians and omnivores in these studies
consumed moderate to high levels of calcium.
Limited observations of vegans suggest there may be an increased risk of bone
loss where dairy products are restricted and calcium intake is low. Chui, et al. (1997)
found lower BMD in long-term postmenopausal vegans. Their study of Taiwanese
Buddhist women following a strict vegan diet for 15 or more years found the women to
be at higher risk of osteopenia and of exceeding fracture thresholds at the femur and
lumbar spine compared to lactoovo vegetarians. In California, Johnston (1999) reported a
significantly lower BMD in premenopausal Caucasian vegans compared to LOVs and
omnivores. Outila, Karkkainen, Seppanen, and Lamberg-Allardt (2000) also found
premenopausal Caucasian vegans in Finland had lower BMDs than LOVs and omnivores,
although the difference was not significant.
These three studies marked a departure from previous research on vegetarians,
segregating the vegans from lactoovovegetarians for comparison. The results raise
concern for the young vegan woman who believes a conscientious whole food vegan diet
without calcium supplements can support optimal bone health.
What is not known is the mechanism behind the lower bone mass in the vegan
women prior to menopausal estrogen loss. There is limited research comparing the effect
of diet on bone turnover in premenopausal vegans, lactoovovegetarians, and omnivores.
It may be possible to detect changes in the bone processes by measuring biochemical
markers of bone turnover during the premenopausal years in long-term vegetarians. Even
if bone mineral density is not significantly different in premenopausal women,
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biomarkers may detect subtle alterations in bone metabolism that over a period of years
or decades contribute to osteopenia. Research is also necessary to determine whether
characteristic dietary patterns affect bone turnover. Such a study would provide evidence
for providing guidance to a growing number of younger persons adopting this popular
vegetarian diet and could provide public health strategists with another protective tool
against osteoporosis. This dissertation attempts to identify whether specific dietary
differences in healthy Caucasian women affect the formation and resorption biomarkers
of bone metabolism and whether the biomarkers are associated with bone mineral
density.
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CHAPTER 2
REVIEW OF THE LITERATURE

A. Osteoporosis
Osteoporosis may be defined as “a reduction in bone mass that increases
susceptibility to fracture” (Cummings, Kelsey, Nevitt, & O’Dowd, 1985). Osteoporosis
predisposes to fractures of the hip (femoral neck), vertebrae (lumbar), distal forearm
(Colics’ fractures), humerus, pelvis, and other less common types of fractures. Whereas,
with sufficient force, fractures can be produced on any bone, osteoporotic fractures
typically occur in the elderly with minimal trauma; “minimal” is described as no more
severe than falling from a standing height (Cummings, et al.).
Bone mass increases most rapidly during childhood and adolescence, slows, and
apparently peaks in the young adult or third decade. After the fourth or fifth decade the
average bone mass tends to decrease. This is so universally seen that bone loss is
accepted as a factor of aging (Hannan, Felson, & Anderson, 1992). The attainment of
genetically programmed peak bone mass is particularly important because greater BMD
decreases the risk for osteoporosis associated with the eventual loss of bone.

B. The Physiology of Bone
The skeleton serves as the body’s reservoir for calcium and is a metabolically
active tissue undergoing a dynamic process of turnover and remodeling. Within the
15

skeleton there are two types of bone. Cortical or compact bone is a layered, dense, solid
structure and is found in shafts of long bones, such as the femur, and as a shell around the
vertebrae. Cortical or compact bone is likely to reach peak bone density in the third or
fourth decades of life. Trabecular or cancellous bone is a bony lattice with a spongy
appearance, found in the vertebrae, at the ends of long bones, and in the pelvis, the most
frequent sites of osteoporotic fractures. Cancellous bone comprises about 20% of the
total bone mass but has a greater surface area, is in greater contact with marrow, is more
responsive to hormonal and homeostatic changes than is compact bone, turns over more
rapidly than does cortical bone and likely to reach maximal density earlier in life (Barr &
Prior, 1994).
Mineralized spicules or trabeculae are found in cancellous bone, arranged along
lines of mechanical force. Cortical bone may be denser, yet the strength of the bone
depends not only on bone density but also on the architecture or connectedness of the
bone structure (Heaney, Avioli, Chestnut, Lappe, Recker, & Brandenburger, 1989). Thus,
less dense bone may have sufficient bone strength to be resistant to fractures.
Bone changes are mediated through the effects of calciotropic hormones on the
five major cells involved in bone turnover—pre-osteoblasts, osteoblasts, osteocytes, pre
osteoclasts and osteoclasts. Pre-osteoblasts determine the number and activity level of
osteoblasts. Osteocytes are osteoblasts encased in bone matrix and have low metabolic
activity. Bone remodeling or turnover always starts with resorption. In remodeling, pre
osteoclasts and osteoclasts are usually considered affector cells that are responsible for
bone resorption or breakdown. Osteoclasts form small scalloped bays, cavities or tunnels
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in bone surfaces where demineralization has occurred. In response to resorptive activities
of osteoclast bone cells, osteoblast bone cells synthesize new bone collagen and noncollagenous proteins and lay down a collagen matrix which will subsequently be
mineralized (Smith, Gilligan, & Tommerup, 1994). Resorption and formation are
coupled reactions. In both types of bone, osteoblast (bone forming) and osteoclast (bone
resorbing) cells move freely on the surface. Although these cells account for only a small
fraction of the bone volume, their function is essential in regulating the balance of
minerals between bone and blood for modeling during growth and remodeling of bone in
adulthood.
Bone turnover occurs throughout life wherein old bone is first resorbed. This
resorption is then coupled with new bone formation. This process takes place at discrete
sites or “remodeling units” over a fixed period of time, usually about 90 days. Bone
remodeling occurs in a cycle. In response to stimuli, the initiation of each cycle occurs
when osteoblastic cells lining the bone surface retract to expose the underlying bone.
This process is called activation. Recruitment and resorption occur when osteoclastic
(resorptive) precursors are drawn from the marrow to the bone surface and over several
weeks erode a resorption tunnel in cortical bone or a lacuna (bay) on trabecular surfaces.
For the next 3-4 months there will be a reversal phase where osteoclasts will disappear
and teams of osteoblasts, recruited to the outer edge of the erosion cavity or bay, will
secrete new bone matrix (osteoid) and gradually fill in the resorption cavity with
collagenous substances and minerals. The cavities can be overfilled (growth) or
underfilled (bone loss) in response to hormonal or mechanical stressors.
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Childhood and adolescent linear bone growth and modeling terminate with
epiphyseal closure; while radial growth continues for a decade longer with additional
mineral deposited during a period of consolidation. Bone mass appears to be almost
completed in the early half of the teen years, but bone gain continues until around age 30
in white women (Hansen, 1994).
Bone modeling occurs in response to endocrine stimuli, as during adolescence, as
well as mechanical stimuli. Mechanical stimuli appear to have a regional effect. Bone
mass changes to accommodate increased stress and will increase most in the areas
experiencing the most stress (e.g., athletes using a dominant arm, activities of daily
living). Stimuli, such as weight bearing or gravity and muscle contraction, must exceed a
threshold level or frequency to stimulate new bone formation (Lanyon, 1981).
Conversely, not meeting that threshold results in decreased osteoblastic function, as
might occur with disuse, convalescence, and weightlessness. The degree of bone
hypertrophy or atrophy is proportional to the changes in magnitude and frequency of
stimuli (Smith, et al., 1994).

C. Factors that Affect Bone Remodeling
In the adult about 10% of the skeleton is remodeled each year. The major factors
affecting the bone remodeling process are listed in Table 1.

When there is sustained net

loss of bone in the remodeling process, osteoporosis may result. Two types of
osteoporosis have been suggested (Riggs & Melton, 1986). Type I involves cancellous
bone loss from the spine and forearm and affects women from menopause to 15-20 years
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post menopause. Type II involves senescent loss of both compact and cancellous bone
and affects both men and women over the age of 70. The primary fractures of Type II
osteoporosis are of the hip. In osteoporosis, bone formation is less than it should be to
maintain bone and the resorption cavities are incompletely filled, leading to eventual
thinning of bone. In high bone turnover states, such as estrogen loss, there are increased
numbers of osteoclasts resulting in such deep resorption cavities that bony trabeculae are
perforated and entire trabeculae may be permanently lost (Dempster, Shane, Horbert, &
Lindsay, 1986).

Table 1.
Major Factors Known to Affect Bone Remodeling
Aging
Female gender
Ethnic Caucasian or White
Hormonal levels of Estrogen, Thyroxine, Growth Hormone
l,25-(OH)2 Vitamin D
Parathyroid Hormone (PTH)
Body mass index, physical exercise
Calcium intake
Protein and sodium intakes
Smoking, excessive alcohol

19

It is at this point that drug and dietary interventions have limited effect on laying
down new bone on remaining bone surfaces. Prevention by maximizing peak bone mass
before skeletal maturation and maintaining bone density through the adult years will
ultimately decrease the risk of osteoporotic fractures. Maintaining mechanical stress
(exercise), hormonal balance (estrogen, vitamin D), and supplying structural building
blocks (protein, calcium) during these years are key.
The maximal amount of bone mass gained during growth (peak bone mass) is an
important determinant of bone mass in later life and thereby an important determinant of
fracture risk. Although genetic factors appear to be primary determinants of peak bone
mass, environmental factors such as physical activity and nutrition also make a
significant contribution during adolescence when peak bone mass may be reached. The
critical role of energy and calcium during growth have been widely supported (Barr &
McKay, 1998; Chan, Hoffman, & McMurray, 1995). Young girls whose dietary calcium
intake was provided primarily from dairy products at or above the recommended daily
levels had increases in bone mineralization. Dietary phosphate, vitamin D, and protein
intakes were also associated with lumbar bone density and total body bone calcium
(Chan, et al.).
A study of adolescent girls with anorexia nervosa reported that in weight recovery
whole body bone mineral density significantly increased, but bone mineral density of the
spine did not change significantly. The persistence of osteopenia after recovery led
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researchers to caution that deficits in bone mass acquired during adolescence may not be
completely reversible (Bachrach, Katzman, Litt, Guido, & Marcus, 1991).

D. Risk Factors for Osteoporosis
1. Age, Gender, and Ethnicity
In all populations studied, including the Framingham Osteoporosis Study in the
United States (Hannan, et al., 1992), universal bone loss was found with increasing age.
Hansen (1994) assessed the effects of age and other risk factors on bone density and bone
turnover in 249 healthy premenopausal women in Denmark. Peak skeletal density
seemed to be accomplished about age 28 years in these white females, with no
appreciable change in bone mineral density (BMD) thereafter before menopause. During
menopause bone undergoes dramatic changes. Bone loss is steeply increased in the first
5-8 years post menopause. Nevertheless, Reed, et al. (1994) reviewed 8 longitudinal
studies published between 1975 and 1990 reporting that all late postmenopausal women
(>10 years beyond menopause) have significant rate rates of loss of both trabecular and
cortical bone.
An important question is whether there is a subtle but slow rate of loss or gain in
women in the childbearing years. McCormick, Ponde, Fawcett, and Palmer (1991) found
female adolescents accumulated spinal mineral more rapidly than male adolescents and
Cohn, et al. (1981) showed peak bone mass occurred earlier in women but they had a
lower value compared to men. However, bone mass appeared to be quite stable between
the ages of 20 and 30 years. Recker, et al. (1992) found positive correlations for calcium
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intake, physical activity and oral contraceptive use with bone gains (increased BMD) in
the radius, the spine and total body bone mineral content in college age women, followed
through their 20s. Other studies showed bone loss in women before menopause. Nordin,
et al. (1990) found a slow linear premenopausal loss in forearm bone. Nilas, et al. (1988)
found a linear loss from the spine before menopause. Riggs, et al. (1986) and Aloia,
Vaswani, Ellis, Yuen, and Cohn (1985) found substantial premenopausal loss of bone
density of the spine and femur. Riggs, et al. suggested that substantial, even half of
vertebral bone loss occurs prior to menopause. Mazess, Barden, Ettinger, Johnston,
Dawson-Hughes, et al. (1987) found no loss between the ages of 26-40, but that half the
vertebral bone loss occurred during the perimenopausal years (0-5 years prior to
menopause). Mazess and Barden (1991) confirmed the rapid perimenopausal loss in a
subsequent study of white women while Elliott, Gilchrist, Wells, Turner, Ayling, et al.
(1990) found accelerated perimenopausal bone loss occurring at both compact and
cancellous bone sites for the total skeleton. Based on these studies, it appears likely that
the rapid growth in bone mass during adolescence is followed by a period of
consolidation, after which there is a phase of slow premenopausal bone loss until about
five years prior to menopause when bone loss becomes more rapid reaching its highest
rate of loss in the years soon after menopause. Entering the perimenopausal and
menopausal period with lower bone mass increases the likelihood of earlier fractures and
the diagnosis of osteoporosis.
In American and western European populations, women have less bone mass than
men of all ages and at all sites (Abelow, Holford, & Insogna, 1992; Gallagher, Riggs, &
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DeLuca, 1980). Elderly women then, are more likely to experience osteoporotic fractures
than elderly men. The predominance of females over males having fractures depends on
the site of fractures. Vertebral fractures occur seven times more often in women than
men; however, the incidence rates for hip fractures are only two to three times higher in
women than in men (Maggi, Kelsey, Litvak, & Heyse, 1991). Although less common
than hip fractures, Colles’ fractures of the forearm and fractures of the proximal humerus
and pelvis are six to eight times higher in women than men (Gallagher, et al.; Maggi, et
al.).
Bone loss is found in all ethnic groups. Table 2 notes that women in the United
States, Sweden and New Zealand have the highest incidence of hip fractures, ageadjusted per 100,000 in the population (Gallagher, et al., 1980). Bacon, Maggi, Looker,
Harris, Nair, et al. (1996) reported similar high incidences of hip fractures in the US and
Sweden, as well as Canada, Finland, Scotland, and Switzerland.
In the United States Afro-American women compared to Caucasian women tend
to have half the risk of hip fractures, possibly benefiting from a higher mean weight and
the effect of weight bearing on strengthening bone density (Maggi, et al., 1991). It has
also been reported that black women compared to white premenopausal women have
higher serum PTH levels and lower urinary calcium excretion (Dawson-Hughes, Harris,
Finneran, & Rasmussen, 1995).
A noninvasive study in 1997 (Parisien, Cosman, Morgan, Schnitzer, Liang, et al.)
of bone mass and turnover in premenopausal black and white women (mean age 33.4 and
32.5 years) living in New York found that there were no differences in bone volume,
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microstructure or turnover between these women. What did significantly differ was the
lower rate of matrix deposition within each remodeling unit and a longer total formation
period in blacks than in whites. The less frequent and/or longer inactive apposition
periods may allow for a greater overall deposit of bone in black women and may help
explain the higher bone mass and bone quality in black women. It has been suggested
that black women have decreased skeletal sensitivity to parathyroid hormone (PTH) and
therefore, are less likely to resorb bone in response to elevated levels of PTH (Cosman,
Morgan, Nieves, Shen, Luckey, et al., 1997). Homeostatis may be maintained more by
renal conservation of calcium rather than bone turnover.
African blacks have a low incidence of osteoporotic fractures. Surprisingly, a
study of Gambians from West Africa living in the UK showed no significant differences
in total bone mineral content, in bone density, in bone turnover markers (osteocalcin,
alkaline phosphatase, deoxypyridinoline), or hormones (PTH, 1,25 OH2 vitamin D,
calcitonin) when compared to whites living in Britain. Urinary calcium and urinary
sodium were also similar in the two groups. This study concluded that there were few
ethnic differences that could account for the gap in fracture rates between blacks and
whites in the UK, with the possible exception of anatomical differences (Dibba, Prentice,
Laskey, Stirling, & Cole, 1999). Biomarkers cannot distinguish ethnic differences in
bone turnover.
Rates of hip fractures in Japan are about one-fifth that of the United States (Fujita
& Fukase, 1992). A correspondingly low incidence was observed in Hong Kong (Lau, et
al., 1998). Despite the reported low incidence, two studies in Hong Kong revealed a
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Table 2.
Incidence Rates of Hip Fractures by Region, Ethnicity, Gender, Protein and Calcium
Region

Ethnicity

Rate in Female
females /male
i
i
ratio

Rate in
women
>50 yr2

Dietary Dietary
animal calcium
protein 4
3

United States
Caucasian
Caucasian
Asians
Blacks
Hispanics

101.6

2.01

510
559
338
219
197

72

950

Sweden
Norway
New Zealand
United Kingdom

Caucasian
Caucasian
Caucasian
Caucasian

87.2

2.75

59
64

1190

96.8
63.1

1.79
2.15

622
1293
620

77

275

57

980
1000

Jerusalem, Israel
Holland
Finland

Caucasian
Caucasian
Caucasian

69.9
51.1
49.9

1.63
1.80
1.78

Yugoslavia,

Caucasian

39.2

1.03

Rochester,NY’65-74
California ‘83-‘84
California ‘83-‘84
California ‘83-‘84
California ‘83-‘84

100

low-calcium diet

Yugoslavia,

Caucasian

17.3

58

985
820
1430

27

500

43

0.95
1100

high-calcium diet

Hong Kong ‘65-‘67
Hong Kong ‘85
Singapore

Asian
Asian
Asian

31.3

1.15

15.3

So. African Bantu

Blacks

5.3

i

0.58

153
353
75

435
35
25

0.94

26

11

670

per 100,000, age-adjusted to US population, 1970; fracture rates for males not given here, Gallagher,
et al., 1980)
2 age-adjusted per 100,000 in population over 50 years of age, Maggi, et al., 1991.
3 gr/day, from Abelow, et al., 1992.
4 mg/day, from Hegsted, 1986.
5 women in Rochester, MN
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fracture rate in 1985 more than twice the rate in 1965 (Maggi, et al., 1991). Secular
changes in lifestyle as well as dietary factors are likely to have influenced the changes.
Asian-American women appear to have slightly less age-adjusted cortical bone mass than
Caucasian women, possibly related to their lighter mean weight. Asian women in
California had similar fracture rates as Asian women in Hong Kong in 1983-1985 (Table
2). It remains to be seen whether fracture risk for Asian-Americans will remain low or
continue to increase. Kin, Lee, Kushida, Sartoris, Ohmura, Clopton, and Inoue (1993)
found in Japanese-American women that increased weight, exercise, early menarche and
years of lifetime estrogen exposure correlated positively with BMD, whereas significant
negative correlates of BMD included percentage of body fat and smoking.
Hispanics living in California have the lowest risk compared to Caucasians,
Asians, and Blacks also living in California (Maggi, et al., 1991). Consistent with this,
Bacon, et al. (1996) reported that South American countries Venezuela and Chili had 3 to
11 times fewer hip fractures than the seven European, North American, and Asian
countries compared.
Bone loss and fractures are seen in men as well as women. However, where the
fracture rates are highest, the female-to-male ratio tends to be the greatest (Table 2).
Caucasian women in the United States, Sweden and the United Kingdom have high rates
of hip fractures and the highest female-to-male ratios (Gallagher, et al., 1980).
Women greater than 50 years of age were found to have fracture rates, adjusted
per 100,000, highest in Norway, Sweden, New Zealand and the United States (Maggi, et
al., 1991). The rates were considerably lower for women from countries in Africa, Asia
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and even Yugoslavia, who consume much less dietary protein and calcium (Abelow, et
al., 1992; Hegsted, 1986).

2. Reproductive History and Estrogen
It is well known that loss of estrogen is associated with a dramatic loss of bone
mass in elderly women and in those who have undergone surgical menopause. In
premenopausal women disturbances in menstruation have also been widely studied, in
particular, estrogen's effect on trabecular bone. Women who experience more frequent
amenorrhea and oligomenorrhea include athletes with body fat below 17%, those with
anorexia nervosa (calorie restriction and low body weight), and vegetarians (Barr &
Prior, 1994; Pederson, Bartholomew, Dolence, Aljadiar, Netteburg, & Lloyd, 1991).
Menstrual irregularity was significantly higher among studied premenopausal vegetarians
(26.5% vs 4.9%) than among nonvegetarians (Pederson, et al., 1991).
In population studies, amenorrhea was associated with lower values for bone
density (Snead, Weltman, Weltman, Evans, Veldhuis, et al., 1992). Up to 44% of
exercising females experience amenorrhea compared to 8% in the general public
(Carlberg, Buckman, Peake, & Riedesel, 1983). Anorexia nervosa patients had
significant changes in bone density that was highly correlated with changes in body mass
index (weight for height), body fat and caloric intake (Bachrach, et al., 1991). The
persistence of osteopenia after recovery indicated that deficits in bone mineral from
adolescent anorexia may not be completely reversible.
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Excessive levels of regular exercise in young women can result in amenorrhea
and a reduced density of trabecular bone in the spine with little or no cortical bone
change in arms and hands (Hetland, Haarbo, Christiansen, & Larsen, 1993). Hetland
reported that elite runners, running up to 140 km/week induced menstrual disturbances,
but bone mass was unaffected except in amenorrhic women. Amenorrhea rose from 1 %
occurrence in control populations to 11 % in elite runners. Bone turnover markers were
similar between controls and elite runners and there was no difference in BMD
measurements except those women who were amenorrheic had 10% reduction in lumbar
bone density (p<.05).
Early studies on amenorrheic runners found 9 of 11 were "vegetarian", eating
<200 g of meat per week, compared to only 2 of 15 in the control group (Brooks,
Sanborn, Albrecht, & Wagner, 1984). Lloyd, et al. (1991) and Pederson, et al. (1991)
reported that among vegetarians the frequency of menstrual irregularities were
significantly higher (26.5% vs 4.9% in nonvegetarians; p=0.009), however the bone
densities of vegetarians were not significantly different from nonvegetarians.
Age at menarche nor the length of the menstrual cycle appear to be important
factors for the risk of hip fracture or decreased vertebral density (Smith, 1967). Age at
first full-term pregnancy also does not appear to be a risk factor (Kreiger, Kelsey,
Holfors, & O’Connor, 1982). Evidence does not support a negative impact on bone
density or bone turnover markers by high parity, frequency or duration of nursing
episodes (Lopez, Gonzalez, Reyes, Campino, & Diaz, 1996). Pregnancy and lactation
may even be protective since these conditions support increased calcium absorption,
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assuming vitamin D and calcium intakes are adequate. At calcium intakes >1200mg/day.
full breastfeeding extending over 6 months is characterized by increased maternal bone
turnover and a transient bone loss which normalizes after weaning (Lopez, et al.).
The use of oral contraceptive agents (OCA) has been associated with a slightly
increased cortical bone mass; this is likely to be related to their estrogen content
(Goldsmith & Johnston, 1975). Estrogen, in premenopausal women or in women on
estrogen replacement therapy (ERT) prevents or retards bone loss for as long as the
estrogen is available. Effective preservation of trabecular and cortical bone mass requires
the daily equivalent of 0.625 mg of conjugated estrogen or 15 mg of ethinylestradiol
(Genant, Cann, Ettinger, & Gordon, 1982; Horsman, Jones, Francis, & Nordin, 1983).
Evidence is inconsistent whether small gains in cortical bone at higher dosages of
estrogen are possible. The addition of progestins does not reduce the efficacy of ERT.
There is much support for the initiation of ERT as soon as possible after natural
menopause. Evidence indicates bone loss significantly accelerates after menopause and
minimizing time delays can preserve more bone (Aloia, Vaswani, Yeh, & Russo, 1996).
Three case-control studies (Hutchinson, Polansky, & Feinstein, 1979; Paganini-Hill,
Ross, Gerkins, Henderson, Arthur, & Mack, 1981, Kreiger, et al., 1982) suggest that ERT
for five years after menopause reduces hip fracture risk by 50% and reduces rates of new
vertebral deformities and fractures. Paganini-Hill, et al. observed that the protective
effect is lost within a few years of discontinuing ERT. Felson, Zhang, Hannan, Kiel,
Wilson, and Anderson (1993) recommend that for longer term preservation of bone
mineral density, women should take estrogen for at least seven years after menopause.
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Without dispute, estrogen is protective of bone density in women. The loss of
estrogen with aging reduces calcium absorption and increases bone resorption. Aloia,
*

Vaswani, Yeh, and Russo (1996) concluded that the addition of ERT results in a marked
decline in bone resorption parameters and maintenance of calcitriol levels. Along with
lower estrogen, a lower testosterone, and a higher sex hormone-binding globulin level
may predispose postmenopausal women to higher hip fracture rates; the most serious
complication osteoporosis (Davidson, Ross, Paganini-Hill, Hammon, Siiteri, & Judd,
1982).

3. Body Build and Body Mass Index
Along with lower estrogen, a lower testosterone and a higher sex hormone
binding globulin level may predispose postmenopausal women to higher hip fracture
rates; the most serious complication of postmenopausal osteoporosis (Davidson, et al.,
1982). . Women who weigh less for their height or appear “thin” have less cortical bone
mass than obese women do (Smith, Johnston, & Yu, 1972; Daniell, 1976; Saville &
Nilsson, 1966). Codes’ fractures are more likely seen in taller thin women and thinner
men are more likely to have vertebral fractures.
A dramatic difference in BMD was observed in the thinnest tertile of over 400
Danish postmenopausal women (lowest percentage body fat, low BMI or low body
weight) participating in the Early Postmenopausal Intervention Cohort (EPIC). They had
up to 12% lower BMD at baseline, a 2-fold higher 2-year bone loss, and significantly
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higher levels of N-telopeptide crosslinks (NTx) and serum osteocalcin (sOC) than women
in the highest tertile (Ravn, et al., 1999).
Since low body weight is associated with osteoporosis, it has been suggested that
obesity might be a protective factor. Obesity is defined as an excess of body fat indicated
by body mass index (BMI) >30 kg/m2. BMI is a convenient measure of weight for
height (kg body weight/meter squared), whether weight is from obesity or greater lean
body mass. A higher BMI in women approaching menopause is seen as protective
against bone loss.
Paganini-Hill, et al. (1981) found a 42% reduction in the relative risk of a hip
fracture in women with a BMI >33. The Framingham study observed a protective effect
on hip fractures with increasing increments of weight (Kiel, Felson, Anderson, Wilson, &
Moskowitz, 1987). Ribot, Tremollieres, Pouilles, Louvet, and Guiraud (1988) conducted
a cross-sectional study on 510 healthy French women ages 25-70 and found a positive
correlation between increasing weight and vertebral BMD. Dawson-Hughes, Shipp,
Sadowski, and Dallal (1987) used 115% over the ideal body weight (IBW) as a means to
compare the bone mineral content and bone mineral density of overweight and normal
weight women. Postmenopausal women with weight >115%IBW had higher mean BMD
and BMC. Kin, Kusjida, Yamazaki, Okamoto, and Inoue (1991) found women with BMI
at or above 25 had higher vertebral BMD only after the fifth decade of life.
It has been suggested that a greater BMI during the adolescent and early adult
years may establish a greater bone mass and thus a greater reserve that would reduce
fracture risk at menopause. However, McCormick, et al. (1991) measured BMD per
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kilogram of body weight in overweight children and adolescents and when compared to
normal control subjects, obese children had less BMD. Aloia, McGowan, Vaswani,
Ross, and Cohn (1991) examined cross-sectional and longitudinal changes in lean mass
and adipose mass in white women. They concluded that a reduction in muscle mass leads
to the loss of skeletal mass and that adiposity was not protective against osteoporosis.
They found that total body fat was not related to any measurement of bone mass;
however, lean body mass, as calculated from total body potassium was significantly
related to total body calcium and BMD of the spine, radius and femur. Reed, et al.
(1994) in a 5-year prospective study on elderly white females (mean age, 81 years)
reported lactoovovegetarians (LOV) and omnivores had similar BMD loss rates.
however, greater BMD loss was associated with a greater loss of lean body mass. This
loss was found to be independent of calcium intake.
Whole body scans for lean body mass (LBM) and fat body mass (FBM) using
dual energy x-ray absorptiometry (DXA) showed LBM had a dominant effect on spinal
bone mass in premenopausal women while both LBM and FBM predicted hip bone
mineral content (BMC) in postmenopausal women (Khosla, Atkinson, Riggs, & Melton,
1996). Both lean mass and fat mass have important effects on bone mass, depending on
the bone parameter used, the skeletal site measured, and menopausal status.
A higher BMI may be protective in three ways. First, if obese, women produce
more biologically available estrone from androstenedione in adipose cells than thin
women (Ribot, Tremollieres, & Pouilles, 1994). This is especially helpful in
postmenopausal women. Second, a greater body weight from lean body mass may be
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associated with greater peak bone mass if the greater body weight occurred before the
early adult years (Lehman, Going, Pamenter, Hall, Boyden, et al., 1995). Third, there is
increased protection against falls. Cummings, et al. (1985) suggested that greater fat pads
may protect the bones in a fall. Also, a body build composed of greater muscle mass may
protect against fractures by improving coordination, balance, and joint flexibility, thus
preventing injury and falls.

4. Physical Exercise
Bones need physical (mechanical or gravitational) stress to maintain its quality
and quantity. In 1990 Ross, Davis, Vogel, and Wasnich published an archeological
discussion on working Germans who lived 900 years ago and who did not lose trabecular
bone despite age-related bone quantity loss. Carrying one’s own weight or “weight
bearing” exerts various intensities on bone. People of nobility who did not do much
physical labor experienced greater degrees of trabecular loss, similar to modem man.
Physical activity, particularly weight bearing activity, is an important stimuli for
bone gain whereas physical inactivity has been linked to bone loss. Extreme inactivity
causes rapid bone loss of up to 40%, while athletic activity results in bone hypertrophy of
up to 40% (Smith & Gilligan, 1991). Bedridden patients and astronauts under
weightlessness lose as much as 1 % of their trabecular bone per week while cortical bone
may be lost more slowly. Resumption of normal weight-bearing activities restores both
types of bone, abeit gradually. Zerwekh, Ruml, Gottschalk, & Pak (1998) examined the
effects of skeletal unloading when normal subjects underwent 12 weeks of bed rest. The
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human skeleton appears to respond to unloading by a rapid and sustained increase in bone
resorption and a more subtle decrease in bone formation, as measured by seven
biochemical markers. All significant increases in biomarkers declined toward normal
during reambulation.
Rikli and McManis (1990) studied two groups of postmenopausal women
participating in either aerobic training or aerobic plus resistance training. In older post
menopausal women, weight-bearing exercise led to significant increases in bone mineral
content which were maintained with continued training. However, studies have also
shown that bone density gains induced by physical exercise are not maintained long
beyond the period of training. A detraining period of 13 months found bone density
rapidly decreasing and it was not significantly different from pre-training levels (Dalsky,
Stocke, Ehsani, Slatopolsky, Lee, & Birge, 1988; Michel, Lane, Bjorkengren, Bloch, &
Fries, 1992).
A 1-year walking program with either an increased or low calcium diet in
postmenopausal women concluded that neither exercise nor dietary calcium had an effect
on lumbar spine (L2-L4), distal radius, or total body calcium measured by DPA, SPA, or
neutron activation (Nelson, Fisher, Dilmanian, Dallal, & Evans, 1991). However, rates
of turnover of trabecular and cortical bone did vary from one site to another in women
who were active versus those who were sedentary and on high versus low dietary
calcium. This study suggests that exercise and high dietary calcium may preferentially
alter bone density at different skeletal sites.
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A review of the effects of several different exercises found no differences on the
bone mass of pre- or postmenopaused women with normal exertion during stretching,
walking, cycling, swimming, or endurance sports (Ribot, et al., 1994). On the other hand,
intense, acute exercise with an elevation of blood lactate and a shift of blood and urine
pH toward acidity can increase calcium excretion, lower PTH and reduce levels of
deoxypyridinoline (Dpy), a resorption marker (Ashizawa, Fujimura, Tokuyama, &
Suzuki, 1997).
Urinary type I collagen crosslinked N-telopeptides (NTx), a biomarker of bone
resorption, in premenopausal Japanese women who exercised regularly was almost half
that of those who did not. Habitual exercise in early adulthood appeared to interfere with
the resorptive process resulting in less bone loss of the lumbar spine (Masatomi, Imai,
Wang, Ikeda, Taketa, et al., 1999).

5. Cigarette Smoking, Medications, and Medical Conditions
a. Smoking.

Aloia, Cohn, et al. (1985) found osteoporotic women had

lower total body calcium levels and bone mineral at the radius, had undergone earlier
menopause and had smoked more cigarettes. A 16-18 year prospective study of women
who smoked cigarettes found a greater risk for hip fractures and lower cortical bone mass
(Hollenbach, Barrett-Connor, Edelstein, & Holbrook, 1993). The direct effect of
smoking on bone mass is undetermined, however, of the 754 women, smokers tended to
be thinner, weigh less, and exercise less than nonsmokers (Hollenbach, et al.). Women
who smoke have lower concentrations of estrogens and transition to menopause 1-2 years
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earlier than women who do not smoke (Kiel, Baron, Anderson, Hannan, & Felson, 1992).
The lower estrogen levels may result in earlier loss of bone.
Upon reviewing the few cross-sectional and prospective studies on smokingrelated deficits in bone mass observed among pre- and perimenopausal women,
Slemenda, Hui, Longcope, and Johnston (1989) speculated that cigarette use reduced the
peak bone mass attained in early adulthood. Krall and Dawson-Hughes (1991, 1999) in a
2-year study of smoking’s effects on BMD and a 3-year calcium and vitamin D
supplementation on smokers’ BMD found a significantly increased rate of bone loss at
the radius and femoral neck in 35 postmenopausal smokers, compared to 285 older non
smoking women. Serum alkaline phosphatase was higher and total and ionized calcium
was lower in smokers at entry. Using a 47Ca load, they found smokers had significantly
lower retention, contributing to the accelerated bone loss. Smokers of at least 20
cigarettes per day had the lowest mean absorption fraction.
The Framingham Study followed 948 women smokers between 28 and 62 years
of age in 1948. By 1987 hip fracture incidence did not differ between smokers and
nonsmokers. However, among smokers on estrogen replacement therapy (ERT), the
estrogen was not protective against hip fractures, whereas ERT was protective against
fractures in nonsmokers (Kiel, Baron, et al., 1992).
b. Certain Medications and Medical Conditions. Certain drugs may have
adverse effects on bone metabolism, hence speeding bone loss. The corticosteroid effect
on bone status is widely published, with trabecular bone loss being more evident than
cortical bone loss. Thyroid hormone in excess has been shown to reduce cortical bone
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mass, whereas in recommended doses, it appears to slightly protective of bone loss
(Cummings, et al., 1985). Antacids containing aluminum taken with a low calcium diet
appears to affect calcium balance adversely, but not when calcium intakes were above
800 mg/day (Spencer, Kramer, & Norris, 1982).
Risk for accelerated bone loss is an established complication of Type I diabetes,
hyperthyroidism, hyperparathyroidism, hyperadrenocorticalism, rheumatoid arthritis, and
gastrectomy. Type I diabetes is usually not associated with obesity and cortical bone loss
has been noted (Cummings, et al., 1985). Other than early-onset diabetes, the other
conditions are rare and probably contribute minimally to the incidence of osteoporosis in
women. Over a dozen studies from 1967 to 1992 reported that women with NIDDM or
Type II diabetes had significantly higher BMD (Barrett-Connor & Holbrook, 1992).
However women in many of the studies tended to be heavier and more likely to use
diuretics. Calcium excretion and calcium absorption may be both reduced by thiazide
diuretics with a slight net effect of slower bone loss. Many women with diabetes report
they have arthritis. Osteoarthritis has been associated with increased bone density
(Verstraeten, Van Ermen, Haghebaert, Nijs, Geusens, & Dequeker, 1991).

6. Dietary Factors
a. Dietary Calcium.

The link between calcium deficiency and

osteoporosis in animals was pointed out by Nordin in 1960. By 1980 it was advocated
that a high calcium diet was important for bone health (Matkovic, Kostial, Simonovic,
Buzina, Brodarec, & Nordin, 1979; Heaney, Recker, & Saville, 1978). Calcium has since
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been widely recommended to women as a means to help prevent osteoporosis. In 1984
the National Institutes of Health held the Consensus Conference on Osteoporosis to
consider raising the RDA for calcium from 800mg to 1500 mg/day for postmenopausal
women. However, it was felt evidence was not convincing enough to change the existing
RDAs for the elderly. The RDAs remained at 1200 mg for ages 11-24 years, at 800 mg
from ages 25 to 50 years, and also at 800 for ages 51+ years (National Research Council
[NRC], 1989) until 1997. In 1997 the Dietary Reference Intakes (DRI) modified the
calcium requirements for adults (19-50 years of age) to lOOOmg/day and for the elderly
(51+ yrs) to 1200mg/day (Institute of Medicine, [IOM], 1997). Heaney, McCarron,
Dawson-Hughes, Oparil, Berga, et al. (1999) estimated healthy white women cannot
maintain zero calcium balance at these levels of intake and may require an average of 990
mg per day for premenopausal women, and 1540 mg for early postmenopausal women
(mean age of 46 years).
The USDA 1987-1988 Nationwide Food Consumption Survey (Fleming, &
Heimbach, 1994) reported women 35-50 years old averaged 530 mg dietary calcium per
day. Black women ingested less dietary calcium than Caucasians (452 mg/day compared
to 640 mg/day) and no group of adult females had a calcium intake that met the previous
RDA of 800 mg/day. The deficit is even greater when compared to the most recent
recommendations. While requirements may be higher for older women, postmenopausal
women in the United States consume an average of only 475—575 mg of calcium per
day. A low calcium intake after menopause is not necessarily a predictor of osteoporotic
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fractures, but may be a reflection of lifelong calcium intake that may affect peak cortical
bone mass (Matkovic, et al., 1979).
Nonetheless, calcium intake as an etiological factor in osteoporosis remains
controversial. Severe calcium deprivation has produced reversible osteopenia in
animals, but in humans, studies have shown mixed results. Mexican Americans were
found to consume less calcium than whites in the U.S. (Bauer and Mayne, 1997).

Yet,

Hispanics (Table 2) living in the United States have fewer hip fractures than Caucasians
(Maggi, et al., 1991). As seen in Table 2, the Yugoslavic survey reported that subjects on
a low calcium diet were more likely to experience hip fractures than subjects on a high
calcium diet (Matkovic, et al., 1979) and osteoporotic Slavs had lower calcium intakes
than healthy subjects (Nelson, et al., 1991). A high consumption of dairy products in this
Yugoslavic district was associated with a 50% lower incidence of hip fractures and a
slightly higher cortical bone volume than found in a comparable group in another district
consuming less dairy foods. However, complicating this finding was the fact that the
subjects in this higher calcium district also consumed higher intakes of calories, fat,
protein, and phosphorus.
A 14-year prospective study on 531 postmenopausal women in southern
California found a significant inverse association of dietary calcium with subsequent risk
of hip fracture, meaning the study strongly supports the hypothesis that increased dietary
calcium intake protects against hip fracture (Holbrook, Barrett-Connor, & Wingard,
1988). This result was found, despite that the healthy women without fractures had a low
mean calcium intake of 401 mg/d (those with fractures averaged 320mg/d). A
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longitudinal study by van Beresteijn, van ‘t Hof, Schaafsma, de Waard, and Duursma
(1991) tracked postmenopausal women for 10 years and found women consuming a
habitual low calcium diet of less than 800 mg (564-796 mg) per day had slightly greater
loss of skeletal bone density than women with intakes greater than 1350 mg per day. It
remains controversial what constitutes adequate dietary calcium in pre- and post
menopausal women, how much clinical significance should be attached to modest
differences in bone mass, and whether these differences result in eventual fractures.
Hegsted (1986) concluded that even if calcium intake had statistically significant effects
on bone, bone mineral content measurements alone may not provide a good indication of
the risk of fractures.
Heaney (2000a) reviewed 139 papers published since 1975 describing the
relationship of calcium intake with bone health. The majority of observational studies
did not show an association between calcium intake and bone balance; most likely due to
the weakness of the methods available for estimating long term calcium intake. Of 52
investigator-controlled calcium intervention studies, all but two showed greater bone gain
during growth and reduced bone loss in the elderly with higher intake. While most
investigators used calcium supplements, six studies used dairy food sources to
supplement calcium in the diet. All six of these studies showed positive bone gain. The
evidence appears to support high calcium intakes promoting bone health. Important
improvements in bone mass can feasibly occur by the consumption of desirable levels of
calcium (Heaney, McCarron, et al., 1999).

40

b. Calcium Supplementation and Bone Loss.

Calcium supplementation

of the diet appeared to slow bone loss in three controlled trials in postmenopausal age
reported by Smith, Eastell, et al. (1981), Recker, Saville, and Heaney (1977), and
Albanese, Edelson, Lorenze, Woodhull, and Wein (1975). With 750-1040 mg of calcium
added to the daily diet for 2-3 years, women were found to have significantly slower rates
of cortical bone loss than controls. Three other controlled trials showed trends toward
slower bone loss in women who were supplemented with 800-1200 mg calcium but
findings were not significantly different from the controls (Nordin, Horsman, Crilly,
Marshall, & Simpson, 1990; Lamke, Engfeldt, & Sjoberg, 1980; Horsman, Nordin,
Gallagher, Kirby, Milner, & Simpson, 1977). Elders (1991) and Elders, Netelenbos,
Lips, van Ginkel, Khoe, et al. (1991) reported that a 1000 or 2000 mg daily calcium
supplement to early postmenopausal women appeared to retard bone loss from the spine
in the first year, compared to controls (given a placebo supplement). However, by the
third year of the study bone mineral density did not differ among the three groups of
women. Dawson-Hughes, Dallal, Krall, Sadowski, Sayhoun, and Tannenbaum (1990)
reported that calcium supplementation was of no benefit in protecting bone mass during
early post menopause (0-6 years postmenopausal), even when dietary calcium was less
than 400 mg per day. Her findings support a prospective study on Dutch women where
consuming a usually high calcium diet (mean 1184 mg/day, range 600-2880 mg/day) did
not alter the rate of bone loss in the first 12 years after menopause (Hansen, Overgaard,
Riis, & Christiansen, 1991). Although manipulating the diet by increasing dietary
calcium or by calcium supplementation during the early postmenopausal period appears
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to have a much less beneficial effect on bone than estrogen replacement therapy,
supplements may benefit younger women during periods of bone consolidation before
peak bone mass is achieved.
c. Calcium Intake and Peak Bone Mass.

Calcium is an important

determinant of peak bone mass in young adults. However, the greatest benefits of
calcium supplementation may be for preadolescent children. Ilich, Skugor, Hangartner,
Baoshe, and Matkovic (1998) studied 456 Caucasian girls, ages 8-13 years. Mean
calcium intake was 956mg/day or about 26% below the recommended 1300 mg (1997
DRI) and about 36% below the threshold intake of approximately 1500mg/day. Chan, et
al. (1995) conducted a one-year trial involving pubertal girls in Utah, comparing usual
diets with a diet supplemented with dairy foods to 1200 mg calcium. After a year there
were significant increases in BMD at the lumbar spine and in total body BMD in the
supplemented group; urinary calcium and hydroxyproline did not differ between groups.
Abrams (2000) found an increase in bone density after an 18-month
supplementation trial in prepubertal children, however that benefit was not maintained in
the 18-month desupplementation period. The observed earlier benefits apparently
disappeared. He concluded that there is no proof at this point that early supplementation
ultimately leads to higher bone density.
Hansen (1994) reported that until maximum skeletal maturity is reached, before
age 30, a dairy calcium intake above 660mg/day significantly increased BMD in the
spine and femur by 3-5%. Heaney (1986) found persons with habitual diets containing
higher calcium levels (>600mg/d) did not benefit from calcium supplementation of 800
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mg or more added to the diet, suggesting a possible threshold effect. When calcium
intakes exceeded 1500 mg/day, urinary calcium was much higher, again supporting a
suggestion that there is a calcium threshold (Matkovic, et al., 1995).
Welten, et al. (1995) reviewed 33 studies of high methodological quality for
evidence of a direct relationship between dietary calcium and bone mass in
premenopausal females. Cross-sectional studies (27) showed a significant correlation
between dietary calcium and bone mass. Intervention studies (4) found that calcium
supplementation of about 1000 mg/d in young women can prevent the loss of 1% of bone
per year at all bone sites except in the ulna. The authors concluded that the meta-analysis
showed an association between dietary calcium and bone mass and it was consistent
across the different study designs.
d. Calcium and Bone Metabolism.

Calcium supplements or a calcium

load can affect bone metabolism, as measured by bone biomarkers in the serum and
urine. A calcium load can acutely decrease pyridinoline (Pyr), deoxypyridinoline (Dpy),
and hydroxyproline (Hyp), the biomarkers of bone resorption or degradation, (Rubinacci,
De Ponti, Shipley, Samaja, Karplus, & Jaffe, 1996; Scopacasa, Horowitz, Wishart, Need,
Morris, et al., 1998; Ginty, Flynn, & Cashman,1998), while showing no effect on serum
osteocalcin (sOC) and skeletal alkaline phosphatase (sALP), bone formation markers
(Ginty, et al.). Scopacasa, et al. concluded that a 1 g calcium load measured over two
days was able to significantly reduce the resorption markers Hyp, Pyr, and Dpy, in early
(0-5 years) postmenopausal women in Australia.
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Calcium supplementation whether achieved by adding milk or calcium carbonate
does appear to slow the rate of bone turnover irrespective of menopausal status and
habitual dietary calcium intake (Recker and Heaney, 1985; Elders, 1991). Manipulation
of the remodeling rate may decrease bone loss, but on the other hand, it may delay
needed skeletal repairs. Kanis (1984) expressed concerns that appreciable decreases of
bone turnover seem to increase the risk of fracture. Heaney (2000b) discussed the “bone
transient”, the period after resorption when spaces are refilled with bone matrix, and
expressed concerns that interventions that suppress resorption before the transient is over
may negatively affect overall BMD and BMC.
e. Calcium Intake in Vegetarians.

With nearly all of the body’s calcium

deposited in bone, logic would support dietary calcium as a dominant factor in bone
status. International studies have pointed out that a large proportion of the world’s
population have much lower calcium intakes than are recommended in the United States
but have lower fracture rates as well. Much of the world’s population where incidence of
fractures is low and calcium intake is low, do not consume the high levels of animal
proteins typical of westernized diets. The question arises whether a vegetarian diet, low
or void of animal proteins, accompanying a low calcium diet would lower fracture rates
in the United States as well. The American Dietetic Association's (ADA) position on
vegetarian diets is that "there is little evidence to show that calcium intakes below the
Recommended Dietary Allowance cause major health problems in the vegetarian
population. The relatively high US recommendations for calcium intake are designed to
compensate for the calciuretic effect of high intakes of animal protein, which are
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customary in the United States" (ADA, 1993). On the other hand, Weaver and Plawecki
(1994) reported that it is difficult without dairy foods, fortified foods, or supplements in a
Western-style diet to obtain sufficient amounts of absorbable dietary calcium to protect
bones and lower the risk of osteoporosis.
Of nutrients that could affect bone dynamics Alexander, Ball, and Mann (1994)
found similar calcium, lower sodium and higher fiber intakes as well as significantly
lower protein intakes in vegetarians, particularly in vegans, when compared to
omnivores. Janelle and Barr (1995) in comparing vegetarian to nonvegetarian women in
Canada found that in general, diets of all women adhered closely to current nutrition
recommendations and that health-conscious nonvegetarians had intakes similar to
vegetarians. The vegetarians did have slightly higher fiber, lower protein and lower
sodium intakes than nonvegetarians. In contrast, the vegan subgroup in this study had
more dissimilar intakes, especially noted was the low calcium intake. Haddad's
preliminary data (unpublished data) on vegans in Weimar, California is disturbing in the
number of females younger than 40 years of age, on vegan diets having such a low
calcium intake. Half of these vegans had calcium intakes 50% below the 1989 RDA of
800mg. There is concern that in vegans very low intakes of calcium in the adolescent and
premenopausal years will result in lower peak bone mass and increased risk for
osteoporosis later in life. Studies suggest that the lactovegetarian diet can provide
adequate calcium but that the vegan diet, without the dairy products, appears to provide
lower than desired calcium intake (Marsh, et al., 1988; Ball & Maughan, 1997; Lau, et
al., 1998; Chiu, et al., 1997). Bone scans and studies on the bone metabolism of vegans
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may shed light on whether low calcium diets are deleterious to the bone, even with a
lower protein intake which has been suggested to be protective.
Of particular interest was a study by Marsh, et al. (1988) of vegetarian women
from all across the United States and Canada attending a Seventh-day Adventist
conference in Lincoln, Nebraska. Of the 304 postmenopausal women tested for bone
mineral density by direct photon absorptiometry eleven (n=l 1) were classified as total
vegetarians (vegans). These women had no milk intake, although six of the eleven used a
calcium supplement for >1 year. When compared to lifetime LOVs who maintained their
bone density well with increasing age, the vegans fared poorly, having the least bone
mineral density of all the various vegetarian and semi-vegetarian groups identified in the
study. Significance could not be determined because the number of subjects were too
few in each group. These studies support the premise that a lactoovovegetarian diet may
be protective against bone disease, but suggest that a vegan diet may not.
The previous studies have not made it clear what are adequate intakes of calcium
for vegetarians, particularly for vegans. Although the associations are positive between
low calcium intake and a concomitant decrease in BMD, the question remains whether
this low calcium intake would lead to an increase in fracture rates. Numerous articles
report significant changes at one skeletal site but not at another, during the same study
period, under the same conditions of high or low calcium. It is difficult to estimate
calcium’s absolute effect on bone mineral content. Secondly, acute calcium
supplementation studies report some slowing of bone loss, but without affecting bone
formation; there is concern that supplementation may interrupt the “bone transient”
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period, delaying needed skeletal repairs (Heaney, 2000b). A threshold effect may also
limit benefits of calcium supplementation where habitual diets contain >600mg/d calcium
(Heaney, 1986). It is doubtful calcium alone can prevent bone loss or effectively treat
bone loss in senescence. Thirdly, the body may have a protective mechanism to adapt to
habitual low or high calcium intakes. So much of the world’s population consumes a low
calcium diet and yet suffers far fewer fractures than many nations consuming a much
higher calcium diet. There are questions of rates of absorption, rates of uptake into the
bones, rates of bone turnover, resistance to fractures (Hegsted, 1994). Lastly, there may
be ethnic or genetic factors that may exert a greater effect on bone status than
environmental factors, such as in blacks, Asians and Hispanics compared to Caucasians
living in the United States. Recommendations for elderly to increase calcium from
1.0—1.5 g/day is controversial because it is unlikely this level can be achieved without
“calcium supplements, an extra quart of milk per day or widespread fortification of
foods” (Hegsted).
f. Dietary Protein.

The earliest study showing that an all-meat diet fed to

humans increased calcium excretion was reported by Sherman in 1920 (Draper, 1994).
Engstrom and DeLuca in 1963 (in Draper) demonstrated doubling dietary protein induced
excess urinary calcium excretion, negative calcium balance, and reduced bone ash in rats.
Mazess and Mather (1974, 1975) observed that Eskimos in Alaska and Canada
consuming a daily average 200 grams of animal protein had bone loss earlier in life and
that the loss was greater in magnitude than bone loss in matched Caucasians surveyed in
Wisconsin. It should be noted that the Eskimos had an extremely high animal protein
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intake that is not typically found in the U.S. Until the time of this published report there
was little concern for protein-induced calcium loss because it was thought protein was
essential for calcium absorption and increased absorption would offset the urinary loss
(Yuen, Draper, & Trilok, 1984). In a followup study with 300 omnivorous white women
20 to 39 years of age, Mazess and Barden (1991) found the mean protein intake of U.S
women was only half that found in the Eskimos (mean 65+/- 20g). Kerstetter and Allen
(1994) reviewed 19 studies on protein intake and urinary calcium and found a linear
relationship up to 175 g/day of protein. Each 50g increment of protein resulted in an
extra 60mg calcium excreted. Kerstetter, Mitnick, Gundberg, Caseria, Ellison, et al.
(1999) defined at-risk “low” protein intake as < 0.7g/kg body weight or < 50g/day,
“medium” intake at 1.0 g/kg body weight, and “high” protein as > 2.1g/kg body weight
or >150 g/day in healthy premenopausal women (n=16, ages 20-40 years).
Bengoa, Sitrin, Wood, and Rosenberg (1983) found that infusing amino acids at
2g/kg, a high protein diet, resulted in urinary calcium loss of 455 mg/day versus 287
mg/day at Ig/kg, a “medium” protein intake. Heaney (1993) discussed protein’s effect
on calcium homeostatis and estimated that when protein intake doubles, urinary calcium
increases by approximately 50%. Allen, Bartlett, and Block (1979) and Schuette, Zemel,
and Linkswiler (1980) observed that while maintaining calcium, magnesium and
phosphorus intakes constant protein induced an increase in urinary calcium and a
decrease in renal tubular reabsorption. Kerstetter and Allen (1994) reviewed 15 studies
on dietary protein and calcium balance. They concluded, “clearly, when protein intake
was higher than 75g/day and calcium intake less than 600 mg/day, negative balance was
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inevitable.” Earlier, Margen, Chu, Kaufmann, and Calloway (1974) concluded that
protein intakes between 0 and 560 g/day resulted in an 8-fold increase in calcium
excretion not reversed by calcium supplementation up to 2300 mg/day. A recent study
(Kerstetter, et al., 1999) indicated that a medium protein (1.0 g/kg) intake induced no
change in mineral homeostasis, intestinal calcium absorption, urinary calcium, or bone
turnover rates. However, after 4 days on the experimental high protein intakes (2.1 g/kg)
compared to low protein intakes (0.7g/kg), bone turnover rates measured by Ntelopeptide (NTx) excretion and serum osteocalcin and skeletal alkaline phosphatase
show significant increase in resorption but no change in formation rates. The authors
suggested that at high protein intakes, at least a portion of the urinary calcium reflects
increased bone resorption levels.
Metabolic acidosis, regardless of cause—dietary proteins with large amounts of
sulfur-containing amino acids, a low calcium diet in relation to dietary protein, high
phosphate soda consumption, starvation, acute exercise or disease—is associated with
increased urinary calcium excretion (Barzel & Massey, 1998). Calcium and other buffers
found in bone are released to neutralize the increased acid load and are excreted in the
urine. Bone is the buffer reservoir for the body, containing 99% of the body’s calcium,
80% of its carbonate, 80% of its citrate and 35% of its sodium. It is thought the
consumption of diets containing large amounts of animal protein would result in a greater
degree of bone loss, particularly if dietary calcium was also low. On the other hand, it is
thought that vegetarian diets, containing proteins low in sulfate but not necessarily
differing in total protein, would be protective of bone. Breslau, McGuire, Zerwekh, and
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Pak (1982) reported that those consuming animal protein diets compared to vegetarian
diets had similar total protein but excreted 6.8 mmol more sulfate, had urine that was
more acidic, pH 6.17 vs. 6.55, respectively, had higher acid excretion, and urinary
calcium (uCa) was 47mg higher. The long term consequence of a small change in
calcium balance can be dramatic. A 50mg increase in uCa loss per day will result in 18g
loss per year, or 365g over 20 years. Since the average adult female skeleton contains
750g of calcium at its peak, this is a 50% loss of total bone calcium! (Barzel & Massey,
1998).
Shapses, Robins, Schwartz, and Chowdhury (1995) reported urinary biomarkers of
bone resorption, (hydroxyproline, pyridinoline and deoxypyridinoline crosslinks,) did not
increase when dietary protein increased from 0.44 to 2.71 g/kg body weight. However, it
should be noted that in this study calcium intake was not controlled and there was a
concomitant increase from 423 to 1589 mg/day as dietary protein increased, potentially
obscuring an effect of protein on bone resorption.
g. Animal Versus Vegetable Proteins.

In a 16-country cross-cultural

epidemiological study, Hegsted (1986) and Abelow, et al. (1992) analyzed dietary factors
and the incidence of hip fracture as an indicator of bone mineral loss in postmenopausal
women. They reported a strong positive association between the incidence of ageadjusted hip fracture in women over 50 years of age, bone mass, and the intake of animal
protein, but not the intake of calcium or energy.
Although a diet particularly high in animal protein is not the sole risk factor to
bone loss, these studies have led researchers to raise the question of whether a lower
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animal protein diet or a vegetarian or vegan diet may be more beneficial protecting
against early and greater bone loss. The association between high animal protein intake,
bone loss and hip fracture rates have raised the possibility that vegetarian diets, low in
animal proteins, may be protective against bone loss and ultimately, in reducing the risk
of osteoporosis in high risk populations. Most recently, Barzel and Massey (1998)
advocated that a moderate protein intake with an alkaline load, such as in a vegetarian
diet high in fruits and vegetables, could be protective of bones.
The Nurses Health Study (Fascinate, Wilted, Stumper, & Colditz, 1996) showed
no increase in fracture risk with plant protein intake compared to animal protein intakes.
Hu, Zhao, Jia, Parpia, and Campbell (1993) studied Chinese women and found positive
correlation between urinary calcium excretion and animal protein intake, but a negative
correlation with plant protein. A recent study from Japan (Itoh, Nishiyama, & Suyama,
1998) confirmed the significant and positive association between animal protein and Ca
excretion, however, no association with plant protein was seen. It has been proposed a
vegetarian diet may have a beneficial effect on bone status.
h. Dietary Protein in Vegetarian Diets.

Janelle and Barr (1995) studied

young healthy vegetarians (20-40y) and found vegetarians had lower protein intake
compared to omnivores and that among the vegetarians, vegans consumed less protein
than LOVs. Hunt, et al. (1989) in California and Tylavsky and Anderson (1988) in North
Carolina reported mean protein intakes of omnivores (63g/d and 68g/d) were
significantly higher than that of LOVs (52g/d and 60g/d), although bone mineral content
(BMC) in postmenopausal lactoovovegetarians (LOVs) and omnivores were comparable.
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It should be noted that in both studies mean calcium intakes (~750mg and ~930mg) were
comparable in LOVs and omnivores, and omnivores in California were twice as likely to
use antacids. Hunt (1994) proposed that there is no significant difference in BMC of
postmenopausal LOVs and omnivores when calcium intakes and protein intakes are
similar and within ranges usually reported for U.S. women (the U.S. daily reference
values (DRV) for protein is 50g/d). Per Kerstetter and Allen’s review (1994) a negative
calcium balance was not expected when protein intakes were below 75g/d and calcium
above 600mg/d. Only high protein intakes above reported normal ranges may promote
the earlier and greater bone loss reported in Eskimos (Mazess & Barden, 1991).
i. Dietary Protein and Bone Health in Vegetarians.

Various forms of

imaging the skeleton or bone scans provide the most direct assessment of current bone
status, indicated as bone mineral content (BMC) and bone mineral density (BMD).
Marsh, et al. (1980, 1988) studied about 1600 vegetarians in Southwestern Michigan who
volunteered for direct photon absorptiometry testing to measure BMC and BMD. They
reported that younger (<40 years) free-living, healthy Caucasian women who followed a
lactoovovegetarian (LOV) diet for twenty years or longer showed no statistical
differences in BMD when compared to matched women on omnivorous diets. However,
women between ages 50 and 87 years showed that with each increasing decade
statistically significant differences were apparent between the vegetarians and omnivores.
By the end of the eighth decade omnivores had significantly lower bone mass than the
vegetarians. Hunt, et al. (1989) studying vegetarians in California ages 31-81 years
(mean 35yr) and Tylavsky and Anderson (1988) studying vegetarians in North Carolina
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ages 60-98 years (mean 77yr) could not confirm Marsh's report of increased BMC and
BMD in elderly vegetarians when compared to omnivores.
Other studies are in consensus with the above findings that there is no significant
difference in BMC in pre-, peri-, and early post- menopausal vegetarian and omnivorous
women. Lloyd, et al. (1991) found no significant differences in the bone density of the
lumbar spine in premenopausal vegetarians and omnivores (mean age 35 years).
Tylavsky and Anderson (1988) showed a LOV diet to be a positive contributor
(p<0.05) to mid-radius BMC. However, the BMC at the mid-radius of the nondominant
arm did not differ significantly between LOV and omnivore women once the means of
BMC were age-adjusted. Chiu, et al. (1997) studied elderly vegans and LOVs in Taiwan
and found protein was a significant correlate of lumbar spine BMD. These vegans and
LOVs had mean protein intakes of 60.7g/d and 61.1g/d.
Lau, et al. (1998) found elderly vegans and LOVs in Hong Kong to have much
lower protein intakes than omnivores (<40g/d vs 60g/d) and that the BMD at the hip was
significantly lower in vegetarians. There was no BMD difference between vegans and
LOVs.
Tylavsky and Anderson (1988), Hunt, et al. (1989), and Lau, et al. (1998)
suggested that dietary protein positively influenced markers of bone turnover, BMC, and
BMD in vegetarian women consuming dairy foods. At lower mean protein intakes and
similar calcium intakes compared to omnivores, it appears the dietary practices of
lactoovovegetarians have no significant effects on BMC.
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Marsh, et al. (1988) found a significant difference in the acidity of the diets of
postmenopausal vegetarians and omnivores. The ash of the LOV diet was basic (+26
mmol NaOH) whereas that of the omnivore diet was acidic (+10 mmol HC1). The meatcontaining diet had a much higher sulfur content, further suggesting that dietary sulfur
may be facilitating bone loss through its effect on urine acidity. LOVs from menopause
to age 80 had higher BMD than omnivores, experiencing half the loss of bone mineral
(18% vs 35%).
i. Calcium-to-Protein Ratio.

Heaney (1998) argued that there is little

evidence outside of a metabolic unit that normal high protein diets reduce bone mass or
increase fracture risk. He summarized from 11 experimental studies, a linear relationship
between the change in protein intake and change in uCa across the entire range of intakes
from subnormal to excessive, meaning that a doubling of protein intake produces about a
50% increase in uCa. Yet, he found that increased protein intake in self-selected mixed
diets had a strongly positive association with calcium intake. Thus, there will generally
be no appreciable effect of protein intake on bone status at the population level. As a
consequence of this association, Heaney suggested that diets should not be evaluated
solely on protein or calcium contents but on their calcium-to-protein ratios. Based on the
1997 DRIs for premenopausal women, he suggested a recommended ratio of 20:1 mg
calcium/g protein (lOOOmg/d Ca: 50g/d protein). Applied to NHANES III data (NCHS,
1994; Alaimo, McDowell, Briefel, Bischof, Caughman, et al., 1994) women in their fifth
decade had a ratio of 9.3:1, a value less than half the recommended. A Ca:Protein ratio
may be a useful predictor of the diet’s effect on bone homeostasis.
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k. Calcium-to-Phosphorus Ratio.

Hegsted, Schuette, Zemel, and

Linkswiler (1981) reported that as protein intake increased, phosphorus from meats and
dairy foods blunted, but did not eliminate, urinary calcium losses. In a calcium balance
study Heaney and Recker (1982) found that as phosphorus intake rose, urinary calcium
excretion decreased, calcium absorption was significantly reduced, fecal secretion of
calcium increased and overall, there was little effect on calcium balance. In a review of
15 studies, Kerstetter and Allen (1994) concluded that while protein intake was held at
150 g/day, phosphorus intakes above 1500 versus phosphorus intakes between 1000 and
1500 mg/day reduced urinary calcium loss. No difference in urinary calcium excretion
was observed when protein was below 150 g/day and phosphorus intakes were high.
Phosphorus intake exceeds the RDA and exceeds calcium intake for women at all
ages (Calvo, 1993). Calcium intake for women falls below the RDA levels as early as
age 12 and continues to decline thereafter with age. This raises concerns for women
between adolescence and the late 20s when peak bone mass is reached. The imbalance
between calcium and phosphorus intake is debated. Some suggest that calcium is a more
critical factor than phosphorus. Spencer, Kramer, and Osis (1988) reviewed studies in
humans and concluded that dietary phosphorus failed to show an effect at adequate levels
of calcium intake. However, Calvo (1994) considered a slight excess of phosphorus
along with a low calcium intake to have a potentially adverse effect on peak bone mass.
Whereas calcium is abundant in few foods, phosphorus is widely distributed in many
foods. In addition, the International Food Additive Council estimated that phosphoruscontaining food additives used in food processing was 400 mg/d/person in 1980 and 470
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mg/d/person in 1990. It was suggested that nutritional databases greatly underestimate
actual phosphorus consumption (Calvo, 1994).
Metz, et al. (1993) found the Ca:P in young Caucasian women was positively
related to BMC at several sites (Ca:P=0.72, calculated from Ca= 1001 mg/d,
P=1361mg/d). Lukert, Carey, McCarthy, Tiemann, Goodnight, et al. (1987) also found a
positive correlation between the Ca:P ratio and bone density in perimenopausal women.
In contrast, Yano, Heilbrun, Wasnich, Hankins, and Voegel (1985) did not find a
correlation between Ca:P ratio and BMC in postmenopausal Japanese women.
Marsh, et al. (1988) conducted a 10-year dietary and bone mineral followup on
vegetarian and omnivorous postmenopausal women in Southwestern Michigan. The
followup study continued to support that the LOV diet was protective of BMD. Weighed
7-day food intakes revealed no statistical differences in intake of calories, protein,
calcium and phosphorus. However, the study showed a highly significant difference in
the Ca:P ratio. Calcium and phosphorus intakes were not significantly different but
calcium intake was slightly higher in the LOV diet and phosphorus intake was slightly
higher in the omnivore diet. Hence the difference in Ca:P ratio reached significance.
Although the Ca:P ratio is not reflective of bone preservation through decreased
urinary excretion, it is significantly associated with bone mass in several studies on pre-,
peri-, and post menopausal women and was found to be significantly different between
vegetarian and omnivore diets.
1. Vitamin D.

Aging reduces the efficiency of intestinal absorption of

calcium, due most likely to an age-related decline in 1,25-dihydroxyvitamin D or
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calcitriol production (Krall, Sahyoun, Tannenbaum, Dallal, & Dawson-Hughes, 1989).
Ergocalciferol and cholecalciferol are derived from dietary sources or synthesized in vivo
from sunlight exposure. These are the precursors to calcitriol, the potent form of the
hormone that modulates calcium absorption from the intestines and the rate of bone
remodeling. With a lower level of vitamin D, less calcium could be absorbed. As serum
calcium levels are lowered, parathyroid hormone (PTH) secretion would be triggered to
maintain serum calcium levels. Increased PTH could speed bone turnover creating the
potential for bone loss. Those disabled with fractures may have been limited in outdoor
activities and sunlight exposure. Because of greater sunlight exposure of younger women
and accessibility to vitamin D fortified foods, women in the United States are unlikely to
develop osteomalacia, a vitamin D deficiency condition where bones are
undermineralized. However, the elderly and frail may be sensitive to seasonal variations
when access to sunlight is already limited. The reference daily intake is 400 lU/d,
however the actual mean intake of vitamin D among uninstitutionalized elderly in North
America and Europe is about 100 lU/d (Krall, et al.)
Wolf, Cauley, Baker, Ferrell, Charron, et al. (2000) studied factors associated
with calcium absorption efficiency in 142 healthy pre and perimenopausal women.
Fractional calcium absorption was positively associated with serum 1,25
dihydroxyvitamin D (l,25(OH)D2) concentrations, as well as PTH concentrations. Krall,
et al. (1989) concluded that a dietary intake of 220 IU (100 IU per cup of fortified milk)
of vitamin D per day by postmenopausal women may be sufficient to maintain serum
calcitriol and PTH levels throughout the year without dependence on sun exposure.
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Supplementation trials with calcium and vitamin D reduce bone loss and prevent
fractures in elderly people. Dawson-Hughes, Harris, Krall, and Dallal (2000)
demonstrated in a 3-year randomized, placebo-controlled trial of calcium and vitamin D
supplementation that there were induced increases in spinal and femoral neck BMD in
295 elderly women and men. However, a 2-year followup where calcium or vitamin D
supplementation was discontinued, much of the spinal and femoral increases were lost,
however small benefits in total body BMD remained in men, but none in women.
Supplementation with vitamin D has limited cumulative effect on bone mass within two
years after supplementation is discontinued.
m. Fluoride.

Studies comparing communities in the United States

consuming 1 ppm fluoridated water with communities without fluoridated water have
provided little support that fluoride is protective against fractures and the use of fluoride
in the prevention of osteoporosis is not recommended (Inkovaara, 1994). In
pharmacologic dosages, fluoride produces abnormal trabecular bone changes and while
reducing vertebral fracture incidence cortical bone may be weakened and hip fracture
incidence increased (Cummings, et al., 1985). High fluoride doses can be very toxic,
should be limited to research use and not be used in the treatment of osteoporosis
(Inkovaara; Cummings, et al.).
n. Caffeine.

Increased caffeine consumption increases urinary calcium

excretion and has been implicated as a risk factor for osteoporosis. Peterson, 1998,
reported at an Experimental Biology meeting that the addition of caffeine to a soft drink
increased calcium excretion by 250% over three hours (from 6 mg to 20 mg per hour).
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The combination of caffeine and sugar almost doubled calcium lost through the urine
(16mg to 30mg per hour). He warned that “the experimental dose used in this study was
far less than the average teen’s daily consumption of caffeine and sugar.”
From the Framingham Study, fracture risk over each 2-year period of age
increased with increasing caffeine intake. Consumption greater than 2 cups of coffee or 4
cups of tea per day significantly increased the risk of fracture (Kiel, Felson, Hannan,
Anderson, & Wilson, 1990). On the other hand, Lloyd, Johnson-Rollings, Eggli,
Kieselhorst, Mauger, and Cusatis (2000) found in 138 postmenopausal women over two
years that habitual dietary caffeine intake had no association with total body or femoral
bone density. Morselli, Neuenschwander, Perrelet, and Lipuner (2000) reviewed dietary
influences on osteoporosis and summarized that caffeine also decreased calcium
absorption, but that this effect is a minor effect, compared to the significantly greater
effect of a high sodium, protein and an acid ash diet on urinary calcium loss.
Caffeine studies have been confounded by covariates including cigarette and
alcohol use, physical activity levels and HRT (Lloyd, et al., 2000). Two studies looked at
the relationships of caffeine, bone mass and calcium intake. Barrett-Connor, Chang, and
Edelstein (1994) found increased lifetime intake of caffeinated coffee to be associated
with decreased BMD in subjects who did not consume milk on a daily basis, but failed to
find a relationship for subjects consuming one glass of milk per day. Harris and DawsonHughes (1994) also found increased bone loss with increasing caffeine intake in subjects
with intakes of calcium below 744 mg/day, but not in subjects with higher calcium
intakes.
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o. Alcohol.

Felson, Zhang, Hannan, Kannel, & Kiel (1995) evaluated

1,154 members of the Framingham Cohort ranging from 68-96 years of age for an
association of alcohol intake with bone density, after adjustment for age, weight, height,
smoking, age at menopause and years of estrogen use. The 20 year cohort found women
who drank at least 7 oz/week of alcohol had higher bone densities at most sites (range
4.2-13.0% across all sites) than women in the lightest category of intake (<1 oz/week).
Lesser amounts of alcohol intake did not affect bone density, however, the authors
indicated that there may be augmentation of endogenous estrogen by the alcohol in
women who consumed the higher amount. Men who were classified as heavy drinkers or
alcoholic (> 14oz/week) have a high risk for osteoporotic fracture.
The Framingham study should not be interpreted as a license to drink more
alcohol. . Chronic drinking is associated with increased risk for falls, predisposing the
person to fractures. In regression analysis, Wolf, et al. (2000) found that dietary fat and
serum l,25(OH)D2 were positively associated and alcohol consumption and dietary fiber
were inversely associated with fractional calcium absorption. These positive and
negative independent predictors of calcium absorption in 142 healthy pre- and
perimenopausal women explained 21% of the observed variation.
p. Sodium.

Urinary sodium, reflective of oral or parenteral sodium

content, has been found to be one of the most influential factors on urinary calcium loss,
more important even than calcium intake alone. Nordin, Need, Morris, and Horowitz
(1993) described sodium’s effect on renal excretion of calcium as calcium being “pulled
out” of the body by sodium rather than excess calcium being “pushed out”. In load tests,
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sodium chloride salt can increase calcium excretion by as much as 30% (Hesse, et al.,
1993). In a sodium load, 100 mmol of sodium takes out approximately 1 mmol of
calcium in the urine (Nordin, et al., 1993). It is estimated that for every gram of sodium
ingested, the urinary loss of calcium increases 20-35 mg. In comparison, with every
gram of animal protein consumed, the urinary calcium increases by 1 mg (McBean, et al.,
1994). Dawson-Hughes, Fowler, Dalsky, and Gallagher (1996) found that at a given
sodium excretion, elderly men excrete more calcium than women. Urinary sodium and
calcium excretion were significantly correlated in both men and women (both p=0.0001),
however this association was significant at intermediate and high calcium intakes but not
significant at very low calcium intake levels. In this cross-sectional study using 24-hr
urinary sodium and calcium data and spine, hip and whole body BMD, urinary sodium
was not correlated with BMD.
q. Calcium-to-Sodium Ratio.

Several authors used a calcium-to-sodium

ratio to describe the association between calcium and sodium intakes and calcium and
sodium excretions, but have not recommended ratios that are more protective of bone
(King, Jackson, & Ashe, 1964; Goulding, 1981; Breslau, et al., 1982; Silver, Rubinger,
Friedlaender, & Popovtzer, 1983).
Animal studies by Goulding (1980) and Goulding and Campbell (1984) found
that salt-loading increased urinary calcium and reduced bone mass in rats, particularly on
a calcium-restricted diet. Nordin and Need (1994) reported that in their studies of preand postmenopausal women sodium-dependent calcium excretion stimulated bone
resorption (measured by hydroxyproline) in postmenopausal but not in premenopausal
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women. They concluded that salt intake is an important determinant of urinary calcium
excretion, particularly on low calcium diets and after menopause, but that sodium’s effect
on bone loss is inconclusive. In the UK, a small number of postmenopausal women
involved in an intervention study with a high sodium diet showed biochemical evidence
(uCa) of increased bone resorption in relation to women on a low sodium diet (Evans,
Chughtai, Blumsohn, Giles, & Eastell, 1997). Breslau, et al. (1982), however, suggested
that sodium induced hypercalciuria may be accompanied by an increased 1,25 (OH)2D
synthesis and intestinal absorption of Ca. This “adaptive mechanism” could result in no
serum calcium change after the salt load.
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E. Vegetarian Diet and Bone Mineral Density
The relationship of vegetarian diets to various chronic diseases has been
investigated in numerous studies. This has included the relationship to bone health. A
multivariate analysis by Finch, Brown, Mori, Nishii, and Slatopolsky (1992) showed that
the major determinant of osteomalacia in Asian Indians in South London was the
vegetarian diet. The authors concluded that "increasing severity of bone disease was
associated with increasingly strict vegetarian practice." Food components that may be
critically low in the vegetarian diet included energy, protein, calcium, vitamins D and
B12, and iron. A review of nutritional assessments of vegetarian diets (Janelle and Barr,
1995; Hunt, 1994) indicated that vegetarian diets contain less protein than non vegetarian
diets and were likely to be low in calcium where dairy foods are excluded. The higher
fiber content of the vegetarian diet also posed some concern regarding the possible
reduced bioavailability of minerals such as calcium. A severe or strict vegetarian diet
(i.e., a vegan or macrobiotic diet) has been associated with rickets in children, bone
demineralization in lactating women and osteomalacia (Specker, 1994; Finch, et al.).
Ellis, et al. reported in 1972 that LOV had more dense bone, however, they
subsequently retracted their findings noting the difference was not significant (Ellis, et
al., 1974). Marsh, et al. (1980) in Southwestern Michigan found younger (age <40 year)
free-living healthy Caucasian women on a LOV diet for 20 or more years showed no
statistical differences in bone mineral density when compared to matched women on
omnivorous diets. However, Marsh (1980, 1988) reported that mean bone mineral
content (BMC) at the radius of postmenopausal LOV women was higher than that of
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omnivores. Women between ages 50-87 years showed that with each increasing decade
statistically significant differences were apparent and by the end of the eighth decade
omnivores had 35% less bone mass whereas vegetarians had 18% less bone mass. In
contrast, Tylavsky and Anderson (1988), Hunt, et al. (1989), and Reed, et al. (1994) did
not find differences in bone density between postmenopausal lactoovovegetarians and
omnivores. Nor did Tesar, et al. (1992) who found that cortical bone density as well as
trabecular bone density were not significantly different in matched pairs of
postmenopausal Caucasian vegetarians and omnivores.
Chiu, et al. (1997) found long-term postmenopausal Taiwanese vegans compared
to LOV were significantly more likely to be osteopenic and to have BMD below the
lumbar spine fracture threshold. Lau, et al. (1998) found no significant difference in
bone mineral density (BMD) of the spine, but they found BMD of the hip was lower in
elderly Chinese vegetarians, both vegans and lactovegarians, than in omnivores. These
studies are remarkable for separating vegans from lactovegetarians for comparison, but
both reports studied postmenopausal vegans.
In premenopausal women with a mean age of 35 years, Lloyd, et al. (1991) found
statistically non-significant differences in density of the lumbar spine in
lactoovovegetarians compared to omnivores. Barr, Prior, Janelle, and Lentle (1998)
found younger (28 ±3.2 years) premenopausal vegetarians, including both vegans and
LOVs, tended to have lower BMD in the spinal region than omnivores. Attempts to
differentiate vegans from lactoovovegetarians failed to show differences in BMD despite
vegans consuming an average about 300 mg/day less calcium. However, the study was
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limited by the small sample of vegans (n=5). The inclusion criteria included women 2040 years of age who had maintained their diets for 2 or more years. Although vegetarian
diets had been maintained for 4.6 ± 2.8 years (range 2-15 years), no data were available
identifying how long the vegans had maintained their diet. Outila, et al. (2000) found
lower BMD of the spine and femur in premenopausal vegetarians in Finland, particularly
in vegans when compared to lactoovovegetarians and omnivores. The BMD differences
were not significant but were attributed to the significantly lower dietary vitamin D and
serum 25-OH vitamin D levels. Calcium intake of vegans did not differ from omnivores
(mean 743 and 808 mg/day). Although vegetarians had maintained their diet for a mean
of 7 years (range 2-16 years), the vegan sample size was very small (n^S) and there was
no information on the length of time the vegan diet was followed. There is concern that
long-term vegetarians, specifically vegans, may have lower bone densities than
omnivores before reaching menopause.
Johnston (1997) reported that premenopausal Caucasian women consuming vegan
diets had significantly lower BMD than women consuming lactoovovegetarian or
omnivorous diets. In this study, premenopausal women had to have maintained their
vegetarian diets 4 or more years. Vegans (n=17) had maintained a vegan diet for a mean
of 12.9 (+ 8.6 SD) years. Most had maintained a LOV diet previously with the mean
total years as a vegetarian being 24.1 + 10.7 years. LOVs (n=17) maintained their diets a
mean of 23.6 + 9.9 years. This study uniquely looked at vegans who have maintained
their diets for a much longer time than previously examined and the sample size that was

65

larger. BMD at the spine was found to be significantly lower in vegans than in
lactoovovegetarians and omnivores (n=16).
Table 3 summarizes recent studies comparing the bone mineral density between
vegetarians and omnivores.

66

Table 3.
The Vegetarian Diet and Bone Mineral Density
Researchers

Design

Characteristics

N=

Findings

Outila, et al.,
2000

BMD at
spine and
femur

Vegans
= 5 Premenopausal
(on diet 2-16yr) Caucasians in
LOVs
= 6
Finland
Omnivores =16

N.S. but lower
BMD in vegans;
low in vit.D

Johnston,
1997,1999

BMD at
spine

Vegans
=17 Premenopausal
(on diet 4-34yr)
Caucasians
LOV
=17
in California
Omnivores =16
Ages 20-42

BMD of spine
significantly
lower in Vegans

Barr, et al.,
1998

BMD at
spine
baseline and
at 1-year

Vegans
= 5 Premenopausal
(on diet 2-1 Syr)
Caucasians
LOV
= 6 western Canada
Omnivores = 9
Ages 20-40

BMD of vegans
and LOVs less
than omnivores
(p=.06)

Lau, et al.,
1998

BMD at
spine, radius,
hip

Vegetarians=76 Elderly Chinese
Buddhists
Omnivore =109
in Hong Kong
Ages 70-89

Hip BMD lower
in vegetarians
than OmVs; no
diff. V & LOV

Chiu, et al.,
1997

BMD at
spine and
femur

Vegans&LOVs= Postmenopausal Longterm vegans
258; 71 of 169
Taiwanese
risk osteopenia at
vegans
Buddhists
spine and femur
(on diet >15 yr)
Ages 40-87

Reed, et al.,
1994

5-yr study of
BMD

LOVs
= 49 Postmenopausal BMD not differ in
Omnivore=140 SDALOVs in
LOVs, OmVs
North Carolina
Ages 76-81

Tesar, et al.,
1992

BMC and
BMD of
radius

=28 Postmenopausal
LOVs
women in
(LOV>10yrs)
Florida;
Omnivores =28

67

BMC and BMD
not differ in
LOVs, OmVs

Table 3 (continued). The Vegetarian Diet and Bone Mineral Density
Researchers

Design

Lloyd, et al.,
1991

BMD at
spine

Tylavsky and
Anderson,
1988

BMD, BMC
at radius

Hunt, et al.,
1989, 1988

BMC

Marsh, et al.,
1988

BMD at
radius

Marsh, et al.,
1988

10-yr study
of BMD

Marsh, et al.,
1980

BMC at
radius

LOV>10y=200
Omnivore = 71
51matchd pairs

Premenopausal
SDA LOVs in
Michigan
Ages 20-49

No difference in
3rd,4th,S"1 decade

Ellis, et al.,
1972,1974

BMD at 3rd
metacarpal

17 LOV
matched w/
17 Omnivores

Postmenopausal
LOVs from
minority groups
in Britain

BMD in LOV
reported higher;
later retractedhigher but n.s.

N=

Characteristics

Findings

LOV
=27 Premenopausal
No significant
Omnivores=37 Mean age 35y, in different BMD
Pennsylvania
in LOVs, OmVs
LOV>16yr =90 Postmenopausal
SDA
Omnivore
Ages
60-98, in
=290
North Carolina

BMD at radius
not differ in
LOVs, OmVs

Omnivore=146 Methodists &
BMC not differ
LOV
=144 SDAvegetarians in vegans,LOVs,
(of which 16
in California
OmVs; diet not
were vegans)
Ages 31-81
corr. with BMC
400Vegetarians
4% Vegan
(subgroups too
sm. for signif.
findings)

SDA women at
conference in
Nebraska

(vegans using no
milk & LOVs
using meat
regularly had
least BMD)

1600
Pre-,
By age 65 BMD
postmenopausal of LOV signif. >
Vegetarians
with subset of Caucasian in SW OmV; BMD not
Michigan
20yr-LOVs
diff <40y
Age < 40 yr
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F. Assessment of Bone Metabolism
The majority of studies investigating bone status in vegetarians have been
conducted on postmenopausal women when the changes leading to osteoporosis are
greater and fracture risks increase. Studies have used various methods to evaluate BMC
and BMD; a few investigated biomarkers of bone metabolism. Measurement of the
biomarkers provides a means of identifying what aspect of bone metabolism is perturbed.
Bone loss is a consequence of an imbalance between bone formation and bone
resorption, that is, decreased bone formation and/or increased bone resorption. Bone
scans are static records of bone status over time, but do not reveal the level of flux
between bone formation and resorption.
Much recent research has focused on highly specific and highly sensitive
biochemical markers of bone metabolism in serum and urine. Biomarkers indicating
osteoblastic or bone formation activity include osteocalcin, alkaline phosphatase, and
propeptides of type I procollagen. Biomarkers indicating osteoclastic or bone resorption
activity include pyridinoline and deoxypyridinoline, and N-terminal telopeptides. The
measurement of parathyroid hormone (PTH), urinary calcium and urinary hydroxyproline
are indicators of the overall rate of remodeling activity in bone.
Urinary calcium and hydroxyproline have been criticized for their low reliability
in reflecting normal bone status, and parathyroid hormone levels, an indicator of bone
turnover activity, for its nonspecificity except in disease states. In order to understand
the usefulness of various biomarkers it is necessary to understand something of bone
biochemistry.
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1. Biochemistry
Type I collagen is the most abundant collagen type in the body. It is found in
loose connective tissue together with other collagen types, such as III, V, and VI. In
bone, osteoid matrix consists principally (90%) of the type I structural protein, which can
be rapidly mineralized. Osteoblasts synthesize three alpha chains, consisting of repeating
units of mostly glycine-proline-hydroxyproline, which fold to form a triple helix. Type I
collagen contains two alpha-1 (a-1) and one alpha-2 (a-2) chains. A newly translated
polypeptide, a pre-pro-alpha-chain, which will ultimately become part of Type I collagen,
includes a signal sequence and amino (N) and carboxy (C)-terminal propeptide
extensions. Once the larger procollagen molecule is formed, the small propeptide
fragments are removed by specific proteases before the collagen molecules are assembled
into fibers. In type I collagen, intramolecular disulfide (S-S) bonds form between the
carboxyl propeptides of the three chains and may guide the triple helical formation. The
procollagen molecule is then transported from the rough endoplasmic reticulum to the
Golgi for additional glycosylation and subsequent secretion into the extracellular space as
collagen. Once secreted and during fibrillogenesis and fibril maturation, the procollagen
Type I N- and C- terminal propeptides (PINT or N-PCP and PICP) are cleaved by
specific peptidases and these propeptides can enter the circulation. In bone, the Npropeptide of the a-1 chain has been found in extracts of the mineralized matrix. While
collagen array into fibrils, cross-linking occurs between lysine and hydroxylysine side
chains. When crosslinks are derived from hydroxylysine, the mature crosslinks are 3hydroxypyridinium structures called pyridinolines. Two forms, pyridinoline and
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deoxypyridinoline can be identified. When osteoclasts degrade collagen fibrils,
circulating molecular fragments of pyridinoline cross-links range from free amino acids
to segments of N-telopeptide (NTx) and C-telopeptide domains (telo = Greek "end").
Upon resorption of bone, hydroxyproline and calcium are released and can be detected in
the urine. Elevated levels of urinary hydroxyproline and urinary calcium have been
associated with increased bone turnover in bone-related diseases.
Other markers of bone turnover are not related to collagen synthesis. Osteocalcin
is a small Ca-binding protein synthesized by osteoblasts that becomes part of the bone
matrix. Some of it spills over into the circulation where its concentration is a commonly
used marker of bone formation rate. The higher the osteocalcin level, the greater the
formation activity or the greater the breakdown of bone, releasing bound osteocalcin.
Serum OC (sOC) can be both a marker of formation and if elevated, of turnover. More
recently, Taylor, et al., 1990, developed an assay for urinary osteocalcin (uOC) that is
more sensitive to changes in bone formation rates than previous assays. Bone-specific or
skeletal alkaline phosphatase (sALP) is an enzyme in serum also arising from osteoblastic
activity; it has been used as a marker of bone formation. Tartrate-resistant acid
phosphatase (TRAP) is an enzyme in serum arising from osteoclastic activity and was
recently introduced as a biomarker of bone resorption (de la Piedra, Torres, Rapado, Diaz
Curiel, & Castro, 1989).
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G. Specificity and Sensitivity of Biomarkers to Changes in BMD
Guerrero, Diaz Martin, Diaz Diego, Disla, Rapado, and de la Piedra (1996) and de
la Piedra, Traba, DominguezCabrera, and Sosa Henriquez (1997) published comparative
studies, both titled, “New biochemical markers of bone resorption... in the study of
postmenopausal osteoporosis.” Guerrero, et al. compared urinary free pyridinolines
(Pyr), serum pyridinoline cross-linked carboxy-terminal telopeptides of type I collagen
(ICTP), the C-telopeptide of the alpha 1 chain of type I collagen (CTx) with the classical
biochemical marker hydroxyproline (Hyp) and with bone mineral density (BMD) of the
lumbar and femur. CTx showed the highest diagnostic accuracy or sensitivity in relation
to the other biomarkers. The second study (de la Piedra, et al.) compared the sensitivity
of several biochemical markers used to detect bone resorption changes, specifically,
urinary calcium, (uCa), pyridinoline (Pyr), deoxypyridinoline (Dpy), CTx, and aminoterminal crosslinked telopeptides of collagen I (NTx). Adjusted by daily creatinine
excretion, all biochemical markers of bone resorption were significantly increased in
osteoporotic patients compared to control women. Among them, Dpy, CTx and NTx
presented the best discrimination between the two groups of women, with respective
sensitivities of 79%, 79%, and 52%, and 100% specificity each. Pyr and uCa, while
useful indices, were significantly less sensitive in detecting differences between normal
and osteoporotic women. Three years later Souberbielle, Cormier, and Kindermans
(1999) reviewed these “new” and the more traditional biomarkers used in clinical
practice. They concluded, “To date, the most valuable bone markers are serum
osteocalcin, bone-specific alkaline phosphatase, and the N-terminal propeptide of type I
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procollagen [PICP] for bone formation and urinary measurements of the phenzopyridine
crosslinks [Dpy, Pyr] and related telopeptides [NTx, CTx] for bone resorption.” In
summary, elevations of biochemical markers of both resorption and formation are
diagnostically accurate in detecting bone loss and may predict, albeit imperfectly, the rate
of bone loss.
Urinary markers are responsive to factors that affect bone metabolism. A 5-day
trial determined that Pyr and Dpy excretions did not vary with high and low protein
intake but they were significantly lower by about 33% during the period of high calcium
compared to low calcium intake (Shapses, et al., 1995). Significant and rapid reduction
in Dpy, NTx, and CTx resorptive markers were reported in the first two weeks after
initiating drug treatment in osteoporotic patients, with urinary excretions reaching a
plateau after 2-4 weeks of treatment (Bettica, Masino, Cucinotta, Vago, Norbiato, et al.,
1997). These are but a few of the studies showing these markers are sensitive to short
term dietary and drug interventions and can be useful in monitoring treatment
effectiveness as well as long-term status of bone.

1. Criteria for Biomarkers of Bone Turnover
Table 4 lists criteria for selecting biomarkers of bone turnover. These biomarkers
listed have all been validated with specific populations and under certain conditions.
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Table 4.
Criteria for Ideal Markers of Bone Turnover

1. The procedure should be minimally invasive—convenient for frequent testing,
without undue risk or discomfort to the patient. Blood sampling and urine
collections are easily obtained.

2. The analyte or biochemical marker is unique to bone, or more specifically to
either the osteoblastic formation of bone or the osteoclastic resorption of bone
matrix.

Biomarkers for Resorption that measure the collagen degradation products
from osteoclastic activities:
•
•
•
•
•

total and free pyridinoline crosslinks (PYR, D-PYR)
crosslinked N telopeptides (NTx)
crosslinked C-telopeptides (CTx)
urinary hydroxyproline (HPr)
hydrosylysine glycosides (Hlg)

Biomarkers for Resorption that measure osteoclastic enzyme levels:
•

tartrate-resistant acid phosphatase (TRAP)

Biomarkers for Formation that measure osteoblastic enzyme levels:
•
•

serum alkaline phosphatase (ALP)
bone-specific or skeletal alkaline phosphatase in serum (bAP or sALP)

Biomarkers for Formation that measure osteoblastic products:
•
•

osteocalcin in serum and urine (sOC, uOC)
type I procollagen peptides (PICP, PINP)
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Table 4 (continued).
Criteria for Ideal Markers of Bone Turnover

3. A validated marker would:
correlate with a standard reference of bone remodeling activity e.g.,
stable
isotopes, radio-calcium kinetics (^^Ca), and bone histomorphometry,
correlate to measured changes in bone mass
respond appropriately after treatment in diseases known to affect bone
turnover
show great responsiveness to small changes (sensitivity)
be assayed reliably, with small %CV in measurement (assay
methodology)

4. Analytes are localized markers that reflect activity at a specific site versus
systemic biomarkers that may reflect not just changes in cortical or
trabecular bone, but collective remodeling throughout the entire
skeleton, and even other tissues (e.g., skin, liver, etc.)

5. Analytes could be controlled for factors of variability, including:
circadian rhythm
gender and ethnicity
age
diet
body and bone mass differences (weight, muscle mass)
physical and metabolic activity
regular menses
renal function, disease states
drugs and supplements
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H. Biomarkers of Bone Formation
1. Osteocalcin (sOC, uOC)
Osteocalcin, also called bone gla protein or BGP, is a 49 amino acid peptide that
is a vitamin K-dependent calcium binding protein. The synthesis of osteocalcin by
osteoblasts, the bone forming cells, is activated by calcitriol (l,25-(OH)2 vitamin D) and
parathyroid hormone (PTH). It constitutes 0.03% of the noncollagenous proteins in
human bone matrix compared to up to 20% of the noncollagenous proteins in bovine
bone matrix (Taylor, Linkhart, Mohan, & Baylink, 1988). Although osteocalcin binds
tightly to hydroxyapatite, the mature bone crystals, a fraction of the newly synthesized
intact molecule is released into the blood and is detectable by various assays. Serum
osteocalcin concentration (sOC) is thought to be an indirect but very specific biological
marker for bone formation rate. Research indicates sOC correlates well with sALP and
can be used as a biomarker for bone formation (Taylor, et al., 1990).
One disadvantage of using sOC is the large flux in circulating levels, peaking
during the late night and early morning and dropping during the late mornings and early
afternoons. sOC has a very short half-life, reflecting acute changes in circulating OC
levels. While urinary osteocalcin (uOC) has a diurnal pattern similar to sOC, the
determination of a 24hr uOC eliminates the concerns with diurnal variation and provides
an integrated value of daily bone turnover. Osteocalcin contains 3 gamma-carboxyglutamic acids (GLA) and 2 potential sites for tryptic digestion at positions 19-20 and 4344. Breakdown of the protein occurs in the liver, kidney and plasma, resulting in
peptides 1-19, 20-43, 1-43, and 20-49 which are excreted in the urine.
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Radioimmunoassay (RIA) is particularly effective in quantifying these peptides of
osteocalcin.
Taylor and colleagues (1990) used a midmolecule specific human OC RIA
(radioimmunoassay) and were able to detect OC in urine of normal and diseased adults
and children. While sera contain primarily intact molecules of OC, urine does not, but
rather contains multiple fragments of OC. Separation by HPLC detected OC fragments
in normal adult urine but not in normal adult serum, and fragments were found in the
urine of diseased subjects that were not seen in sera previously (Taylor, et al.). The
major uOC peak corresponds with the peak of intact serum OC. Urinary OC is highly
correlated with both sOC (r=0.83, p<0.001) and sALP (r=0.91, p<0.001), both markers of
bone formation. Statistical analyses support uOC as a useful indice of bone formation
and as better able to detect high rates of bone turnover than sALP or sOC (Taylor, et al.).
Osteocalcin has been shown in histologic studies to be correlated to bone
formation. A Finnish study (Parviainen, Kuronen, Kokko, Lakaniemi, Savolainen, &
Mononen, 1994) observed an age-related decrease in serum intact osteocalcin in females
younger than 50 years while an increase was observed in older women. In younger
females the findings suggest a decrease in bone formation activity, while an increase in
the older women suggests increased bone remodeling, including both resorption and
formation. However, the Finnish study should be considered cautiously as the study
population consisted of only 14 females aged 2-77 years.
Johnston, Hunt, Murphy, Baylink, and Clemens (1987) found that age-adjusted
mean BMC was significantly lower in postmenopausal women who had high plasma
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osteocalcin. Subjects with osteocalcin levels greater than one standard deviation above
the mean had significantly lower BMD. Significantly greater osteocalcin and alkaline
phosphatase levels were found in vegetarian postmenopausal women compared to women
consuming an omnivorous diet (Johnston, 1987). Although there were no significant
differences in BMD between the vegetarian and omnivore groups, the significantly higher
plasma activity indicated a higher rate of bone turnover in vegetarians. A tendency
(p=0.053) toward an inverse relationship between plasma osteocalcin and dietary calcium
intake was demonstrated for the first time in postmenopausal women.
Kung, Luk, Chu, and Chiu (1998) studied three groups of Chinese women in
Hong Kong consuming low calcium diets. The mean calcium intake of the three groups
was not significantly different and was between 554-587 mg/d. There were 25
postmenopausal women with osteoporosis (BMD < 2.5 S.D. below the normal mean), 25
age-matched controls, and 15 premenopausal women with normal BMD. Elevated
serum osteocalcin and alkaline phosphatase, indicating high bone turnover, were found in
those women with osteoporosis. Osteocalcin was significantly reduced when
osteoporotics received supplements of 1200mg calcium.

2. Skeletal Alkaline Phosphatase (sALP)
Bone-specific or skeletal alkaline phosphatase (sALP) is an osteoblast membranebound protein. Quantitative measurement of sALP activity in serum can provide an
index of bone formation rate. sALP is stable in serum with a long half-life and it requires
no rigorous specimen handling. A recently accepted assay of sALP uses monoclonal
anti-sALP antibody coated microplates to capture and quantitate serum sALP activity
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(Metra Biosystems, Inc, Mountain View, California). Elevation of sALP reflects
increased osteoblastic activity and is symptomatic for bone disorders. In bone disease,
sALP is markedly elevated in osteoitis deformans, moderately elevated in rickets,
osteomalacia, hyperparathyroidism and metatastic bone disease; and slightly elevated in
healing fractures (Metra kit).
It is known that other factors than osteoblastic activity can alternately stimulate or
inhibit sALP and collagen activity. Osteoclastic precursors include the monocytes and
macrophages that produce the cytokines and growth factors interleukin-1 (IL-1) and
tumor necrois factor (TNF). IL-1 and TNF stimulate and inhibit DNA and collagen
synthesis depending on concentration and exposure time. Both IL-1 and TNF have been
shown to inhibit sALP and osteocalcin production (Metra kit). Despite the ability of
these factors to alter sALP activity, it remains a well-accepted measure of bone formation

3. Procollagen Type IC- and N- terminal Propeptides (PICP, NPCP)
Type I collagen is synthesized by osteoblasts as a larger procollagen molecule
with propeptide extensions at both the N-terminal and C-terminal ends. Once formed, the
small propeptide fragments are removed by specific proteases before the collagen
molecules are assembled into fibers. The propeptide removed from the C-terminal end of
the procollagen molecule (Procollagen type I C-terminal Propeptide or PICP) is found in
blood with levels reflecting the synthesis of type I collagen. Increased levels of PICP are
seen in a number of conditions involving somatic growth or an enhanced rate of
metabolism in bones, such as in children, in Paget disease, or in rapid bone loss states
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after menopause (VA Bone Metabolism Lab and RIA kit, INCSTAR Corporation,
Stillwater, Minnesota).
The N-terminal propeptide of type I procollagen (N-PCP) is a recently elucidated
biomarker of bone formation for which a commercial assay is currently being developed
(VA Bone Metabolism Lab and INCSTAR). Santi, Monti, Vigano, D’Aprile, Rampoldi,
et al. (1995) correlated PICP with alkaline phosphatase (r=0.50, p<0.01) as a marker of
bone formation. PICP was also correlated with the resorption biomarker, tartrateresistant acid phosphatase (TRAP) (r=0.34, p<0.05), reflecting the coupled processes in
bone turnover. However, the researchers suggested that clinical usefulness of PICP and
NPCP needed further evaluation.

4. Parathyroid Hormone (PTH)
Over the past 20 years, much work has been done to differentiate factors leading
to the pathogenesis of Type I osteoporosis, which affects predominantly cancellous bone.
Patients with Type I osteoporosis tend to be females who are postmenopausal. They have
decreased circulating estrogen levels which lead to increased osteoclastic bone
remodeling and bone destruction. The resulting increase in bone loss leads to an increase
in plasma calcium, which initially suppresses PTH secretion. However, osteoclastic bone
activity also initiates bone formation, which decreases serum calcium and results in
increased PTH secretion with its increased intestinal absorption and increased renal
resorption of calcium. Elevated PTH is a biochemical marker for bone remodeling
activity and is currently measured by ^5j0(jine_ra(iioimmunoassay (PTH, Nichols RIA
kit).
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I. Biomarkers of Bone Resorption
1. Hydroxyproline
Research has emphasized the importance of comparing serum indicators of bone
formation with urinary excretion of resorption biomarkers to obtain an adequate
evaluation of bone metabolism. Until recently, there was no simple, reliable method for
monitoring bone resorption rate. Urinary hydroxyproline had long been the standard
biochemical marker and used as an index of bone degradation in Paget’s bone disease and
severe hyperparathyroidism. It is clinically useful when there are greatly increased rates
of bone resorption. Unfortunately, it is also acknowledged that there are sources of
hydroxyproline other than bone resorption, including the diet, turnover of soft connective
tissue, and byproducts of collagen biosynthesis (Hanson, Weis, Bollen, Maslan, Singer,
& Eyre, 1992). Thus, hydroxyproline, while useful, is not as specific an indicator as
needed.

2. Pyridinoline Crosslinks—Pyridinoline (Pyr) and Deoxypyridinoline (Dpy)
Bone resorption can be estimated by measuring the various breakdown products
of the bone. These include pyridinoline (Pyr) or hydroxylysylpyridinoline and
deoxypyridinoline (Dpy) or lyslpyridinoline crosslinks, which stabilized interactions
among collagen chains and provided strength to tissues. Pyr is abundant in bone and
cartilage, while Dpy is largely, but not entirely, confined to bone. The crosslinks appear
in serum and urine after collagen is degraded or bone is resorbed. Pyridinoline crosslinks
have proved to be sensitive indicators of rapid change in bone metabolism.
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Both Pyr and Dpy can be measured by enzyme-linked immunosorbant assays
(ELISA kits) or by high pressure liquid chromatography (HPLC, VA Bone Metabolism
labs). Although the HPLC method has been greatly refined and has been validated as the
standard method for determining pyridinoline crosslinks, it is still a difficult and tedious
procedure with over forty pipeting steps in a span of four days for each sample.
Bone formation is a dynamic process where osteoblasts form new bone apparently
in response to osteoclastic resorption activity. Both these processes appear to have
circadian rhythms, with increased bone activity at night. Eastell, Calvo, Burrit, Offord,
Russell, and Riggs (1992) showed that urinary excretion of Dpy is increased at night in
both premenopausal and postmenopausal women. Schlemmer, Hassager, Jensen, and
Christiansen (1992) showed a marked, almost twofold increase in night excretion values
of urinary pyridinium crosslinks compared to afternoon values. A complete 24 hour
urine collection eliminates the marked diurnal variation with peak Pyr and Dpy
excretions at night and troughs in the afternoon. Thus, as specific as Dpy is to bone, it
also shows considerable day-to-day variation—up to 20% in the same person. The
concentration of Pyr and Dpy is not constant in bone, also being sensitive to estrogen
therapy, age, bone type, and possibly diet and exercise as well. These factors may affect
the ability of these assays to discriminate between different clinical populations.
A study by Schlemmer, Hassager, Pederson, and Christiansen (1994) used 27hour urinary samples, collected in 3-hour aliquots beginning at 1400 hour and ending at
1700 hour. Meal times were controlled but the content, including gelatin was not
controlled. This Copenhagen study included 45 pre- and post-menopausal women
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divided into 4 groups—9 healthy premenopausal women, 12 healthy, early
postmenopausal women (mean 55 years), 12 elderly postmenopausal women (mean 73
years), and 12 osteopenic women (mean 73 years). Schlemmer tried to resolve the
questions raised earlier due to study design. He was able to conclude that the significant
circadian variation in pyridinium crosslinks measured as pyridinoline/creatinine and
deoxypyridinoline/ creatinine was not related to age, menopausal status, or asymptomatic
osteopenia. Further, after eliminating diurnal differences, a highly significant 23-43%
increase in both Pyr/cre and Dpy/cre was seen at the time of menopause, indicating
increased levels of bone resorption. Arbault, Grimaux, Pradet, Preaudat, Seguin, and
Delmas (1995) studied 41 premenopausal women and 42 postmenopausal women and
found that urinary Pyr increased significantly with age in women, averaging 55%
increase between the pre- and post- menopausal women (p<.001).
Claassen, et al. (1995) found free urinary Pyr and Dpy correlated well with total
hydroxyproline (r=0.7). Alvarez, Guanabens, Peris, Monegal, Bendini, et al. (1995) in a
study of Paget’s disease found pyridinoline crosslinks to be the most sensitive marker of
bone resorption (73%) when compared to hydroxyproline (64%), deoxypyridinoline
(60%), telopeptide C-terminal propeptide of type I collagen (ICTP, 41%) or tartrateresistant acid phosphatase (TRAP, 39%).

3. N-Telopeptide Crosslinks (NTx)
The N-telopeptide (NTx), a pyridinoline-forming fragment, is the short sequence
of amino acids from the N-terminal end of type I collagen molecules that have cross-
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linked to other collagen molecules via a ring structure. NTx is a direct product of bone
resorption.
Hanson, et al. (1992) established that the NTx was abundant, consistently
recovered and could provide a quantitative index of the total pyridinoline pool by
immunoassay. They were able to show that NTx within-subject variability was one-half
to one-third less than that observed for other biomarkers of resorption—fasting urinary
calcium, hydroxyproline and Pyr/day. The telopeptide significantly and positively
correlated with serum osteocalcin, a formation marker, and significantly and inversely
correlated with lumbar spine BMD.
Gamero, Shih, Gineyts, Karpf, and Delmas (1994) studied 46 premenopausal
women and used several methods to test the sensitivity and clinical usefulness of serum
markers of bone formation, such as osteocalcin and bone alkaline phosphatase, and
markers of bone resorption, such as urinary NTx and urinary free-pyridinoline (F-Pyr).
Bone mineral density was measured at the spine and hip with DXA (dual energy x-ray
absorptiometry) bone scans to provide baseline data. Seven blood and urine collections
were made over 15 months as well as after an intervention. Highly significant
correlations were observed between the percent change in bone markers at 6 months and
the percent change in spine BMD after 18 months, with NTx and F-Pyr the most sensitive
markers for resorption and sALP and sOC the most sensitive for formation. The
functional properties of these eight methods in assessing bone metabolism were
compared. Multiple measures were made over time on the same subjects, thus testing
reproducibility and reliability of results. The assays were conducted at baseline and with
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intervention-placebo groups to determine sensitivity of the test under different conditions,
and results were verified by DXA bone scans at two sites. The sensitive and specific
application of NTx to both normal and diseased subjects and the relative ease of the assay
encourages its use in future studies on bone resorption.

J. Urinary Markers of Calcium Loss
1. Urinary Calcium
Fasting urinary calcium (uCa), corrected by creatinine excretion (uCa/cre), is the
oldest marker of bone resorption and is widely used all over the world as the first step in
biochemical assessment of bone metabolism (Lakatos, Takacs, Buki, Nemeth, &
Horvath, 1997). The uCa/cre ratio increases with age in both men and women with
significant differences before and after 45 years of age in women (0.37 + 0.36 vs 0.52 +
0.41, p<.001) (Lakatos, et al.). Use of uCa/cre is limited, however, because of the
influence of circadian variations, age, dietary protein, sodium and calcium, starvation,
and even acute exercise. Because bone resorption is active at night, 24hr urine specimens
are used in most studies. Contributing factors may include an increase of uCa with age, a
decrease of creatinine clearance with age, and/or a decrease of lean body mass, reflected
by creatinine levels, with age (Lakatos, et al.).

Metabolic acidosis, induced by an

increase in dietary protein, fasting induced ketoacidosis, or an intense bout of exercise,
exceeding aerobic capacity, can increase urinary calcium excretion (Lakatos, et al.).
Increased urinary calcium (uCa) excretion may ultimately lead to calcium loss
sufficient to induce osteoporosis (Einhom, 1990). Dietary protein and sodium at high

85

intake levels are known calciuretic factors (Einhom). The increased calcium excreted
results from the potential use of calcium to buffer the acid-ash loads typical of diets high
in non-dairy animal proteins. A low protein diet (Linkswiler, Zemel, Hegsted, &
Schuette, 1981) or a diet low in animal protein but high in soy protein (Zemel, 1988) was
found to maintain the balance of Ca.
The increase in uCa excretion resulting from a high intake of protein may in part,
reflect an increase in bone resorption (Kerstetter, et ah, 1999). However, Tesar, et al.
(1992) did not find significant differences in cortical or trabecular bone density at any site
except the skull in 28 matched pairs of postmenopausal Caucasian LOVs and omnivores
despite several differences in dietary intakes, including significantly lower protein intake
by vegetarians. The urinary calcium and creatinine excretions were similar between the
groups and serum total protein was higher in vegetarians.
Urinary Ca excretion and its association with biomarkers of bone metabolism
have not been compared among premenopausal women consuming vegan,
lactoovovegetarian and omnivorous diets.

2. Urinary Sodium
Dawson-Hughes, et al. (1996) reported significant links between urinary sodium
and urinary calcium (r=0.26, p<0.0001) at moderate to high calcium intakes but not at
low calcium intake in 665 elderly women. She found no correlation between urinary
sodium and BMD. Evans, et al. (1997) reported biochemical evidence based on uCa of
increased bone resorption resulting from a high sodium diet in relation to a low sodium
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diet. However, Lietz, Avenell, and Robins (1997) found that at a fixed 816 mg
calcium/day, a high or low sodium diet affected uCa, but did not affect Dpy, a marker for
bone resorption. The study concluded that dietary sodium can affect calcium metabolism
but that at sodium levels used in this intervention trial, bone resorption changes could not
be demonstrated.
Ginty, et al. (1998) found that as dietary sodium doubled, urinary sodium
increased two-fold in both salt-sensitive and salt-insensitive young women, and urinary
calcium increased 73% only in the salt-sensitive women. Pyr and Dpy, sOC, sALP,
biomarkers of both bone turnover and formation, were unaffected by dietary sodium
levels. The researchers concluded that in salt-sensitive healthy young women, sodiuminduced calciuria might not be the result of increased bone turnover but a possible
adaptation of increased dietary absorption to compensate for the increased uCa loss.
Lau, et al. (1998) conducted a study on 76 Chinese elderly vegetarian women and
109 elderly omnivores. Urinary sodium was correlated with urinary calcium excretion.
The urinary sodium/creatinine was significantly higher in vegetarians than in omnivores
and the uNa/cre was negatively and significantly associated with BMD. There were no
differences, however, in biomarkers and BMD between vegans and lactoovovegetarians.
Evans, et al. (1997) studied pre- and postmenopausal women in the United
Kingdom on a high or low sodium intake for two weeks. Urinary sodium and urinary
calcium were significantly elevated with the high sodium intake. Bone resorption
markers in this study were affected in postmenopausal women, but not in the younger
women.

87

Mizushima, Tsuchida, and Yamori (1999) found that Japanese women consuming
a higher calcium diet were likely to receive the calcium from small salted fishes, and thus
would be consuming a higher sodium diet. Comparing 48 women on the higher calcium
(and salt) vs lower calcium (<600mg/day) diet, the higher calcium and salt diet was
related to a significantly lower BMD. Despite the higher calcium intake, moderate salt
restriction was recommended by the authors to decrease BMD loss.
Another Japanese study (Itoh, Suyama, Oguma, & Yokota, 1999) measured
urinary sodium as part of the assessment of sodium intake in 421 women, ages 50-79
years. They found that deoxypyridinoline was positively and significantly correlated
with the excretion of urinary sodium (p<.05) and urinary calcium (p<.01). The
researchers concluded that habitually high levels of sodium in the diet may result in bone
loss through accelerated bone resorption and calcium loss.
Several authors have used a calcium/sodium ratio to describe the association
between calcium and sodium intakes and calcium and sodium excretions, but have not
recommended ratio levels that are more protective of bone (King, et al., 1964; Goulding,
1981; Breslau, et al., 1982; Silver, et al., 1983). When dietary sodium was elevated or
restricted, urinary calcium responded similarly (King, et al.). As urinary sodium
approached zero, urinary calcium also converged towards zero (Goulding). When
calcium intake was held constant, and sodium intake was increased, urinary calcium
increased (Breslau, et al.). On an unrestricted calcium intake and sodium intake at two
levels, urinary calcium showed significant increases with higher urinary sodium output,
more so than with dietary sodium levels (Silver, et al.).

88

Nordin and Need (1994) plotted the urinary calcium:urinary sodium clearance
ratio as a function of sodium intake in premenopausal women and found a “L” shape
inverse relationship. As dietary sodium increased, urinary sodium excretion increased
and the uCaiuNa ratio declined, despite increased uCa. A relatively low Ca: Na intake
ratio (i.e., a higher Na intake) suggests there will be increased urinary sodium and
concomitant increased calcium excretion. A relatively low uCa:uNa ratio is associated
with higher sodium intakes (Nordin and Need). This may suggest a potential for negative
calcium balance and bone loss.

3. Urinary Creatinine
Creatine, synthesized in the kidneys, liver, and pancreas, is transported to muscles
and the brain where it is phosphorylated to phosphocreatine, a potential source of cellular
energy. Some free creatine in muscle is converted daily to creatinine and the amount of
creatinine produced is proportional to muscle mass. Creatinine is then excreted without
further metabolism. In the absence of renal disease, the excretion rate of creatinine in an
individual is relatively constant. It is this expected daily constancy that makes creatinine
useful to standardize other urinary metabolites.
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CHAPTER 3
METHODS

A. Research Design
This was a cross-sectional study with a non-random, non-experimental
retrospective design of three groups of Caucasian premenopausal women who have
maintained their present Vegan(Xl), Lactoovovegetarian(X2), or Control-Omnivore(X3)
diets for at least 4 years. The diet was the independent variable. The dependent variables
of bone formation were urinary osteocalcin (uOC—01,02,03), serum osteocalcin
(sOC—04,05,06), skeletal alkaline phosphatase (sALP—07,08,09), and Procollagen
Type I C-terminal Propeptide (PICP—010,011,012). The dependent variables of bone
resorption are urinary deoxypyridinoline (Dpy—013,014,015), urinary pyridinoline
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(Pyr—016,017,018), N-terminal Telopeptide (NTx—019,020,021). Urinary calcium
(uCa—022,023,024) and urinary sodium (uNa—025,026,027) were also assayed as
dependent markers of calcium loss. All urinary variables were adjusted by creatinine
(Cre).
Additionally, the biomarkers were correlated with each other, with bone mineral
density in all 50 women and in the women by diet groups, and with dietary factors in all
50 women and in the women by diet groups.

B. Research Hypotheses
By the study design, there will be no statistically significant differences in the
characteristics of vegans, lactoovovegetarians and omnivorous premenopausal Caucasian
females, other than diet. Characteristics include age, height, weight, body mass index
(BMI), and 24-hour creatinine excretion.

1. Vegans will have:
a. increased bone resorption biomarkers (urinary N-terminal telopeptides,
pyridinoline and deoxypyridinoline crosslinks, and urinary calcium and sodium
excretions) compared to both lactoovovegetarians and omnivores.
b. increased bone formation biomarkers (serum and urinary osteocalcin, skeletal
alkaline phosphatase, and procollagen type I C-terminal propeptide levels)
compared to both lactoovovegetarians and omnivores.
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2. Lactoovovegetarians will have lower mean concentrations of biomarkers of bone
resorption and bone formation compared to omnivores and vegans

3. Concentrations or activities of biochemical markers of bone turnover will correlate
with bone mineral density.

4. Concentrations or activities of biochemical markers of bone turnover will correlate
with dietary intakes of calcium, phosphorus, and calcium ratios with protein,
phosphorus.

C. Study Participants
Sixty premenopausal Caucasian women (20 vegans, 20 lactoovovegetarians, 20
omnivores) were recruited for the study from the San Bemardino-Riverside areas through
posted advertisements at the Loma Linda University (LLU) School of Public Health,
LLU Medical Center, LLU Center for Health Promotion, Mentone and Norwalk SDA
Churches, non-SDA churches, and local markets. The women were screened with
respect to age, height, weight, body mass index, physical activity level, socioeconomic
status, past medical history, and overall dietary habits.
The following selection criteria were employed: women were Caucasian, were
between ages 20-42 years, had BMI < 30 kg/m2, did not engage in aerobic exercise >5
hours/week or participate in upper-body resistance exercise programs, had regular
menstrual cycles, had not missed more than one menses in the last twelve months and had
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no symptoms of menopause, had no previous history of kyphosis, fractures, chronic
illness or any abnormality that was associated with metabolic bone disease, had not been
pregnant or lactating in the last 12 months, were not taking any drug known to affect
bone metabolism, including oral contraceptives and calcium supplements, and had
maintained consistent dietary habits for the past four or more years. Women with
hysterectomy or unilateral oophorectomy qualified; women with bilateral oophorectomy
did not.

1. Operating Definitions
a. Vegans: Women who ingested no milk, dairy products or any other
animal foods for at least four years. Calcium supplements were not taken more than once
per month..
b. Lactoovovegetarians (XOVk

Women who consumed milk, other

dairy products and eggs regularly, but did not use meat (beef, chicken, and fish) more
than ten ounces per week.
c. Omnivores: Women who had no dietary restrictions and consumed
more than ten ounces of meat per week.

D. Study Protocol
After giving informed consent, the women completed a 24 hour dietary recall, a
food frequency questionnaire and a 3 day diet record, provided a 24 hour urine collection,
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gave a small blood sample, and underwent a quantitative computed tomography (QCT)
bone scan.
Women were excluded if they were unable to provide the required specimens,
dietary information, or bone scan, or failed to meet selection criteria. The resulting study
population was composed of 17 vegans, 17 lactoovovegetarians, and 16 omnivores. This
research on biochemical markers of bone metabolism was an extension of a study
comparing bone mineral density among the three groups of women.

E. Consent and Data Collection
The study objectives, power analysis and protocol for subject recruitment and
specimen collection were approved by the Institutional Review Board for Human
Subjects (IRB) at Loma Linda University in 1993. Subjects were recruited in 1996-1997.
Biochemical assays were conducted in 1997-1998.

1. Dietary Intake
A 24-hour dietary recall was administered by a trained nutritionist and a three-day
food record was completed by subjects. Data was analyzed by The Food Processor
software (ESHA Research, Salem, Oregon, 1999) at the School of Public Health, Loma
Linda University. Mean daily intakes of energy, protein, calcium, sodium, phosphorus,
caffeine and alcohol were determined.
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Additional questions from a food frequency questionnaire elicited information on
past calcium and dairy intakes during adolescence and adulthood. Also, if a subject
stopped drinking milk earlier in life, the age at which this occurred was recorded.

2. Health History Questionnaires
Health history questionnaires were used to obtain information on menstrual
history, pregnancies, live births, lactation history, use of estrogens and various drugs, use
of nutrient supplements, cigarette smoking, alcohol consumption, caffeine use, exercise
habits, chronic diseases, and family history of fractures.

3. Blood
A small amount of blood was collected in red-top tubes (no anticoagulants) the
morning subjects completed the urine collection. The blood was processed and the sera
was frozen at -70°F. The frozen sera were thawed, and aliquoted into 0.5 and 1 ml vials
for analysis of serum Osteocalcin (sOC), skeletal Alkaline Phosphatase (sALP), and
Procollagen type I C-terminal Propeptide (PICP). All sera were analyzed at the VA Bone
Mineral Metabolism Lab, Loma Linda, California. Appropriate precautions were taken
to assure consistency and reliability of results for all biochemical assays.

4. Urine
The subjects were instructed on the careful collection of a 24 hour urine collection
in containers without preservatives or acid. The refrigerated urine was brought to Loma
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Linda the morning the collection was completed. Individual collections were weighed,
refracted to determine specific gravity and total volume measured in milliliters. Aliquots
were frozen at -70°F.
Fifteen of the first 35 urine samples were acidified to pH levels <3 (3 V, 5LOV,
70MV). None of the remaining samples had preservatives added. Repeated analyses of
NTx, an assay sensitive to low pH, indicated the lower pH of these urine samples did not
invalidate the results. Results of all analyses were within the full linear reportable range.
Analyses of uOC, NTx, Pyr, Dpy, uCa and creatinine were conducted at the VA Bone
Mineral metabolism Lab, Loma Linda, California. Urinary sodium was analyzed in the
Nutritional Assessment lab at the School of Public Health, Loma Linda University.

5. Creatinine
Creatinine was used to normalize the values of urinary osteocalcin, NTx,
pyridinoline, deoxypyridinoline, and urinary calcium. Most methods for assaying
creatinine are based on the yellow/orange color Jaffe reaction. The metabolite reacts
with picric acid in an alkaline solution and the intensity of the color change is
proportional to the concentration of the metabolite. Unfortunately, there are a number of
interfering substances in urine that may also react with alkaline picrate and produce color.
Slot (1965) improved the specificity of the method by noting that under acid conditions
the creatinine color faded faster than the color of interfering chromogens, resulting in a
measure of interference. Hence, the current method determines creatinine concentration
as the color intensity derived before and after creatinine color is destroyed at acid pH.
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SIGMA Diagnostics (Sigma-Aldrich Corp., St. Louis, Missouri) creatinine
reagents (kit 555-A) were used for the quantitative, colorimetric determination of
creatinine in urine. A validated method adapted for microplate analyses by the Mineral
Metabolism Lab of the Jerry L. Pettis VA Medical Center, Loma Linda, California was
followed. The assay was performed in a 96-well plate and read on the Tecan (Research
Triangle Park, North Carolina) SLT Plate Reader at 492 nm. Results (mg/dL) were used
to calculate total creatinine excretion per day.
The linear reportable range for creatinine excretion is 0.25—10.0 mg/dL. The lab
reference range is 700—2000 mg/24hr. SIGMA reference range for women is 900-1600
mg/24hror7.9—14.1 mmol/24hr.

6. Serum Osteocalcin (sOC):
Serum levels of OC were measured by CIS US ELSA OSTEO (CIS bio
international, Paris, France; kit 3F1201077), a solid-phase sandwich immuno-radiometric assay (IRMA). Two monoclonal antibodies prepared sterically against remote
sites of amino acids 5-13 and 25-37 are used in this immunoassay. The anti-OC25-37 is
coated on the tubes (solid-phase) and the anti-OC5-13 is the I 125 -tracer. Osteocalcin
molecules present in the standards or the sample are sandwiched between the two
antibodies. Excess unbound tracer is easily removed during the washing step and the
tubes retain only the adsorbed antibody/antigen/tracer antibody combination. The
amount of radioactivity bound to the tube is proportional to the amount of osteocalcin
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present in the sample. A Beckman 5500 gamma counter (Beckman Coulter, Inc.,
Fullerton, California) was used to measure the radioactivity .
OC in serum stored at -70°C is stable and a newly thawed aliquot of serum was
used for this assay. A standard curve was constructed from kit standards of human
osteocalcin, and in-lab serum controls of pooled high, medium and low values were run
at the front of each assay. All samples were run in duplicate and agreed with <10%
coefficient of variability (CV). The linear reportable range of sOC is 2.9-270.0 ng/ml.
The expected reference range on premenopausal women, ages 19-47, is 20.1 ng/ml ±5.0
(range 13.0-30.0).

7. Urinary Osteocalcin (uOC)
Urine samples were pretreated using Baker (Mallinckrodt Baker, Inc.,
Phillipsburg, New Jersey) 10 SPE cl8 columns to desalt and remove substances that
interfere with the radioimmunoassay (RIA) for human OC. The OC was eluted from the
columns, dried, redissolved, and assayed using the midmolecule human OC RIA
developed in the Mineral Metabolism Laboratory at the JL Pettis VA Medical Center
(Taylor, et al., 1990).

8. Skeletal Alkaline Phosphatase (sALP)
Alkaline phosphatase (ALP) activity in serum is primarily derived from a mixture
of liver- and bone-specific isozymes. The assay used in this study is based on the
premise that the liver isozyme is more heat stable than the bone isozyme. Heating one
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aliquot of samples, standards and controls before assaying for ALP activity determines
the amount of ALP from the liver which is insensitive to heat. A second aliquot is
assayed without heating and represents total ALP activity. The difference between the
two activities is the skeletal component. The substrate for the enzyme is p-nitro-phenylphosphate. ALP cleaves off the phosphate molecule, liberating p-nitrophenol, which
absorbs at 405nm. The sALP assay is performed in a 96-well plate and read on the Tecan
(Research Triangle Park, NC) SLT Plate Reader (VA Bone Metabolism Lab).
ALP is stable at -70°C and to freeze/thawing at least 3 times. A standard grid
was constructed from a standard extract of bone cells and a standard of nearly 100% liver
isozyme. All samples, heated and not-heated were run in triplicate and results agreed
within 10% CV. In healthy adults, the reference range for sALP is 0-19.4 U/L (U/L =
pmol/min/L).

9. Procollagen Type I Carboxyterminal Propeptide (PICP)
The INCSTAR (Stillwater, Minnesota) Procollagen (PICP)

RJA (kit 35100)

assay is an equilibrium radioimmunoassay. Samples are incubated with I 125 PICP tracer
and rabbit-antihuman PICP polyclonal antibody for 2 hours at 37°C. A pre-precipitated
second antibody complex is added to separate bound from free tracer and incubated for
30 minutes. The resulting pellet is counted with a gamma counter. Counts are inversely
proportional to the amount of PICP present in each sample. A Beckman (Fullerton, CA.)
5500 gamma counter was used in this study.
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Serum aliquots, stable at -70°C, were thawed for analysis. A standard curve was
constructed from PICP kit standards, run in duplicate, and results agreed within 10% CV.
Kit controls in the middle and high part of the standard curve were also run while an inhouse control in the low end of the curve was pooled from lab serum samples. The linear
reportable range is 15.0-400.0 ng/ml. The laboratory’s reference range for
premenopausal women, ages 19-47 years is 136.7 ng/ml + 48.7 (range 39.3—234.1
ng/ml).

10. Urinary Crosslinked N-terminal Telopeptides of Type I Collagen (NTx)
The Osteomark (OSTEX International, Inc., Seattle, Washington) NTx assay (kit
9006) measures the crosslinked N-telopeptides of type I collagen present in human urine.
The assay is a competitive enzyme-linked immunosorbent assay (ELISA), which utilizes
a horseradish peroxidase labeled monoclonal antibody directed against the NTx present
in urine. The solid phase is the microwell plate onto which NTx has been adsorbed. NTx
in the specimen, control or standard competes with the solid phase NTx for antibody
binding sites. The resulting amount of antibody bound to the solid phase is indirectly
proportional to the amount of NTx in the specimen, which is determined from a standard
curve. Assay values are standardized to an equivalent amount of bone collagen and are
expressed in nmol bone collagen equivalents (nM BCE) per liter.
The NTx antigen is stable and shows no loss of immunoreactivity after short-term
storage at 4°C, long term storage at -20°C or multiple freeze/thaw cycles. NTx shows
little of the diurnal variation characteristic of the pyridinolines measured by the HPLC
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assay. Acid pH inactiviates the horseradish peroxidase used in this method and it is
important that acidified samples not be run in this assay. The pH of urine samples was
tested before the first NTx run. There were concerns about the fifteen samples that had
been acidified to

pH < 3. The NTx results of the acidified samples appeared to be

within the linear reportable range with both high and low NTx values implying that the
horseradish peroxidase labeled monoclonal antibody was not inactivated in these
samples. Re-running urine samples, this time diluted to decrease the effect of the acid,
resulted in adjusted values very similar to the first run and further attempts to neutralize
the samples prior to running were not done.
The linear reportable range is 22—3000 nM BCE while the reference range is
18.5—84.5 nM BCE / mM creatinine or 0—176.7 nM BCE/24 hours.

11. Pyridinoline (Pyr) and Deoxypyridinoline (Dpy) Crosslinks
The total Pyr and Dpy in urine were analyzed by high pressure liquid
chromotography (HPLC). In this method the crosslinks are first hydrolyzed by 6N HC1
acid to free bound proteins. Then they are partially purified and concentrated in a
reversed phase Cl8 column and eluted with a gradient of heptafluorobutyric acid, an ion
pairing reagent, and acetonitrile. Quantitations on HPLC are detected as fluorescent
peaks. The excitation wavelength is 295 nm and emission wavelength is 395 nm.
Acetylated-Pyr is added as an internal standard and the method is quantitated using an
external standard curve of Pyr and Dpy in known concentrations.
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Pyr and Dpy are light sensitive and the assay is foil-protected from light during
the thawing of urine, sample preparation, hydrolysis and extraction. Analysis was
conducted at the VA's Mineral Metabolism Laboratories in Loma Linda, California. The
equipment included a Beckman (Beckman Coulter, Inc., Fullerton, California) 126 HPLC
autosampler, analog interface module, programmable solvent module, and fluorescence
detector capable of excitation X=295 nm and emission X=395 nm. The linear reportable
ranges are: Pyr 30-300 (peak area of highest standard) peak area units and Dpy 5-100
peak area units. The HPLC printout provided peak area units, which were computerconverted to ng/ml.
Results are reported as nmol/mmol creatinine (Cre) or as nmol/24 hours. The
creatinine conversion is as follows:
nmol Pyr / mmol Cre

= Pyr ng/ml x 26.34 / Cre mg/dL

nmol Dpy / mmol Cre

= Dpy ng/ml x 27.36 / Cre mg/dL

The lab reference ranges for premenopausal women are:
Pyr

29.3 - 57.3

nmol/mmol creatinine

Dpy

4.9-14.9

nmol/mmol creatinine

12. Urinary Calcium (uCa):
The assay for urinary calcium is based on the direct combination of orthocresolphthalein complexone (OCPC) with calcium to form a stable colored reaction
product, which is then measured in a spectrophotometer at 550 nm. The procedure is
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based on the micromethod of Sarker and Chauhan (kit insert, SIGMA, St. Louis,
Missouri).
Calcium is first disassociated from proteins with 6N HC1 acid to a pH< 3,
followed by its direct reaction with OCPC. In an alkaline medium, the Ca—OCPC
complex forms a purple color, the absorbance of which is proportional to the calcium
concentration. Magnesium interference is blocked when 8-hydroxyquinoline is added
and heavy metal interference is controlled by potassium cyanide.
The urinary calcium analysis was conducted at the VA in Loma Linda, California.
Reagents used included Stanbio Total Calcium Color Reagent and Base Reagent (Fisher
Scientific, Tustin, California, catalog # SB-0150-250) and Calcium/Phosphorus
Combined Standards (SIGMA (St. Louis, Missouri) catalog # 360-11). The Tecan
(Research Park Triangle, NC) SLT Spectra Plate Reader recorded the triplicate results of
the 96-well plates.
The linear reportable range is 2.5-15.0 mg/dL. The reporting format is mg/24hr
or mg/g creatinine. The expected reference range is 50—250 mg/24hr.

13. Urinary Sodium (uNa)
Urinary sodium was determined by Dr. Ella Haddad’s laboratory in the
Department of Nutrition at Loma Linda University, using a Varian AA475 Atomic
Spectrophotometer (Springvale, Australia). The expected reference range, based on the
mean sodium excretion from the Intersalt studies, is 3800 ± 1750 mg or 2050—5550
mg/day.
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14. Quantitative Computed Tomography (QCT) Bone Scan
Bone density was evaluated by QCT of the lumbar spine. This densitometric
technique selectively measured the trabecular compartment of the vertebra. QCT has
been reported to discriminate between normal and osteoporotic bone better than dual
energy radiography (Pacifici, Rupich, & Avioli, 1990). All subjects after submitting their
24 hour urine collection and providing a fasting blood specimen underwent a QCT bone
scan at the Loma Linda Community Hospital. Crude BMD (mg/cc) and percent of the
expected BMD for age (% exp. BMD) were reported. Technical assistance on these
parameters was provided by Eloy Schultz, M.D., Loma Linda Community Hospital.

F. Data Analysis
SPSS version 9.0 for Windows (SPSS Inc., 1998) and Power and Precision for
Statistical Power Analysis and Confidence Intervals (Biostat, 1997) softwares were used
in data analysis. Descriptive analysis was used to detect outliers and extreme values.
Reference values were compared to determine the clinical validity of the values obtained
by biochemical means. Kolmogorov-Smimov and Shapiro-Wilk tests were applied to
raw and transformed data to determine normality of continuous data distribution.
Levene’s test of homogeneity was used to test the assumption that the data for each
variable came from diet groups with the same variance. Departures from normality
reflected skewed distributions. Transformations of the data were made when this
occurred. The Spread-versus-Level Plot tool was used to construct a suggested power
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transformation for the data. Ultimately, log transformations proved sufficient to
normalize variables.
One-way analysis of variance (ANOVA) was applied to each biomarker,
anthropometric and dietary variable to evaluate differences among women on vegan,
LOV and omnivorous diets. Independent t-tests were subsequently run on those variables
identified by the ANOVA analysis as having significant differences to identify which diet
groups were different. Bivariate correlations were run on groups of variables—resorption
biomarkers alone, formation biomarkers alone, resorption biomarkers with formation
biomarkers, and all markers with anthropometric, BMD, and dietary components. BMD
and significant dietary components were stratified into diet groups (vegan, LOV,
omnivore) and correlations were sought between the biomarkers and BMD and dietary
factors stratified by diet. Tables summarizing significant associations were constructed
for each set of correlations. We treated diet as the independent variable and the
biomarker variables as dependent variables, looking at the effect of diet on bone turnover.
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CHAPTER 4
RESULTS

A. Subject Characteristics
The subjects were a relatively homogeneous group of premenopausal Caucasian
women. Table 5 displays their age, anthropometric measurements and bone mineral
density by diet groups. There were no statistically significant differences among groups
for age, height, weight and body mass index (BMI).

1. Age
There was no significant difference in age of the women in the three diet groups;
however, the vegan group tended to be slightly older than the LOVs and omnivores. The
50 women were between ages 20-42 years with a mean age of 32.6 years.
Levene’s test for homogeneity showed no significant differences, however, the
Shapiro-Wilk and Kollmogorov-Smimov’s Lilliefors tests found the vegan group did not
meet the test for normality. An outlier, one vegan subject aged 20, was identified but
retained because the subject met the inclusion criteria.

2. Height, Weight, and Body Mass Index (BMI)
There were no significant differences in mean height or weight among the groups,
but omnivores were slightly heavier and vegans were the lightest (Table 5). BMI did not
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Table 5.
Age, Anthropometric Measurements, and Bone Mineral Density (Mean, SEM)*

Age (years)

Height (m)

Vegan
n=17

Lacto ovo vegetarian
n=17

Omnivore
n=16

34.76
(1.44)

31.82
(1.39)

31.25
(1.73)

1.65

1.65

1.66

(0.02)

(0.02)

(0.02)

Weight (kg)

58.21
(2.57)

60.46
(1.88)

63.68
(2.25)

BMI (kg/m2)

21.18
(0.84)

22.39
(0.71)

23.25
(0.87)

Crude BMD (mg/cc) f

151 (4.9)**

187 (6.9)

171 (7.6)

% Expected BMDf

88 (2.75)**

108 (3.86)

99 (4.82)

*

No significant differences were found among the groups for age, height,
weight, and BMI

** vegans < lacto ovo vegetarians, p<0.01
f

BMD data provided by P. Johnston, Loma Linda University
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differ among the three diet groups. The mean BMI for all subjects was 22.3 kg/m and
o

ranged from 17 to 30 kg/m .

3. Bone Mineral Density
Mean BMD was significantly lower in vegans compared to LOVs (p<0.01)
measured both as crude BMD (mg/cc) and as percent of the expected BMD for age.
Although the differences were not significant, mean BMD in omnivores tended to be
greater than vegans and less than LOVS. The mean BMD in the omnivores was at the
level expected within the general population (99% of 100% expected), while that in the
LOVs was greater (108%) and in the vegans was lower (88%).

B. Dietary Patterns
Vegans and LOVs participating in this study were required to have maintained
their diets for a minimum of four years. Table 6 shows the length of time vegans and
LOVs had consumed their diets. The seventeen vegans in this study had maintained their
diets for a mean of 12.9 years, with a range from 4 to 34 years. Thirteen of the vegans
had previously followed a lactoovovegetarian diet for a mean of 14.7 years. One-third of
the vegans had been a vegetarian (vegan and LOV) for more than 30 years, two-thirds for
20 years or more.
The seventeen LOVs in this study maintained their diets a mean of 23.7 years,
with a range of 5 to 40 years. Twelve of these women had maintained this diet for more
than 20 years and eight of these were lifelong lactoovovegetarians.
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Table 6. Summary of the Number of Years Subjects Consumed Vegan and
Vegetarian Diets
VEGAN subjects
Yrs
Yrs
Total years as
vegan
LOV
vegetarian*
>4 to 10 yrs

4
4
5

11

15

30

34

31

36
9

6
6

18

7
7

17

8
10

28

3

2

LOV subjects

5

24
7
24

10
38

11 to 20 yrs

8
11

14
14
14

14
6
9

20
23

15
19
20
20
20

12
20

20
32
40

21 to 30 yrs

22
24
24

26

4

30

25
25
25
26
27

31 to 40 yrs

33
34

34

35
38
40

YEARS, mean
(SEM)

n=17
12.88
(2.09)

n=13
14.69
(2.85)

n=17
24.12
(2.59)

* Yrs Vegan + Yrs LOV = Total years as Vegetarian
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n=17
23.65
(2.40)

C. Nutrient Intake
1. Calorie and Protein Intakes
Table 7 shows there were no significant differences among the three groups in
energy intake (kcals), kcals per kilogram body weight, protein, or protein per kilogram
body weight. Mean caloric intake for all women was 1715 kc/day and 28.7 kc/kg body
weight. According to the Recommended Dietary Allowances (RDA, 1989), adult women
undertaking light to moderate activity, will need approximately 2200 kc or 36-38 kc/kg
body weight. The three groups of women had mean calorie intakes 18-27% lower than
the RDA. Vegans had a higher calorie per body weight ratio than LOVs and omnivores
although the difference was not significant. While weight did not differ among vegans,
LOVs, and omnivores, vegans reported a higher but non-significant level of daily
exercise than LOVs or omnivores (data not reported here).
Mean protein intake for all women was 55.8 g/d and 0.93 g/kg body weight. The
RDA recommends a protein intake of 46-50 grams per day or 0.8 g/kg body weight, but
the groups’ mean protein intakes ranged 4-26% greater than recommended values.

110

Table 7.
Dietary Characteristics (Mean/Day, SD)
Vegan
n=17

LOV
n=17

Energy (kc)

1737
(360)

1617
(366)

1795
(676)

2200

Kcals per kg
body weight (kc/kg)

30.6
(8.2)

27.1
(6.8)

28.4
(10.8)

36-381’2

Protein (g)

52.2

52.4

501

(12.6)

(11.4)

63.2
(21.0)

Protein per kg
body weight (g/kg)

0.92
(0.29)

0.88

0.8 i

(0.23)

0.99
(0.31)

Calcium (mg)

461 * t
(163)

727
(200)

772

10003

Ca-to-Protein
ratio

8.99 * f
(2.8)

13.6

12.3

(3.7)

(2.7)

Phosphorus (mg)

982
(312)

997
(290)

1150
(446)

0.51 * f
(0.22)

0.74
(0.24)

0.69
(0.16)

Ca-to-Phosphorus
ratio

Omnivore
n=16

Reference
values

i

(299)
203

7003

1.44

* vegans < lacto ovo vegetarians, p<0.05
t vegans < omnivores, p< 0.05
1 based on 1989 RDA for females
2
based on 1989 RDA for adult females >24yrs and for young females 19-24 yrs
3 based on 1997 DRI for adults
4 calculations based on 1997 DRI values
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2. Calcium and Phosphorus Intakes
Total calcium intake (Table 9) was significantly lower in vegans than in either
LOVs or omnivores (p <0.01). LOVs and omnivores had mean intakes within 30% of the
1997 DRI of 1000 mg calcium for adult women; however, mean calcium intake in vegans
was 54% less than the DRI.
The mean phosphorus intake of all women was 1041 mg/day. Phosphorus intakes
of all three groups exceeded the DRI of 700 mg/day, ranging from 40% to 64% greater.
Omnivores had the highest phosphorus intake compared to the other two groups;
nevertheless, there were no significant differences among the groups in phosphorus
intake.

3. Nutrient Ratios
There were significantly lower ratios of CaiProtein and Ca:P in vegans compared
to LOVs or omnivores (p<0.01). Using the 1989 RDA, the suggested Ca:Protein ratio
would approach 16, or using the 1997 DRI for calcium, the Ca:Protein ratio would be 20.
No group of women met the DRI or the RDA recommended CaiProtein ratios. Vegans
had a CaiProtein ratio one-third lower than LOVs and vegans met only 45% of the ratio
of 20 based on current DRI. The Ca:P calculated from the 1997 DRIs would be 1.4. The
Ca:P ratio of vegans was only 36% of this level and the lowest of the three groups of
women. LOVs had the highest CaiProtein and CaiP ratios of the three groups, but in both
ratios, LOVs met only 68% and 53%, respectively, of the recommended levels.
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D. Biomarkers of Bone Turnover
All urinary biomarkers were adjusted by creatinine to normalize for differences in
body size. There were no significant differences among the groups in mean 24-hour
creatinine excretion (Table 8). Although the individual group means were lower than the
expected 900-1700 mg/d (SIGMA Diagnostic Kit insert), they were well within the
ranges of normal excretion for normal healthy adult women (VA Labs).

1. Bone Resorption
There were no statistically significant differences among vegan, LOV and
omnivore groups in mean values of urinary biomarkers of bone resorption (Table 9).
Additionally, urinary calcium excretion, a biomarker for potential increased calcium loss,
was lowest in LOVs compared to vegans and omnivores (81.6, 92.6, 96.4 mg/d,
respectively). All mean values were within the reference range of 50-250 mg/day
Deoxypyridinoline and pyridinoline crosslinks of type I collagen, biomarkers for
bone resorption, were lowest in LOVs and highest in vegans, measured both as total per
day and adjusted by urinary creatinine. The differences, however, were not significant
(Table 9). N-Telopeptides of type I collagen are another byproduct of bone degradation
but showed very little difference among the diet groups (Table 9).
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Table 8.
Urinary Creatinine (Mean, SD)*

Vegan
n=17

Creatinine
(mg/day)

Lacto ovo vegetarian
n=17

Omnivore
n=16

744

665

724

(248)

(345)

(387)

* No significant differences among groups
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Table 9.
Urinary Biomarkers of Bone Resorption (Mean, SD)*

Vegan
n=17

LOV
n=17

Omnivore
n=16

Deoxypyridinoline
(pg/day)

32.5

24.7

(17.1)

(16.7)

28.8
(21.0)

Dpy/creatinine
(nM/mM ere)

12.2
(5.9)

9.9
(4.9)

(4.0)

Pyridinoline
(pg/day)

130
(47)

109
(62)

127
(71)

Pyr/creatinine
(nM/mM ere)

47

43

(11)

46
(9)

29.3-57.3

(12)

N-Telopeptides
(nM BCE/day)

342

318

335

0-1767

(197)

(323)

(175)

NTx/creatinine
(nM BCE/mM ere)

52

55
(20)

55
(20)

(21)

10.5

Reference
values i

4.9-14.9

18.5-84.5

* No significant differences were found among groups
1 Reference Values are those provided with the assay protocol unless otherwise
stated
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2. Bone Formation and Bone Turnover
The mean serum osteocalcin (sOC) values were highest in vegans and lowest in
LOVs, however they were within the expected range for premenopausal women ages 1947 years (VA reference). Nonetheless, the mean value for the vegans was at the upper
limit of normal and it was significantly higher compared to LOVs (p=0.05) (Table 10).
In vegans mean urinary osteocalcin (uOC) adjusted by creatinine, a biomarker for
bone turnover, exceeded the normal reference range and was also higher compared to
LOVs, although the difference was not significant (p=0.112). Again, the difference in
mean uOC/day was greatest between vegans and LOVs but only approached significance
(p=0.078). There were no differences between the mean uOC of omnivores and vegans
or between omnivores and LOVs.
Mean skeletal alkaline phosphatase (sALP) values followed a similar pattern with
highest values in vegans and lowest in LOVs with all values within the expected 0-19.4
U/L range for premenopausal women ages 19-47 years (VA reference). Differences were
not significant.
Mean serum procollagen type I carboxyterminal propeptide (PICP) values were
higher in vegans compared to LOVs and omnivores but not significantly so, and were
also within the expected range. Compared to LOVs and omnivores, vegans had the
highest levels of all indicators of bone formation activity, although not all differences
were significant.
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Table 10.
Serum and Urinary Biomarkers of Bone Formation (Mean, SD)

Vegan
n=17

LOV
n=17

Omnivore
n=16

Serum osteocalcin
(ng/ml)

30.6*

24.5

13-30ng/ml i

(10.2)

(6.8)

26.8
(13.2)

uOC/creatinine
(Hg/gm)

192

157

(70)

(53)

181
(71)

89.9-183.1
ng/mg i

Urinary osteocalcin
(Hg/day)

147
(82)

103
(56)

123
(64)

Skeletal alkaline
phosphatase (U/L)

12.3
(7.8)

9.5
(3.6)

11.4
(2.7)

0-19.4 U/L i

PICP
(ng/ml)

146
(46)

133
(46)

130
(36)

39.3-234.1
ng/ml i

* vegans > lacto-ovo vegetarians, (p=0.05)
i

VA reference ranges for premenopausal women
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Reference
values

3. Mean of Biomarkers for Diet Groups as Percent of the Mean ofAll Subjects
Analysis of variance did not show significant differences among diet groups in
any biomarker except serum osteocalcin, however, the means of all biomarkers by diet
groups showed an increased level of bone resorption and turnover in vegans and a
reduced level of bone activity in LOVs (Figures 3 and 4). Vegans had means of
resorption and turnover biomarkers (NTx, Pyr, Dpy, uOC, sOC, sALP, and PICP) that
were 3-18% above the means of those biomarkers in all 50 subjects, while LOVs had
mean values 4-17% below the means of all 50 subjects. Omnivores had means of
resorption and turnover biomarkers within 0-4% of the means of all subjects.
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Figure 3. Mean + SEM of Resorption Biomarkers
by Diet Group Compared to the Mean of All Subjects
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Figure 4. Mean + SEM of Turnover and Formation Biomarkers
by Diet Group Compared to the Mean of All Subjects
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4. Biomarker by Quartiles of BMD
Data from all 50 women were combined to evaluate the biomarkers compared
with the highest (n=12) and lowest quartiles (n=12) of bone mineral density. Resorption
biomarkers NTx, Pyr and Dpy were significantly higher in those in the lowest quartile of
BMD (Table 11). Deoxypyridinoline, adjusted for creatinine, was also higher in those
women in the lowest quartile of BMD compared to those in the highest quartile, with the
difference approaching significance (p=0.06).
Likewise, there were significant differences in uOC, a biomarker of bone
turnover, whether looking at total daily excretion or when adjusted by creatinine (Table
12). Serum osteocalcin, a formation biomarker, was also higher in those in the lowest
quartile of BMD, with the difference approaching significance (p=0.079).

5. BMD Differences by Quartiles of Biomarkers
BMD was evaluated at the highest and lowest quartiles of each biomarker (Tables
13 and 14). Differences in mean BMD approached significance in subjects in the highest
and lowest quartiles of NTx and Dpy per day, indicators of bone resorption (Table 13).
Mean BMD in subjects with the highest and lowest quartiles of urinary osteocalcin was
significantly different whereas the differences approached significance in those with the
highest and lowest serum osteocalcin (Table 14).

121

Table 11.
Biomarkers of Resorption in Subjects in the Top and Bottom Quartiles of BMD
(Mean, SD)
Biomarker value
Top quartile of BMD
n=12

Bottom quartile of BMD
n=12

p value

Deoxypyridinoline
(pg/day)

19.03
(11.58)

37.12
(16.91)

0.006

Dpy/creatinine
(nM/mM ere)

9.55
(4.48)

14.14
(6.57)

0.060

Pyridinoline
(pg/day)

88.22
(46.94)

136.94
(45.17)

0.017

Pyr/creatinine
(nM/mM ere)

42.45

0.157

(9.63)

49.59
(13.79)

N-Telopeptides
(nM BCE/day)

240.90
(106.58)

425.57

0.018

(218.20)

NTx/creatinine
(nM BCE/mM ere)

52.57
(19.52)

65.85
(27.23)
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0.185

Table 12.
Biomarkers of Formation in Subjects in the Top and Bottom Quartiles of BMD
(Mean, SD)

Biomarker value
Top quartile BMD
n=12

Bottom quartile of BMD
n=12
p value

Serum osteocalcin
(ng/ml)

23.34

32.65
(15.78)

0.079

(6.52)

Urinary osteocalcin
(pg/day)

87.86
(44.92)

170.03
(71.82)

0.003

uOC/creatinine
(pg/gm)

163.13
(46.00)

229.78
(84.00)

0.027

Skeletal alkaline
phosphatase (U/L)

9.30

13.75
(8.16)

0.104

(3.35)

PICP
(ng/ml)

154.67
(41.05)

0.710

(47.35)

147.86
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Table 13.
BMD in Subjects in the Top and Bottom Quartiles of Resorption Biomarkers
(Mean, SD)

Top quartile
of biomarker
n=12

BMD (mg/cc)
Bottom quartile
of biomarker
n=12

p value

Biomarker:
Deoxypyridinoline
(ng/day)

158.50
(35.59)

185.83
(27.85)

0.052

Dpy/creatinine
(nM/mM ere)

161.58
(32.60)

183.92
(28.20)

0.087

Pyridinoline
(ng/day)

162.42
(37.39)

185.00
(22.37)

0.090

Pyr/creatinine
(nM/mM ere)

161.58
(23.84)

177.42

0.146

(27.43)

N-Telopeptides
(nM BCE/day)

157.08
(27.50)

178.17
(22.23)

0.051

NTx/creatinine
(nM BCE/mM ere)

161.83

172.25
(37.88)

0.466

(30.42)
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Table 14.
BMD in Subjects in the Top and Bottom Quartiles of Formation Biomarkers
(Mean, SD)

Top quartile
of biomarker
n=12

BMD
Bottom quartile
of biomarker
n=12

p value

Biomarker:
Serum osteocalcin
(ng/ml)

154.50
(29.81)

179.33
(32.08)

0.062

Urinary osteocalcin
(pg/day)

150.75
(26.56)

177.83
(23.20)

0.014

uOC/creatinine
(pg/gm)

161.83

178.00
(32.18)

0.241

(33.54)

Skeletal alkaline
phosphatase (U/L)

157.33
(24.84)

177.25
(41.54)

0.171

PICP
(ng/ml)

180.75

177.67
(32.77)

0.814

(30.54)
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6.

Biomarkers by Quartiles ofAge

Activity of most biomarkers was significantly lower between ages 27-33 years
(2nd quartile), compared to ages 20-26 years (1st quartile of age). These included
resorption biomarkers Pyr and Dpy as total per day, and Pyr, Dpy and NTx adjusted by
creatinine (Table 15). Similarly, formation biomarkers sOC, uOC, uOC/creatinine, and
sALP were significantly lower in the 2nd quartile of age.
h contrast to the 2nd quartile, turnover and resorption biomarkers showed
increased activity in the 3rd quartile, with Dpy, Dpy/cre, Pyr, Pyr/cre, NTx, and uOC at
significantly higher levels. No significant difference was seen in any biomarker between
the 3rd and 4th (39-42yr) quartiles of age. Most biomarkers remained higher in the 4th
quartile than in the 2nd quartile, with Pyr/cre and Dpy/cre significantly so (p=0.002,
p=0.054).
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Table 15.
Biomarkers in Subjects by Quartiles of Age (Mean, SD)
Age by quartiles
n=
Resorption biomarkers:
Deoxypyridinoline
(pg/day)

12

34-38
14

39-42
11

16.6
(11.8)

35.2 b
(16.2)

31.1
(25.96)

20-26 yrs
13

27-33

30.7

(13.4)

Dpy/creatinine
(nM/mM ere)

(4.3)

7.4
(3.4)

12.4b
(6.1)

10.5 d
3.97

Pyridinolinne
(Hg/day)

130.0
(49.5)

80.2
(41.2)

148.1 b
(62.4)

124.5
(67.4)

Pyr/creatinine
(nM/mM ere)

50.7
(10.5)

36.0
(7.6)

48.8 b
(11.6)

45.0 b
(4.3)

N-Telopeptides
(nM BCE/day)

419.1
(352.3)

210.4C
(86.0)

366.0 b
(201.7)

315.2
(188.7)

NTx/creatinine
(nM BCE/mM ere)

65.99
(28.9)

42.1
(9.7)

55.3
(26.2)

48.3c
(9.7)

Formation biomarkers:
Serum ostoecalcin
(ng/ml)

32.9
(13.6)

23.23

28.1
(11.5)

24.2c

(5.9)

Urinary osteocalcin
(pg/day)

134.6
(52.6)

84.63
(46.7)

151.2 b
(85.6)

121.5
(73.2)

uOC/creatinine
(pg/gm)

206.7
(75.2)

143.93
(37.2)

189.1
(82.6)

161.7
(30.5)

Skeletal alkaline
phosphatase (U/L)

13.4
(3.7)

8.23
(2.5)

12.9 d
(7.9)

9.0
(2.1)

150.9
(37.7)

133.8
(41.4)

146.9
(53.6)

122.4c
(31.6)

PICP

(ng/ml)

12.7

3 significantly different (p < 0.05) from the first quartile of age
b significantly different (p < 0.05) from the second quartile of age
c difference approached significance (p < 0.058) from the first quartile of age
d difference approached significance (p < 0.054) from the second quartile of age
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(5.5)

E. Correlations of Bone Biomarkers
Because of the small number of subjects in the individual diet groups, all subjects
were combined to evaluate correlations among appropriate variables.

1. Inter-Correlation of Biomarkers
Bivariate correlations demonstrated that bone formation indices were significantly
correlated with each other in all subjects combined, with the exception of skeletal
alkaline phosphatase (Table 16). Skeletal ALP was significantly correlated only with
PICP. Similarly, significant correlations were found among most biomarkers of bone
resorption (Table 17).
Some biomarkers of bone resorption (Dpy/cre and Pyr/cre) were significantly and
positively correlated with biomarkers of bone formation (Tables 18). Twenty-four hour
urinary excretion of osteocalcin, an indicator of formation activity, had a highly positive
and significant correlation with daily urinary levels of NTx, pyridinoline and
deoxypyridinoline (Table 18). Values among these same biomarkers was also highly
significant when all were adjusted by creatinine.
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Table 16.
Correlations Between Biomarkers of Bone Formation in the Entire Study
Population*

sOC

sOC
n=50

uOC/d
n=50

uOC/cre
n=50

sALP
n=49

PICP
n=50

*****

0.552
(0.000)

0.753
(0.000)

0.189
(N.S.)

0.525
(0.000)

*****

0.644
(0.000)

0.018
(N.S.)

0.422

*****

0.241

0.567
(0.000)

uOC/d

uOC/cre

(N.S.)
*****

sALP

(0.001)

0.298
(0.037)
*****

PICP

* Pearson r (p value)
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Table 17.
Correlations Between Biomarkers of Bone Resorption in the Entire Study
Population*

NTx/d

NTx/cre

Pyr/d

Pyr/cre

Dpy/d

Dpy/cre

uCa/d

■k-k-k-k-k

0.710
(0.000)

0.709
(0.000)

0.295
(0.038)

0.716
(0.000)

0.350
(0.013)

0.172
(N.S.)

0.197
(N.S.)

0.546
(0.000)

0.313
(0.027)

0.531
(0.000)

-0.168
(N.S.)

kkkkk

0.354

0.920
(0.000)

0.378
(0.007)

0.446

0.428
(0.002)

0.836
(0.000)

0.018
(N.S.)

*****

0.613
(0.000)

0.420
(0.002)

*****

0.190
(N.S.)

n-50

NTx/d

NTx/cre

kk-kkk

Pyr/d

(0.012)
*****

Pyr/cre

Dpy/d
Dpy/cre

*****

uCa/d

* Pearson r

(0.001)

(p value)
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Table 18.
Correlations Between Biomarkers of Bone Resorption and Bone Formation*

Resorption
NTx/d
NTx/cre

Pyr/d

Pyr/cre

Dpy/d

Dpy/cre

uCa/d

n=50

Formation
sOC

0.303
(0.033)

0.421
(0.000)

0.207
(N.S.)

0.314
(0.027)

0.277
(0.052)

0.334

-0.284

(0.018)

(0.045)

uOC/d

0.716
(0.000)

0.390
(0.005)

0.817
(0.000)

0.356
(0.011)

0.823
(0.000)

0.412
(0.003)

0.119
(N.S.)

uOC/cre

0.355
(0.011)

0.618
(0.000)

0.221
(N.S.)

0.587
(0.000)

0.327
(0.020)

0.537
(0.000)

-0.322
(0.023)

sALP
n=49

-0.090
(N.S.)

0.137
(N.S.)

-0.010
(N.S.)

0.554
(0.000)

0.100
(N.S.)

0.580
(0.000)

0.242

PICP

0.429
(0.002)

0.587
(0.000)

0.207
(N.S.)

0.389
(0.005)

0.322
(0.022)

0.476
(0.000)

-0.114
(N.S.)

* Pearson r (p value)
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(N.S.)

2. Correlation of Biomarkers with BMD
When all subjects were combined, we found significant negative correlations
between BMD and certain biomarkers of formation and resorption. In other words, when
bone turnover activity was greater, there was lower BMD in these women. The
significant correlations were between BMD and the biomarkers urinary osteocalcin, both
total and adjusted for creatinine, total deoxypyridinoline, and total pyridinoline (Table
19).

3. Correlation of Biomarkers with Dietary Ratios
No correlation was found between bone biomarkers and dietary calcium intake in
all 50 women or by diet groups. However, the Ca:Protein ratio was significantly and
negatively correlated with certain biomarkers of both formation and resorption, uOC/day,
uOC/cre, Dpy/day, Dpy/cre, and Pyr/day (Table 20) in the entire group.
The Ca:Phosphorus ratio was also significantly and negatively correlated with
certain formation and resorption biomarkers. As Ca:P ratio rose, urinary OC, Pyr, and
Dpy, all adjusted by creatinine, decreased.
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Table 19.
Significant Correlations Between Selected Bone Biomarkers and BMD *

BMP
All subjects
N=50

Formation:

Resorption:

uOC/day

-0.402
(0.004)

Dpy/day

-0.323
(0.022)

uOC/cre

-0.322
(0.023)

Pyr/day

-0.283
(0.047)

* Pearson r (p value)
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Table 20.
Significant Correlations Between Bone Biomarkers and Dietary Calcium *

All subjects
n=50

CaiProtein ratio

Ca:P ratio

uOC/day

-0.327
(0.021)

uOC/cre

-0.364
(0.009)

uOC/cre

-0.313
(0.027)

Dpy/cre

-0.356
(0.011)

Dpy/day

-0.293
(0.039)

Pyr/cre

-0.398

Dpy/cre

-0.305
(0.031)

Pyr/day

-0.288

(0.004)

(0.043)

* Pearson r (p value)
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CHAPTER 5
DISCUSSION

As vegetarian diets have become more popular and are maintained for many
years, even lifelong, concerns have arisen that some may not be wholly adequate for
health. Published reports have supported vegetarian diets as adequate in nutrients except
for some more limited in food choices; possibly they may be inadequate in energy,
protein, calcium, vitamins D and B12, and iron (Finch, et al., 1992; Outila, et al., 2000).
One study supported a long term LOV diet, compared to an omnivorous diet, as
potentially beneficial in promoting a greater BMD in post menopausal women (Marsh, et
al., 1980), but most studies have found a LOV diet no different than an omnivorous diet
as a factor in osteoporosis (Tesar, et al., 1992; Reed, et al., 1994; Lloyd, et al., 1991;
Hunt, et al., 1989; Tylavsky & Anderson, 1988). Another study found postmenopausal
women and two studies found premenopausal women on a LOV diet, compared to a
vegan diet, had less osteopenia (Chiu, et al., 1997; Outila, et al., 2000; Johnston, 1999)
but others did not (Barr, et al., 1998; Lau, et al., 1998).
When this dissertation study was proposed in 1995, only Marsh, et al. (1988) had
previously studied bone status in vegans as a subgroup of vegetarians. However, it was
not possible to determine differences in BMD between LOVs and vegans because the
vegan subgroup was too small. The question was raised whether vegans consuming a
diet without dairy products and their abundant calcium content would be at greater risk
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for early bone loss. Finch, et al. (1992) reported "increasing severity of bone disease was
associated with increasingly strict vegetarian practice." A strict vegetarian diet was
associated with rickets in children and bone demineralization in lactating women and
osteomalacia (Specker, 1994; Finch, et al.). What has become clear in subsequent
published studies is that vegans with lower BMD than omnivores (Outila, et al., 2000;
Johnston, 1999; Barr, et al., 1998; Lau, et al., 1998; Chiu, et al., 1997), and very low
calcium intake may be at greater risk for osteopenia.
A question remained whether biomarkers of bone turnover predicted this
reduction in BMD. However, a review of literature did not yield any published
biomarker studies on vegetarians. An unpublished dissertation by Johnston (1987) who
studied vegetarians in California reported that BMC was significantly lower in both
postmenopausal vegetarians and omnivores with high plasma osteocalcin levels, an
indicator of increased bone turnover. Vegetarians had significantly greater osteocalcin
levels compared to women consuming an omnivorous diet, however there were no
differences in BMD between the two groups. Whether the suggested higher rate of bone
turnover was a result of increased bone resorption and coupled stimulation to rebuild the
bone could not be determined. A higher rate of bone turnover when accompanied by an
imbalance between resorption and formation may result in an earlier onset of
osteoporosis.
Our research question was whether biomarkers of bone turnover—of bone
resorption and bone formation—found in serum and urine were associated with the

136

differences in bone status previously found in premenopausal vegans, LOVs, and
omnivores.

A. Subject Similarities and Differences
The women recruited for this study were carefully selected so that the groups of
premenopausal vegans, LOVs and omnivores were comparable except for their diets. The
vegetarian diet must have been maintained for four or more years, so that any
biochemical and bone change would more likely be evident. Vegans maintained their
diet for a mean 12.9 years (range 4-34 years). LOVs maintained their diet for a mean
23.7 years (range 5-40 years). Although two published reports from Asia studied long
term vegans (>15 years) the women were postmenopausal (ages, 70-89 and 40-87). Only
two studies on the bone status of premenopausal vegans have been published (Outila, et
al., 2000; Barr, et al., 1998). In Finland, Outila, et al. studied 5 vegans and 6 LOVs who
maintained their diet 2-16 years. In Canada, Barr, et al. studied 5 vegans and 6 LOVs
who maintained their diet 2-15 years. To date our study on bone status involves the
largest number of premenopausal vegans (17) and LOVs (17) and is the first to report
biomarkers in these vegetarian women.
Caucasian women have a higher risk for osteoporosis than other ethnicities and
were selected as subjects for this study. The subjects were carefully screened and could
not have used bone-affecting hormones or drugs, including supplements, or engaged in
excessive exercise. They were within + 20% ideal body weight (IBW). The women
were recruited from the Inland Empire in southern California, where the climate is sunny
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most of the year and unlike vegetarians in Finland (Outila, et al., 2000), would not likely
be low in serum vitamin D. Fifty premenopausal women, 17 vegans, 17 LOVs, and 16
omnivores, met the selection criteria.
The three groups of women in this study were comparable in mean age, height,
weight, and body mass index. Dietary components that were comparable included
energy, calories per kg body weight, protein, protein per kg body weight, and phosphorus
intakes. Daily urinary creatinine used to adjust urinary biomarkers did not differ among
the groups. Urinary calcium excretion, an indicator of acute changes in dietary calcium
(Akesson, et al., 1998) did not differ among groups.

B. Biomarkers and Age
The biomarker results suggest the possibility of a ‘U’ shaped effect of bone
activity with age, particularly in women < 26 years and > 34 years of age having higher
biomarker levels. Young women in their early 20s may still be in the process of attaining
peak bone mass and may have higher bone turnover and formation activities, and older
women may have more rapid bone activity where both biomarkers of turnover and
resorption are elevated due to declining estrogen. Previous studies suggest that the most
rapid bone growth occurs in the adolescent years with peak bone mass reached in the
twenty’s, that bone loss occurs slowly, if at all, during the premenopausal years, and that
bone loss occurs more rapidly during the postmenopausal years (Cohn, et al., 1981;
Nordin, et al., 1990; Nilas, et al., 1988; Riggs, et al., 1986; Aloia, Cohn, et al., 1985;
Recker, et al., 1992). Rapid bone growth and loss is associated with elevated biomarker
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activities, particularly biomarkers of resorption and turnover. Our biomarker and age
findings support previous studies on bone changes in women in their early 20s. There
were no significant differences in BMD between the lowest and highest quartiles of age
(range 20-42y), however, the increased resorption and turnover biomarker activities in
women ages 34-42 years may predict the “age-related linear bone loss” that occurs after
age 45yrs (Pouilles, et al., 1994; Ribot, et al., 1988).
Biomarkers by quartiles of age showed subjects in the 1st quartile, between ages
20-26 years, had higher activities of both formation and resorption markers, compared to
subjects 27-33 years of age (2nd quartile). In the third quartile of age biomarkers
associated with bone formation, were not significantly different, while uOC, a biomarker
of turnover, and Dpy, Pyr, and NTx biomarkers of resorption were significantly greater
than levels in the second quartile. Resorption activities appear to be dynamic with
significantly lower levels in the 2nd quartile and significantly greater levels in the 3rd
quartile. Elevated resorption with no change in formation activity may predict future
BMD loss. Biomarker levels in the fourth quartile were not significantly different from
any in the third quartile, and generally, as in the third quartile, they were greater than in
the second quartile.

C. Biomarkers by Diet Groups
Of the various biomarkers measured for bone formation and turnover, the only
significant difference among the diet groups was found in serum osteocalcin with the
vegans showing a significantly higher level of bone turnover activity compared to the
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LOVs. Similarly, vegans had greater uOC/d and uOC/cre values than LOVs, although
differences were not significant (p=0.078, p=0.112, respectively).
No significant differences were found among the three groups in any biomarker of
bone resorption, nevertheless, the values for the vegans were consistently greater than the
overall mean, while those of the LOV were consistently below and those of the
omnivores approximated the overall mean.
To date there have been no published reports on biomarkers of bone metabolism
in vegetarian women. Johnston’s unpublished dissertation and subsequent abstract (1987,
1987) reported on postmenopausal vegetarians whereas we studied premenopausal
women. Johnston’s population of 145 LOVs had significantly greater plasma OC and
sALP than the 146 omnivores, apparently indicating a higher rate of bone turnover.
Although BMD did not differ between the diet groups, those women with the lowest
BMD had the highest OC levels.
In our study, premenopausal LOVs had lower uOC and sALP compared to
omnivores and had sOC values significantly lower than vegans. Thus the LOVs had an
apparently lower rate of bone turnover compared to vegans and omnivores. Similar to
Johnston’s earlier study (1987), women in the lowest quartile of BMD had higher sOC.
Women in the lowest quartile of BMD also had significantly higher uOC. Other than the
difference in pre- or post-menopausal status, the diets and other lifestyle practices were
very similar between LOVs and omnivores in the two studies, with the exception that
many of the postmenopausal women used calcium supplements, whereas our subjects did
not. The supplement use was significantly greater in the omnivores and resulted in a
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significantly greater mean daily calcium intake approximating 1300mg for omnivores
compared to 1 lOOmg for LOVs. The postmenopausal LOVs had significantly higher
levels of sOC and sALP than the comparable omnivores, whereas the premenopausal
LOVs in the present study had lower levels of sOC, uOC, and sALP than the omnivores.
The differences were not significant and there was no difference in calcium intake
between the LOVs and omnivores. There may be other factors influencing biomarker
levels in postmenopausal women that are not present in premenopausal women. Kung, et
al. (1998), Weaver (1998), and Heaney, et al. (1999) discussed inefficiency of the bone
remodeling process, decreased ability to adapt to changes in dietary calcium intake, and
decreased absorption of 1,25 (OH)2 vitamin D in postmenopausal women, all of which
may affect bone status.
A tendency toward an inverse relationship between plasma osteocalcin and
dietary calcium intake was demonstrated for the first time in postmenopausal women by
Johnston (1987). Although premenopausal women showed no significant relationship
between biomarkers and dietary calcium, a significant negative association was seen
between uOC and Ca:Protein and Ca:P ratios.
Vegans had significantly lower BMD, significantly greater serum and urinary
osteocalcin, and non-significant but consistently greater levels of all other turnover and
resorption biomarkers compared to LOVs. The LOV diet appeared to benefit
premenopausal women as the BMD of LOVs was significantly greater than the BMD of
vegans and tended to be greater than omnivores and all biomarker levels were the lowest
compared to vegans and omnivores (Figures 2 and 3).
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An increased turnover and resorptive rate without accompanying increased
formation would suggest increased bone loss, particularly if accompanied by a calcium
poor diet. In a calcium depletion study by Akesson, et al. (1998) Dpy and sOC,
indicators of resorption and turnover, respectively, were significantly increased, while
PICP, an indicator of formation, was reduced. This seemingly contradictory effect on
bone during calcium depletion was explained from past histomorphometric studies in
rodents as a depletion-associated increased resorption (Dpy) and increased number of
mature but inactive osteoblasts, (represented by sOC), while bone formation (PICP) was
inhibited. In our study, subjects were not purposely calcium-depleted, however, vegans
consumed a very low calcium diet and it is suggested by the pattern in Figure 2 that
vegans had increased resorption (Pyr, Dpy, NTx) and increased turnover activity (sOC,
uOC) where inactive osteoblasts increased, but levels of formation (sALP, PICP) were
not increased to the same extent.
Vegans had biomarker levels about 10% above the mean of all subjects, compared
to LOVs who had biomarker levels about 11% below the mean of all subjects, and to
omnivores whose biomarker levels approximated the mean of all subjects (Figure 2).
Examination of vegans with the highest biomarker levels for resorption and turnover
compared to vegans with the lowest biomarker levels, found no difference in the length
of time they maintained their vegan diet (4-26 years versus 4-34 years). The age when
the subjects adopted the vegan diet, calcium intake and Ca:Protein and Ca:P ratios did
differ, however. Seven vegans adopted their diet between ages 0-21 years, prior to
reaching expected peak bone mass, and their current biomarker levels were generally
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lower, their BMD significantly higher, and Ca intake, Ca:Protein and Ca:P ratios higher
than the ten vegans who adopted their vegan diet between ages 23-34 years. Those who
became vegans at an older age had the highest turnover and resorption biomarker levels,
lowest BMD, and had 33%, 11%, and 23% lower Ca, Ca:Protein and Ca:P than those
who became vegans at an earlier age. Subjects adopting the vegan diet early in life may
have maintained a higher calcium intake with higher Ca:Protein and Ca:P ratios through
the peak BMD years. Vegans adopting their diet later in life may have adopted a more
extreme diet with a very low calcium intake. Despite these differences between vegans
with high and low biomarker levels, vegans had higher mean biomarker levels and lower
BMD than LOVs and omnivores. Dietary differences, particularly calcium intake, must
be considered influential factors.

D. Biomarkers and BMD
Biomarkers of resorption and turnover, Dpy, Pyr, NTx and uOC were
significantly higher at the lowest quartile of BMD compared to the highest (Tables 1314). Studies have shown that bone resorption biomarkers are significantly increased in
osteoporotic patients compared to control women (Guerrero, et al., 1996; de la Piedra, et
al., 1997), and that Dpy and NTx presented the best discrimination between these two
groups of women (de la Piedra, et al.; Souberbielle, et al., 1999).
Inter-correlations of the formation and turnover biomarkers with each other were
all significant except for sALP, which only correlated with PICP (Table 18) and inter
correlations of resorption biomarkers were all significant with each other (Table 19).
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Resorption biomarkers were positively and significantly associated with formation and
turnover biomarkers (Table 20). Elevations of biochemical markers of both resorption
and formation are diagnostically accurate in detecting bone loss and may predict, albeit
imperfectly, the rate of bone loss (Souberbielle, et al., 1999). In our study, elevated
resorption biomarkers, Dpy and Pry, and turnover biomarker, uOC, were significantly
and negatively associated with BMD. That is, as both formation and resorption activities
decreased, BMD increased in these women. Thus, the healthy premenopausal women in
this study with significantly higher levels of both resorption and turnover biomarkers and
lower BMDs appear to be at greater risk for osteoporosis.
Healthy premenopausal women consuming a LOV diet appeared to have a lower
risk for low BMD, while vegans consuming a diet comparable in protein but significantly
lower in calcium appeared to have a greater risk for low BMD. Shapses, et al. (1995)
determined in a short-term dietary trial that Pyr and Dpy excretions did not vary with
high and low protein intakes but they were significantly lower by about 33% during the
period of high calcium compared to low calcium intake. Women consuming lower
calcium, as with vegans in this study, are at greater risk for increased levels of bone
biomarkers and lower BMD.
Analysis of variance (Table 15) showed that BMD was significantly lower at the
highest quartile of resorption biomarkers Dpy and NTx. Vegans comprised one-third to
half of the subjects in the quartile with the highest resorption activity, whereas, LOVs
comprised nearly two-thirds of the subjects in the quartile with the lowest resorption
activity.
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BMD in the highest quartile of uOC, an indicator of turnover, was significantly
less than BMD in the lowest quartile (Table 16). The difference in BMD by sOC levels
approached significance. The principal diet consumed by subjects in the quartile with the
lowest bone turnover was LOV; while vegans comprised nearly two-thirds of the subjects
in the quartile with the highest bone turnover.

E. Biomarkers and Dietary Characteristics
1. Calorie and Protein Intakes
As observed in previous studies, there was no statistically significant difference in
the caloric intakes of LOV and omnivore women in our study, whether calculated as
calories per day or calories adjusted for weight. Vegans, also did not differ in caloric
intake per day from LOVs and omnivores.
In a review of nutritional assessments of vegetarian diets Hunt (1994) indicated
that vegetarian diets were usually lower in total protein than non-vegetarian diets. The
women in our study had a wide range of protein intake and the mean protein of the three
groups of women did not differ significantly. All three groups had a mean protein intake
(52-62g/d) meeting 104-126% of the current DRI recommendations. Adjusting protein
intake by body weight, the mean values were above the recommended dietary level of 0.8
gm protein/kg body weight (NRC, 1989).
ferstetter and Allen (1994) stated when protein intake was higher than 75g/day
and calcium intake less than 600 mg/day, negative calcium balance would occur. A later
study by Kerstetter, et al., (1999) indicated that a medium protein (<150 g/d) intake

145

induced no change in mineral homeostasis, intestinal calcium absorption, urinary
calcium, or bone turnover rates. However, at high protein (>150 g/d) intakes compared
to low protein intakes (<50 g/d), bone turnover rates measured by N-telopeptide (NTx)
excretion, serum osteocalcin and skeletal alkaline phosphatase showed significant
resorption.
The subjects in our study consumed low to moderate levels of protein. Only six
of the 50 subjects had protein intakes above 75gm/day (range 79—94gm/day). Of these,
five were omnivores and one was LOV (79gm). Further, these subjects had calcium
intakes ranging from 866—1421 mg/d. We found no significant associations between
protein intake and urinary calcium or any biomarker of bone formation or bone resorption
in all subjects in this study.

2. Calcium Intake
It was suggested that vegetarian diets are likely to be low in calcium when dairy
foods are excluded (Hunt, 1994). Some found no significant differences between LOVs
and omnivores in calcium intake (Hunt, et al., 1989; Tylavski & Anderson, 1988).
However, Janelle and Barr (1995) reported that vegans had low calcium intake compared
to LOVs and omnivores. Our study on premenopausal vegetarians found that calcium
intake in LOVs was not different from that in omnivores. In contrast, vegans, consuming
no dairy products, had significantly lower calcium intakes compared to both LOVs and
omnivores (p=0.002). However, calcium intake alone was not significantly correlated
with any biomarker in all 50 subjects or in subjects by diet group.
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Weaver and Plawecki (1994) reported that it is difficult without dairy foods,
fortified foods, or supplements in a Western-style diet to obtain sufficient amounts of
absorbable dietary calcium to protect bones and lower the risk of osteoporosis. The
World Health Organization (WHO) recommends 400-500 mg/day in cereal-based diets
with few milk products and little other animal protein, an amount much lower than that
recommended in the United States (1000 mg/day). Haddad's preliminary data
(unpublished data) on vegans in Weimar, California found 50% of young females on
vegan diets had calcium intakes <40% of their age-specific DRI or less than 400mg. In
our study the LOVs and omnivores had mean calcium intakes of 727 and 772 mg/day,
respectively, while vegans had a mean intake of 461 mg/day. All 17 vegans were below
the DRI. Nearly half of vegans (n=7) in this study consumed <400mg/d. Since vegans
in this study had a mean age of 34.8 years and had maintained the vegan diet for a mean
of 12.9 years, it is likely that a habitually low calcium diet had been consumed prior to
and during the early adult years, before peak bone mass had been reached. There is
concern that such a low calcium diet in the adolescent and premenopausal years will
result in lower peak bone mass and increased risk for osteoporosis later in life.

3. Ca:Protein Ratio
Heaney (1998) suggested that the effect of protein and calcium intakes on the
skeleton is associated with the apparent opposite effect of the nutrients themselves and
that a Ca:Protein ratio may be a more sensitive predictor of a diet that has adverse effects
on calcium balance than intake of either nutrient alone. Heaney (1998) proposed that a
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Ca:Protein ratio less than the suggested 20 may be a useful predictor of the diet’s effect
on bone homeostasis. All three diet groups in our study had Ca:Protein ratios below 20,
however, vegans had a significantly lower ratio than LOVs or omnivores. The
Ca:Protein ratio was the best predictor of BMD in these subjects (Johnston, 1999).
Biomarkers of turnover (uOC and uOC/cre) and resorption (Dpy, Dpy/cre, Pyr)
were significantly and negatively correlated with the Ca:Protein ratio in all 50 women
(Table 22). When analyzed by diet groups, only uOC and Dpy in omnivores were
significantly and negatively correlated with Ca:Protein ratio. When Ca:Protein ratio is
low, turnover and resorption activities are increased. A low ratio occurs when there is an
imbalance in the intake of either nutrient relative to the recommended amount. In the
vegan subjects the low ratio was due to the very low intake of calcium while protein was
at the recommended level.

4. Gi:P Ratio
ffegsted, et al. (1981) reported that as protein intake increased, phosphorus from
meats and dairy foods blunted, but did not eliminate urinary calcium losses. Kerstetter
and Allen (1994) concluded that phosphorus intakes above 1500 versus phosphorus
intakes between 1000 and 1500 mg/day while protein intake was held at 150 g/day,
reduced urinary calcium loss. No difference in calcium excretion was observed when
protein was below 150 g/day and phosphorus intakes were high. However, Heaney and
Recker (1982) found that a higher phosphorus intake increased fecal calcium loss while
urinary calcium loss was decreased, resulting in no net impact in calcium balance.
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Mirsh, et al. (1988) found in their study of 10 LOVs and 10 omnivores that there
were no significant differences in calcium and phosphorus intakes between the two
groups. However, LOVs had a slightly higher calcium intake and omnivores had a
slightly higher phosphorus intake, resulting in a highly significant difference in the Ca:P
ratios.
/II three groups of women in this study had dietary phosphorus levels above the
current recommended 700mg/d while calcium intakes were below the recommended
intake. LOVs had the Ca:P ratio that most closely approached the DRI’s ratio of 1.4,
followed by omnivores, and then the vegans. Ca:P ratios were significantly different
between vegans and LOVs and between vegans and omnivores. Calcium intakes were
>70% DRI for LOVs, however vegans consumed only 46% of the recommended levels.
h all 50 subjects, the Ca:P ratio was significantly and negatively correlated with
biomarkers of turnover (uOC/cre) and resorption (Pyr/cre and Dpy/cre). Where Ca:P
ratio was low, turnover and resorption activities were elevated. Among diet groups, only
Pyr/cre was negatively and significantly associated with the Ca:P ratio in vegans.

F. Limitations
1. Post Hoc Power Analysis
Using deoxypyridinoline and pyridinoline for resorption and osteocalcin for
formation, post hoc power analysis was performed by the Power and Precision (Biostat,
1997) software. Based on Casagrade and Pike computation (Fisher approximation) the
alpha was set at 0.05 for two-tailed analysis. Power was set at 0.80; that is, 80% of
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studies would be expected to yield a significant effect, rejecting the null hypothesis that
two population proportions are equal. The effect is "the smallest effect that would be
important to detect, in the sense that any smaller effect would not be of clinical or
substantive significance. It is also assumed that this effect size is reasonable, in the sense
that an effect of this magnitude could be anticipated in this field of research" (Power and
Precision). Should the current effect be real and moderate to large, the necessary sample
size to find additional significant results would be in diet groups almost 50% to 300%
bigger than were recruited for this study. The original study proposed 20 subjects for
each diet group. Several subjects had to be eliminated due to incomplete collection of
data or samples. Sixteen or seventeen subjects in each diet group completed the study.
Additional significant differences may have been seen if the sample was increased to 24
to 54 subjects.

2. Healthy Subject Bias
The women recruited for this study may not be typical of young premenopausal
Caucasian women in the United States. Women in the United States generally weigh
more, and consume higher levels of protein, especially animal sources. Many women
also take supplements. The selection criteria excluded women who took supplements and
this limited the number of qualified subjects. It takes more conscientious planning to
follow a vegetarian lifestyle without relying on supplements to fill in missing or low
levels of nutrients. Many of the women who volunteered were lifelong vegetarians,
indicating years of discipline in adhering to their diet. Many women, both vegetarian and
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non-vegetarian, never smoked and never drank alcohol. It is possible that the differences
in BMD, diet, and biomarkers may be greater with a control group that was more
typically “American.”

3. Cross-Sectional Studies
Cross-sectional studies are limited in their ability to show whether highest levels
of biomarkers in premenopausal women will lead to osteopenia and eventually, will
result in osteoporotic fractures as they age. There have been few prospective studies.
Marsh, et al. (1988) and Reed, et al. (1994) reported 10-yr and 5-yr BMD studies of
postmenopausal women and Barr, et al. (1998) reported a 1-year followup study on
premenopausal women. None of these three studies reported biomarker levels.

4. Diet, Weight, Exercise, and Menstrual History
Peak bone mass is reached during adolescence and the early twenties in young
women. All the factors that contribute to bone density starting from pre-adolescence
need to be addressed in the same women studied for bone biomarkers and BMD. The age
of menarche needs to be reported as studies have indicated that delayed menarche is
associated with lower BMD at the spine in women (Elliott, et al., 1990; Ribot, Pouilles,
Bonneau, & Tremollieres, 1992). History of calcium, protein, and phosphorus intakes,
vitamin D levels, exercise, and body weight during adolescence also contribute to
building peak bone mass and need to be reviewed. Of the three studies on premenopausal
vegetarian women, Barr, et al. (1998) attempted to address the influence of the menstrual
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cycle and current diet to bone mineralization.

The other studies did not report

associations with BMD in the women studied.

5. Vitamin D, PTH, and Growth Hormone
PTH was not evaluated to rule out vitamin D-related bone changes. We assumed
that premenopausal women recruited from the Inland Empire, where it is sunny and hot
most of the year, would have adequate sun exposure and sun-stimulated vitamin D levels.
Outila, et al. (2000) found premenopausal vegans in Finland had vitamin D levels and
BMD that was lower but not significantly so, compared with LOVs.

6. lean Body Mass
Giteria for this study included being within 20% of IBW and not exercising
excessively. The relatively narrow range, thus precluded examining these in relation to
biomarkers or BMD. Neither lean body mass (LBM) or body fat (BF) was measured.
Aloia, McGowan, et al. (1991) concluded that a reduction in muscle mass leads to the
loss of skeletal mass but that adiposity was not protective against osteoporosis. Reed, et
al. (1994) in a 5-year prospective study on elderly white females reported LOVs and
omnivores had similar BMD loss rates, however, greater BMD loss was associated with a
greater loss of lean body mass. This BMD loss was found to be independent of calcium
intake. Whole body scans for LBM and fat body mass (FBM) showed LBM had a
dominant effect on spinal bone mass in premenopausal women while both LBM and
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FBM predicted hip bone mineral content in postmenopausal women (Khosla, et al.,
1996).
Ibrbes, Virgili and other researchers have shown that urinary creatinine can be a
predictor of lean body mass in adults (Forbes & Bruining, 1976; Virgili, et al., 1994). It
has long been established that 24-hr creatinine excretion has little day-to-day variation
and can be used to adjust for the completeness of urinary specimens. Baseline or
multiple values may be taken in intervention or prospective studies to monitor changes in
renal function or in body mass, however, in cross-sectional studies with healthy subjects,
a urine collection within normal volume and specific gravity ranges usually yields
creatinine within the normal range. Creatinine excretion is most consistent for those on
meat-free diets; exogenous sources of preformed creatinine are found in meats and fish.
Nevertheless, prediction formulas of lean body mass are based on omnivore populations.
Mean 24-hour urinary creatinine values for the female subjects in this study were slightly
less than the expected range of 900 to 1600 mg/day (SIGMA Kit insert). No significant
difference in mean urinary creatinine was found among the three groups of women. It
can be suggested that vegans had comparable leanness and there were no significant
differences in lean body mass among the diet groups.
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CHAPTER 6
SUMMARY AND CONCLUSIONS

A. Vegetarianism and Bone Health
1. Prevalence and Types of Vegetarianism
Traditionally, vegetarian diets were consumed for religious, philosophical,
ecological, or health reasons. In the last two decades ecological and environmental
concerns, media and sports celebrities, and the influx of vegetarian Asian and AsianIndian immigrants have rapidly expanded the popularity of the vegetarian cuisine and
lifestyle in the United States, especially among the young. The scientific community has
also increasingly embraced vegetarianism as research has demonstrated its health benefits
in lowering the incidence of chronic degenerative diseases such as atherosclerosis,
obesity-related diabetes and some cancers (Fraser, 1988; Position of the ADA, 1993).
Traditional vegetarian groups such as the Seventh-day Adventists (SDA) have been
frequently cited for their lower incidence of these diseases.

2. Concerns of the Vegetarian Diet Related to Bone Status
Although the loss of bone density is a multi-factored process, it is well accepted
that dietary inadequacies can affect bone formation and accelerate bone resorption. An
omnivorous or mixed diet should provide a variety of foods, including milk and dairy
foods, which provide high levels of calcium and vitamin D. Lactovegetarians typically
have removed animal meats from their diets and have sought to replace animal proteins
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with increased dairy and plant proteins. This change appears to be compatible with bone
health. The LOV diet is thought to benefit bones by increasing dietary calcium and
vitamin D while lowering animal proteins and phosphorus compared to the usual
American dietary levels. A deletion of all animal foods, including milk and dairy
products, results in a vegan diet that some believe may affect bone density negatively.
However, this potential effect has not been extensively studied.
Only six BMD studies have been reported where vegans were evaluated
separately from LOVs. Marsh, et al., 1988, found the vegan subgroup too small to
evaluate. Chiu, et al., 1997, and Lau, et al., 1998, studied elderly Chinese and Taiwanese
women. One study found vegans did not differ in BMD from LOVs, while the other
study found longterm vegans to be at greater risk for osteopenia at the spine and femur.
Of the most recent three studies, all involving premenopausal Caucasian women, Outila,
et al., 2000, in Finland and Barr, et al., 1998, in Canada each had only 5 vegans in their
studies. They both found a non-significant, but lower BMD in vegans, compared to
LOVs and omnivores. The 17 subjects in this study comprised the largest investigation
of premenopausal vegans reported to date. No previous study on vegans has reported
biomarkers, BMD and diet together.

B. Biomarkers, BMD, and Diet Among Premenopausal Vegan, LOV, and
Omnivore Women
This study investigated biomarkers of bone activity in 50 healthy young
Caucasian women, ages 20-42, with normal BMI, consuming vegan, LOV, and omnivore
diets, and whose BMD was previously reported by Johnston (1997, 1999). The vegans
155

had maintained their diet longer than premenopausal vegans in other studies and had a
significantly lower mean BMD than LOVs.

1. In All 50 Subjects
•

Biomarkers of both resorption and turnover were significantly and negatively
correlated with BMD, that is, the highest activities of turnover and resorption
were associated with the lowest BMD.

•

Biomarkers in the bottom quartile of BMD were significantly elevated, compared
to the top quartile of BMD.

•

Subjects in the top quartile of biomarkers had significantly lower BMD than those
subjects in the bottom quartile of biomarkers.

•

There were no significant differences in biomarkers, BMD, BMI, and dietary
factors at the top compared to the bottom quartile of age, however, biomarkers
indicated dynamic changes between the 1st (20-26yr) and 2nd (27-33yr), 2nd and
3rd (34-3 8yr), and 2nd and 4th (39-42yr) quartiles of age.

•

Biomarkers of both resorption and formation were significantly lower in 2nd
quartile, compared to the 1st quartile of age.

•

Resorption biomarkers were significantly elevated in the 3rd quartile, compared to
the 2nd of age.

The results lead to the following conclusions. Higher levels of biomarkers in the
1st quartile appear to be indicative of a continuing high level of bone metabolism,
consistent with previous studies that found bone density increased into the third decade of
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age. In contrast, the significant lower levels in both formation and resorption biomarkers
in the 2nd quartile suggest a period of low bone turnover and of bone stability.
The significantly greater activity of resorption but not formation biomarkers in the
3 rd quartile may predict the beginning of changes leading to an imbalance in bone
metabolism and future osteopenia. Fourth quartile activities continued the pattern seen in
the 3rd quartile.

2. In Vegans, LOVs, and Omnivores
Serum OC, a marker of bone turnover in adults, was significantly higher in
vegans than in LOVs. Higher turnover is consistent with the significantly lower BMD
found in vegans compared with LOVs. Resorption biomarkers did not differ among
vegans, LOVs, and omnivores, however, vegans consistently had mean biomarker values
above the mean of all 50 women, while LOVs consistently had values below the mean
and omnivores approximated the mean. Post hoc power analyses suggested group sizes of
24 to 54 would be needed to detect substantive significance in biomarkers, however, no
previous study has reported biomarker activities in premenopausal women consuming a
vegan diet and this was the largest group of premenopausal vegan women studied to date.
Vegans, LOVs and omnivores in this study were comparable in physical and most
dietary characteristics. Dietary components that differed and defined the differences
between vegans and LOVs and between vegans and omnivores included animal versus
plant protein sources, Ca intake, and Ca:Protein and Ca:P ratios. Vegans were
significantly lower in Ca, Ca:Protein, and Ca:P than LOVs and omnivores, and met less
than half the recommended levels. Seven of 17 vegans were below 90% expected BMD
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and had mean Ca and Ca:Protein and Ca:P ratios of 37%, 41%, and 29% of
recommended levels. Ca:Protein and Ca:P ratios were significantly and negatively
correlated with selected biomarkers in the entire group of subjects. Higher resorption and
turnover were seen where these ratios were lower, as in vegans.
The increased risk among vegans for increased biomarker activity and osteopenia
do not appear to be associated with increasing age or the number of years a vegan diet
had been maintained. It was observed that most vegans with higher BMD adopted the
vegan diet early in life (0-21 years of age), during the period of life when bone growth is
most rapid and peak BMD is established. The vegans whose BMDs were lowest adopted
the vegan diet between 23-34 years of age, after the period of most rapid bone
metabolism and growth. In some ways this seems contradictory. However, it may be
that persons who adopted the vegan lifestyle early conscientiously sought sources of
information and markets of vegan foods, and made careful selection of Ca-rich foods and
had adequate but not excessive intakes of protein and phosphorus. These nutrients
appeared to contribute to beneficial biomarker activity levels and improved BMD.
Adopting a vegan diet in early adulthood may negatively affect BMD, especially if the
diet during the formative years was inadequate in calcium, CaiProtein and Ca:P ratios; or
if the adoption of the vegan lifestyle was accompanied by an extreme diet very low in
calcium. Future studies should include detailed retrospective records of dietary habits to
determine whether or not this observation is correct.
Increased biomarkers of turnover and resorption may be early predictors of future
BMD loss, especially in premenopausal women with low CaiProtein and low Ca:P ratios.
This study found vegans were at risk. This may have been because they consumed a diet
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very low in calcium, particularly in relationship to protein and phosphorus. Such a diet
may have resulted in the significantly higher turnover rates found in the vegans compared
to the LOVs as well as the significantly lower BMD. To ensure that a vegan diet
adopted at any age does not pose a greater risk for osteopenia than other diets, early
education on good nutrition for healthy bones is important for all children through high
school when BMD is increasing most rapidly. An adequate vegan diet needs to include
acceptable calcium-rich foods.
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